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ABSTRACT 
Oocyte cryopreservation represents one of the most recent developments in the 
field of reproductive technologies. However, despite of significant progress, the 
efficiency of oocyte cryopreservation is still very low. Cryopreservation of mature 
metaphase II (MIl) oocytes has been reported to induce disorganization of the 
meiotic spindle and chromosome damage. However, cryopreservation of immature 
oocyte at germinal vesicle (GV) stage may provide an alternative which avoids 
these problems. Slow freezing protocols have more recently been replaced by 
vitrification approaches. In this thesis, recovery, viability and subsequent 
developmental potential following in vitro fertilisation (IVF), parthenogenetic 
activation or somatic cell nuclear transfer (SCNT) of ovine oocytes vitrified at GV 
stage and matured in vitro were studied. Solid surface vitrification (SSV) and 
cryoloop technologies share the advantages of using a containerless system and 
small volumes of solution (less than t J.ll) which favours rapid cooling. 
Maturation, fertilisation, cleavage and blastocyst development were significantly 
decreased in SSV vitrified oocytes as compared to controls. Following cryoloop 
vitrification, frequencies of in vitro maturation (43.4 vs 63.2%), oocytes with 
normal spindle and chromosome configuration (50.0 vs 70.4%) and fertilisation 
(54.0 vs 74. t %) did not differ significantly between vitrified and control oocytes. 
Numbers of cleaved embryos that developed to the blastocyst stage following 
IVM/IVF/IVC did not differ significantly between vitrified and control groups 
(29.4 vs 45.1 %). In vitro matured ovine oocytes vitrified at GV stage using 
cryoloop were activated by two different protocols (I) a combination of calcium 
ionophore (A 23187), cycloheximide and cytochalasin 13 (CA+CHX/CI3), (2) 
strontium and CB (Sr/Cll). No blastocysts developed in vitrified oocytes activated 
by CA+CHX/CB; however, 3.8% were obtained following Sr/CI3 activation. 
Developmental competence of ovinc oocytes vitrified at GV stage and used as 
cytoplast recipients for SCNT was evaluated. Although the frequencies of cleaved 
embryos were significantly decreased in vitrified oocytes as compared to control, 
development to morula and blastocyst stage embryos was not significantly 
different. No significant differences were observed in total cell numbers, number 
of apoptotic nuclei as detected by Hoechst and TUNEL assay and proportions of 
diploid embryos in day 7 blastocysts produced following IVF or seNT of vitrified 
oocytes as compared to control. Pre-treatment of ovine GV-oocytes with 
cytochalasin 13 (7.5 J.lglml for 60 min) or demecolcine (0.1 flg/ml for 20 min) prior 
to vitrification improved frequencies of maturation, fertilisation and subsequent 
development following IVF or parthenogenetic activation. Caffeine treatment 
during IVM (10 mM for 6 h) increased the frequencies of blastocyst development 
in vitrified/thawed GV ovine oocytes. 
Taken together, these studies suggest that, ovine oocytes vitrified at GV stage can 
be matured, fertilised and develop in vitro to blastocyst stage embryos. Cryoloop 
vitrification resulted in higher maturation, fertilisation and subsequent 
development as compared to SSV. Strontium can be used effectively for 
parthenogenetic activation of vitrified/thawed ovine GV oocytes. Ovine oocytes 
vitrified at GV stage can be used effectively as cytoplast recipients for SCNT. 
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Chapter I Literature review 
CHAPTER 1 
LITERA TURE REVIEW: 
Cryobiology 
1.1 INTRODUCTION 
Cryobiology is the branch of biology that studies the effect of low temperatures on 
living things. The word cryobiology is derived from the Greek "Cryo = Cold", 
"Bios = Life", and "logos = science". In practice, cryobiology is the study of 
biological material or systems at temperatures below physiological conditions. 
Materials or systems studied include proteins, cells, tissues, organs, or whole 
organisms. There are six major areas that can be identified in the study of 
cryobiology: I) study of cold-adaptation of microorganisms, plants, and animals, 
2) cryopreservation of cells, tissues, gametes, and embryos of animal and human 
origin, 3) storage of organs under hypothermic conditions for transplantation, 4) 
lyophilization (freeze-drying), 5) cryosurgery, and 6) physics of supercooling, ice 
nucleation/growth and mechanical engineering aspects of heat transfer during 
cooling and warming. Cryopreservation as an applied aspect of cryobiology is the 
process where cells or whole tissues are preserved by cooling to low sub-zero 
temperatures such as -196°C (the boiling point of liquid nitrogen, LN2). At these 
low temperatures, any biological activity including the biochemical reactions that 
would lead to cell death are effectively stopped. People have long believed that 
very low temperatures would only be detrimental to cells and tissues. They could 
not possibly imagine the advances in cryobiology which have been achieved and 
the possibilities that this has opened. The history of cryobiology can be traced 
back to antiquity, as early as in 2500 BC low temperatures were used in Egypt in 
medicine. The use of cold was recommended by Hippocrates to stop bleeding and 
swell ing. In the late 1600s, Henry Power froze a jar of vinegar eels in salt water 
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and after thawing, he found that they were still as active as they were prior to 
freezing. Power was the first to theorize that, cold did not have so-called "killing 
properties" that are possessed by heat (Sittig 1963). With the emergence of 
modern science in 1683, Robert Boyle wrote a monograph "New Experiments and 
Observations Touching Cold" in which he described the effects of freezing on 
living animals (Parkes 1960). Another pioneer in cryobiology, Lazzaro 
Spallanzani conducted extensive studies on tissues of several species and their 
reaction to low temperatures in late 1700s (Sittig 1963). In 1913, Maksimov 
described the beneficial effects of glycerol and non-permeable cryoprotectants 
including sucrose on plant cryostability (Maksimov 1913). In 1940, Luyet and 
Gehenio published a book entitled "Life and Death at Low Temperatures" in this 
book, they outlined the basic components for the study of cryobiology (Luyet and 
Gehenio 1940). In the late 1940s, Cristopher Polge and his colleagues at the 
University of Cambridge accidentally discovered the protective capabilities of 
glycerol when they used bottles of chemicals that had been inadvertently miss 
labelled. This accidental discovery enabled them to successfully cryopreserve 
spermatozoa of chickens and cattle (Polge et al. 1949). Therefore, a spermatozoon 
was the first reproductive cell to be cryopreserved in LN2• The discovery of the 
ability of glycerol to protect the cells against freezing damage led to the derivation 
of the science of low temperature biology. In 1951, the first calf produced by 
artificial insemination (AI) with frozen thawed spermatozoa was born (Stewart 
1951). In 1960, Peter Mazur conducted extensive experiments to model the 
response of microorganisms when subjected to low temperatures and freezing. 
These early studies resulted in the development of the discipline that is now 
known as cryobiology (Mazur 1963; 2004). The cryopreservation of reproductive 
cells and embryos embraces a science in which there is a considerable background 
of theory. Since the discovery of the protective action of glycerol (Polge et al. 
1949), a wealth of experience of freezing and thawing of a great variety of cells 
and tissues has been accumulated, not least that associated with cryostorage of 
spermatozoa and embryos. The oocyte, on the other hand, has so far largely 
evaded a satisfactory solution, presenting as it does a large cell which is highly 
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differentiated and arrested part-away through the reduction divisions of meiosis in 
which the genetic information is mixed and the chromosome complement is 
halved. Its specialization implies that the unique features peculiar to its state must 
be preserved in order to carry out its purpose. While this can also be true of 
spermatozoa, their large numbers allow less than optimal procedures to be 
acceptable. Oocytes, however, are available in strictly limited numbers; thus, 
cryopreservation protocols have to be very successful before they can become 
useful (Watson and Holt 2001). The last decades have witnessed a revival of 
interest in reproductive biology, owing in part to successful application of gamete 
and embryo culture to medical. veterinary and biotechnology practice, and in part 
to pressing needs of today's society. In medical science, assisted reproductive 
technologies (ART) have been developed primarily to alleviate sterility, while in 
agricultural sciences the growing needs of the booming world population has 
provided the impetus to improve the efficiency of livestock production (Elder and 
Dale 2000). There have been an extraordinary series of exciting developments in 
knowledge of and technology applied to animal reproduction at the gamete, 
embryo and whole animal level during the past fifty years. These developments 
include AI, freezing and sexing of sperm, superovulation, oestrus cycle regulation, 
recovery of embryos developed in vivo, embryo freezing and sexing, and embryo 
transfer. In addition, recovery of oocytes for in vitro maturation (IVM), in vitro 
fertilisation (lVF) and in vitro culture (lVC) have led to new experimental 
approaches, advancing knowledge and ability to assist with problems in 
reproduction. All of these technologies utilize sperm, oocytes andlor the product of 
fertilisation at some stage. Thus, all involve sexual reproduction which helped to 
achieve asexual reproduction in mammals by cloning (Wolf and Zelinski-Wootn 
200 I). In this chapter, I will present a brief discussion on some aspects of assisted 
reproductive technologies (ART) in both humans and animals. In addition, I will 
give a detailed overview on oocyte cryopreservation, its application and 
consequent cryoinjuries as well as different approaches involved in oocyte 
cryopreservation in different mammalian species. 
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1.2 ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) 
Infertility can be considered as an international health problem. It considers one of 
the most frequently occurring chronic health problems, affecting young and adult 
people. It is time-consuming and costly; it concerns all social classes and races. 
Infertility has high prevalence; it affects at least 10% of married or cohabiting 
women of 1 8 ~ 4 4 years (VanSteirteghem 2004). A quarter of all married or 
cohabiting women in that age range are confronted at least once in their life time 
with infertility. The infertile male and female partners represent a substantial part 
of the population in developed countries. Different aetiologies have been reported 
to induce infertility such as ovulation disorders, sperm abnormalities, tubule 
causes, idiopathic infertility and endometriosis (VanSteirteghem 2004). Over the 
past decades, several developments have increased the knowledge about 
reproductive medicine, such as developments in reproductive technologies and 
microsurgery which played a role in treatment of infertility in women and men. A 
major milestone has been in vitro fertilisation; the first baby born from IVF was 
reported in 1978 (Steptoe et af. 1980). After that, the technique was applied 
worldwide in 1980's. IVF has proved to be the treatment of choice to alleviate 
infertility associated with women causes (VanSteirteghem 2004). A similar 
solution for treating male factor infertility was the development of 
intracytoplasmic sperm injection (lCSI) (Palermo el af. 1992). Since the first birth 
in 1992, ICSI has proved to be a choice for treatment of infertility caused by male 
factor (VanSteirteghem 2004). Historically, progress in cellular and molecular 
embryology in domestic animals had been difficult due to the limited availability 
of suitable experimental materials at an acceptable cost. Gametes and embryos 
were obtained in vivo usually from superovulated donors and collected at required 
developmental stage. In addition to cost; animal welfare concerns have more and 
more limited the use of animals in such research. For these and many other reasons 
development of in vitro techniques for the production of mammalian embryos has 
received great attention in the past twenty years. In vitro embryo production (IVP) 
in mammalian species provides an excellent source of low-cost embryos for basic 
research on developmental biology and physiology as well as for commercial 
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application of the emerging technologies such as nuclear transfer and transgenesis 
(Baldassare et al. 2002). In addition, the application of IVP has been proposed as a 
strategy for the rescue of some endangered species (Ptak et al. 2002). From a 
health point of view, embryo transfer in domestic animals has the potential to 
facilitate safe worldwide movement of germplasm (Cognie et al. 2003). IVP 
technology is well established in cattle, but has limited application in other 
domestic animals (Galli and Lazzari 2003). IVP involves three main steps; oocyte 
maturation, fertilisation and culture of putative embryos for up to 7 days until 
formation of the blastocysts (Cognie et al. 2003). 
1.1.1 Oocyte maturation 
In the dominant follicles, oocytes remain arrested at the diplotene stage of the 
meiotic prophase which is comparable with the G2 phase of the cell cycle. In vivo, 
resumption of meiosis is initiated by a preovulatory Luteinizing hormone (LH) 
surge, disruption of the gap junctions between oocytes and cumulus cells occurs 
shortly after this surge. During the period between the LH surge and ovulation, the 
oocytes undergo nuclear and cytoplasmic maturation. Nuclear maturation, lasting 
for 24 h in cattle and sheep, 44 h in pigs and 36 h in horses, involves two 
consecutive meiotic divisions (M-phase) in the absence of DNA replication (S-
phase). The 15t meiotic division reduces the chromosome content of the oocyte by 
50%, the discarded DNA being extruded as the 1 st polar body (PBI). The oocyte 
then initiates but does not complete the second meiotic division, becoming arrested 
at metaphase (Mil) until fertilisation. Ooplasmic maturation involves the ability of 
oocytes to block polyspermy, decondense penetrated spermatozoa and form 
pronuclei after fertilisation in addition to redistribution of organelles and 
accumulation of granules along the oolemma (van den Hurk and Zhao 2005). 
Following oocyte maturation along with the LH surge and reaching the maximal 
size of the follicle, ovulation takes place by rupture of follicular wall at one side-
the stigma. At this time the follicles respond to the LH surge with a shift in the 
granulosa cells estrogenic environment to a progesterogenic one and with the 
production of hyaluran by the cumulus cells which is responsible for the 
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mucification and expansion of the cumulus cells and termination of oocyte-
cumulus junctions (Picton et al. 1998). The changes associated with the above 
mentioned steps for in vivo maturation, can be replicated in vitro, but the 
cryopreservation properties of most oocytes matured from GV to MIl stage in vitro 
differ from those matured in vivo (Leibo and Loskutoff 1993; Leibfried-Rutledge 
et al. 1997). Developmental events in mammals including oocyte formation, 
growth, maturation and sperm penetration are presented in Fig 1.1. 
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Figure 1.1 Developmental events in mammals. Diagrammatic representation of 
the di fferent stages of oocyte formation , growth, maturation and sperm penetration 
in different mammalian species (Adapted from Baker 1972). 
1.2.2 Fertilisation and polyspermy 
Fertilisation is the union of a single sperm with an egg (Coy el ai, 2008), This is a 
multistep process which includes interaction of the sperm with the outer vestments 
of the oocytes, penetration of the zona pellucida (ZP), fusion of the sperm and 
oocyte plasma membranes, pronuclear formation followed by DNA synthesis, then 
pronuclear fusion (syngamy) and alignment of their respective chromosomes on 
the first cleavage spindle (Raymond el al. 1981; Williams 2002). Before 
7 
Chapter 1 Literature review 
fertilisation, mammalian spermatozoa undergo a series of biochemical and 
biophysical changes called capacitation (Wani 2002), by which the sperm acquire 
the ability to fertilise. Capacitation involves the removal of sperm coating 
materials that are acquired during epididymal transit or during exposure to seminal 
plasma and cholesterol depletion resulting in an increased membrane permeability 
to calcium (Wani 2002). Fertilisation results in increased intracellular calcium 
(Cat) and intracellular insitol triphosphate (lP3) in the egg. As a consequence of 
increase in Cat+ , exocytosis of cortical granules, hardening of the ZP, blocking of 
polyspermy and decondensation of sperm chromatin occur. After fertilisation, 
sperm mitochondria dissociate and remain aggregated in the cytoplasm of the 
oocytes; however, they do not persist beyond the pre-implantation stages and only 
maternal mitochondria are inherited (Williams 2002). The sperm tail also 
penetrates the oocyte at fertilisation, in most mammals the sperm centriole is 
responsible for nucleation of a microtubule network for pronuclear migration 
(Williams 2002), but most of the remaining structural elements of the sperm tail 
rapidly disappear after penetration (Williams 2002). Several hours after sperm-
oocyte fusion, calcium oscillations cease at the time of pronuclear formation but 
reappear during the first mitosis which is important in the first cleavage (Ozil 
1998). Calcium causes inactivation of cytostatic factor (CSF) which stabilises 
maturation promoting factor (MPF), and then cyclin degradation occurs (Williams 
2002). Loss of active cytostatic factor and inactivation MPF allows entry of the 
female chromatin into anaphase II (Williams 2002). Following DNA synthesis, 
male and female pronuclei migrate to the centre of the newly formed cell zygote, 
the pronuclear membranes breakdown and the chromosomes undergo syngamy 
(Williams 2002). Polyspermy refers to the fertilisation of an oocyte by two or 
more spermatozoa, this is a common problem following IVF in cow (Wang et af. 
1997; Coy et af. 2005), sheep (Slavik et af. 2005), goat (Mogas et af. 1997), 
human (Aoki et af. 2005) and is particularly frequent in pigs (Hao et af. 2006). In 
most mammals, initiation of calcium oscillations induces the fusion of the cortical 
granules (CG) with the oolema thus releasing their content into the perivitelline 
space (cortical reaction). CG enzymes change the ability of the ZP to bind sperm 
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or induce acrosome reaction, so preventing further sperm penetration. Therefore, 
polyspermy can be caused by incomplete migration of CG, low Cat+ transients, 
less endoplasmic reticulum (ER) containing Cat+ (Wang et 01. 2003). However, 
incomplete or delayed ZP reaction could be a major cause of polyspermy (Coy et 
01.2002; Wang et 01.2003). 
1.3 CRYOPRESERVATION OF REPRODUCTIVE POTENT-
IAL IN ASSISTED REPRODUCTION 
During the last few years, cryopreservation has become a relevant addition to 
therapeutic concepts in reproductive medicine (Nawroth et 01. 2005). Valuable 
genetics can be preserved through the cryopreservation of sperm, oocytes or 
embryos. Methods to cryopreserve sperm and embryos have been successful 
(Mazur et 01. 2008). However, despite advances in cryobiology, cryopreservation 
of oocytes from most species is inefficient, and the results are inconsistent (Yavin 
and Arav 2007). 
1.3.1 Sperm cryopreservation 
Sperm were among the first vertebrate cells to be successfully cryopreserved in 
frogs, roosters, cattle and humans (Mazur et 01. 2008). The success in the latter 
three species stemmed primarily from the discovery of the protective action of 
glycerol (Polge et al. 1949). In agriculture, over 250, 000, 000 doses of semen 
from genetically superior bulls were preserved worldwide in 1998, and over 100, 
000, 000 cows received their first insemination from that frozen semen (Thibier 
and Wanger 2002). Frozen sperm allows dissemination of genetics and this results 
in the increase in milk production over the last several decades (Mazur et 01. 
2008). In human, the first birth following the use of cryopreserved sperm were 
reported in the 1950's (Bunge et al. 1954) and this approach is now in widespread 
use for storage and quarantine of donated sperm and storage of reproductive 
potential when loss of fertility is imminent (Gook and Edgar 2007). Recently, 
cryopreservation of spermatozoa has become a standard practice for all semen 
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donors until tests demonstrate that it is free from HIV and other pathogens (Mazur 
et af. 2008). In endangered species, AI with frozen thawed spermatozoa helps in 
genetic management through the distribution of genes among geographical 
dispersed breeding centres and zoos (Dinnyes et af. 2007). Sperm cryopreservation 
would also allow international transport of genetic materials without 
compromising political and legal restrictions. The shape and size of the sperm 
head could be factors that determine the cryosensitivity of spermatozoa 
(Liebermann et af. 2002). Comparative studies between different species such as 
boar, bull, ram, rabbit, cat, dog, horse and human revealed a negative correlation 
between the size of the sperm head and cryostability (Nauk 1991). Among the 
above mentioned species, human spermatozoa have the smallest size with maximal 
cryostability (Gao et af, 1997). 
1.3.2 Embryo cryopreservation 
Birth of the first live offspring from cryopreserved embryos (Whittingham et af. 
1972) opened the door to the possible application of this technology in the context 
of animal breeding and clinical assisted reproduction (Gook and Edgar 2007). 
Since the birth of first mice from cryopreserved embryos (Whittingham et al. 
1972), live births have been reported in over 20 mammalian species (Table 1.1). 
In 2004, approximately 550,000 bovine embryos were transferred into recipients 
(Thibier 2004); about half of them were cryopreserved (Walker et af. 2006). 
Successful cryopreservation of embryos have been reported in several species 
including cattle (Nedambale et af. 2004; Walker et af. 2006), sheep (Green et af. 
2009; Shirazi et af. 20 I 0), pigs (Dobrinsky 1997), horses (Campos-Chillon et af. 
2009), mice (Kasai et af. 1990), and humans (Edgar et af. 2005). 
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Table 1.1 Mammalian species yielding normal offspring following the transfer 
of cryopreserved embryos to foster mother 
Species Years Reference 
Mouse 1972 Whittingham et al. (1972) 
Cattle 1973 Wilmut and Rawson (1973) 
Rabbit 1974 Bank and Maurer (1974) 
Rat 1975 Whittingham (1975) 
Sheep 1976 Willadsen et al. (1976) 
Goat 1976 Bilton and Moore (1976) 
Horse 1982 Yamamoto et al. (1982) 
Human 1984 Zeilmaker et al. (1984) 
Baboon 1984 Pope et al. (1984) 
Marmoset 1986 Summers et al. (1986) 
Cynomologus macaque 1986 Balmaceda et al. (1986) 
Cat 1988 Dresser el al. (1988) 
Rhesus macaque 1989 Wolf et al. (1989) 
Pig 1989 Hayashi el al. (1989) 
Red deer 1991 Dixon et al. (1991) 
Wapiti 1991 Wenkoffand Bringans (1991) 
Hybrid macaque 1992 Cranfield et al. (1992) 
Swamp buffalo 1993 Kasiraj et al. (1993) 
Fallow deer 1994 Morrow et al. (1994) 
Mongolian gerbil 1999 Mochida et al. (1999) 
Hamster 1999 Lane et al. (1999a) 
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1.3.3 Oocyte Cryopreservation 
Oocyte competence can be defined as the ability of an oocyte to be fertilised 
develop into an embryo, establish a pregnancy and produce healthy offspring 
(Anguita et al. 2007). The availability of viable developmentally competent 
oocytes has been a limiting factor preventing progress in the development of IVF, 
embryo culture and related reproductive technologies in many species. 
Additionally, the relatively short fertilisable life span of mammalian oocytes limits 
implementation of many in vitro technologies. This limitation could be overcome 
by the ability to cryopreserve oocytes. However, to date the developmental 
potential of cryopreserved mammalian oocytes is typically highly compromised. 
Therefore, research on the cryopreservation of oocytes has become a priority. 
Success in this area could have important practical implications in both animal and 
human assisted reproductive technologies. Cryopreservation of oocytes from 
several mammalian species at different developmental stage is summarized in 
(Appendix B). 
1.3.3.1 Rationale for oocyte cryopreservation in mammals 
The cryopreservation of female gametes is an important technology that is appl ied 
in both human and animal reproduction. Cryopreservation permits the long-term 
storage of cells and tissues such that acceptable numbers of cells are viable upon 
subsequent warming. Oocyte cryopreservation in mammals has a series of 
potential applications (Table 1.2) aimed at the maintenance of biodiversity 
(Ambrosini et al. 2006). 
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Table 1.2 Applications of oocyte cryopreservation 
Human reproductive medicine 
• Improve the efficiency of IVF 
• Alternative to embryo freezing 
• Oocyte banking 
• Oocyte donation program 
• Oocyte preservation for patient with ovarian hyperstimulation 
syndrome 
• Treatment of premature ovarian failure 
• Preserve future fertility 
• Treatment of congenital infertility disorders 
Research applications 
• Preserve germ plasm of genetically- modified animals 
• Nuclear transfer program 
Livestock production 
• Preserve valuable genetic blood lines 
• Improve breeding programs 
• Avoid seasonal variations and sanitary constraints 
• Transportation 
• Preservation of endangered species 
1.3.3.1.1 Oocyte cryopreservation in human reproduction 
Infertility is considered one of the most serious problem facing human (Alesi 
2005). As mentioned earlier, IVF is considered the treatment of choice for women 
infertility. In IVF programs, ovarian response is artificially stimulated through 
hormonal administration which subsequently increases the number of ovarian 
follicles. As is common practice in IVF clinics, oocytes are collected from all 
stimulated follicles, however, due to the lack of suitable methods for oocyte 
cryopreservation, all of them are subjected to IVF and only two or three of the 
best quality embryos selected for transfer. The majority of the remaining embryos 
are frozen for future use (Gomes et of. 2008). This will produce supernumerary 
embryos (Hoffman et of. 2003). Therefore; cryopreservation of oocytes would be 
helpful to solve this issue and permits the production of only required embryos. 
13 
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Oocyte cryopreservation could also be an alternative to embryo storage due to 
ethical issues and legal restrictions in some countries. 
Additionally, oocyte cryopreservation would offer the possibility for the 
establishment of oocyte banks (Gomes et al. 2008). An oocyte bank is important 
in oocyte donation program (Karow 1997; Chang et al. 2009). Also, oocyte 
banking provides women with the option to delay childbearing plan until their 
professional careers are established (Leibo 2004). Establishment of oocyte banks 
could eliminate the problems associated with synchronization of donor and 
recipient cycles; it will also allow more effective screening of donors for 
infectious disease (Karow 1997). Oocyte cryopreservation could be useful in 
treatment of congenital infertility disorders, prevention of post- operative fertility 
loss and treatment of ovarian failures (Gomes et al. 2008). Moreover, it may also 
offer alternatives for infertile patients who are subject to ovarian hyper-
stimulation syndrome or polycystic ovarian syndrome (Fabbri et al. 2001; Fabbri 
2006; Lucena et af. 2006). In addition, oocyte cryopreservation may be helpful in 
cases of male factor infertility or problems associated with difficulty of sperm 
collection, inadequate seminal samples or nonviable spermatozoa at the time of 
oocyte retrieval (Lucena et al. 2006). 
Also, oocyte cryopreservation could be used to conserve fertility in women 
diagnosed with cancer who subsequently loose their gonadal function as a 
consequence of chemo-and radiotherapy (Leibo 2004; Gomes et al. 2008). 
1.3.3.1.2 Application of oocyte cryopreservation in research 
Since the successful isolation of mouse embryonic stem cells (Evans and 
Kaufman 1981) and the development of targeted gene disruption strategies (Koller 
et al. 1989), hundreds of genetically-modified mouse strains have been produced 
(Critser and Russell 2000, Mazur et al. 2008). Keeping these strains is important 
for future research, due to their value as models for biological systems. By 
increasing the numbers of strains, it has become impossible in terms of cost and 
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space to maintain all of them as breeding colonies (Mazur et al. 2008). 
Cryopreservation of germplasm offers an alternative way by allowing the 
preservation of frozen colonies as a backup in case of disease outbreak. Genetic 
modifications of domestic animals such as sheep, cattle, and pigs also can produce 
animals for the production of pharmaceuticals which are important for the 
treatment of some human diseases (Lindsay et al. 2004). Moreover, genetically 
modified animals may be used for organ xenotransplantation (Lai et al. 2002) or 
disease modeling. Thus, preservation of genetic materials from these animals is 
useful for biomedical applications (Turk and Laughlin 2004). 
Due to the absences of embryonic stem cells in livestock species and generation 
lines, the use of nuclear transfer (NT) technology is an important technique for 
genetic modification (Ward and Brown 1998). However, the efficiency of NT 
technology is relatively low and depends primarily on freshly collected and 
matured oocytes. Therefore, oocyte cryopreservation would provide an alternative 
option for a stable supply of oocytes for NT. This would also help to avoid 
changes in oocyte quality which are associated with seasonal variations (et al. 
Dinnyes et al. 2000; Hou et al. 2005; Sung et al. 20 I 0). 
1.3.3.1.3 Application of oocyte cryopreservation in livestock production 
From a commercial point of view, in livestock farming there is a need for 
cryostoring oocytes from domestic animals (e.g. cattle, pigs and sheep) with high 
economic value in order to enhance the development of improved breeding 
program. Additionally, producers could preserve valuable genetic blood lines 
from females and could market oocytes rather than embryos whose sire had 
already been chosen. In livestock, where large numbers of ovaries can be easily 
obtained from slaughterhouse, many oocytes can be collected, preserved and then 
used for IVP when re-warmed, thus diminishing seasonal variations or sanitary 
constraints. Also, oocyte cryopreservation could be used to rescue gametes when 
females die unexpectedly or accidentally (Ledda et al. 2007; Checura and Siedel 
2007). In the future, cryopreserved oocytes could be used in genetic 
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recombination through fertilisation and production of cross-bred animals. Oocyte 
banking also permits international exchange of oocytes, avoiding animal 
transportation and its sanitary risks and injuries (Pereira and Marques 2008). 
Moreover, oocyte cryopreservation and banking may be important to preserve 
endangered species (Watson and Holt 2001). Cryopreservation of the oocytes 
from these rare species would allow the application of assisted reproductive 
technologies. Also, oocyte and embryo banks as an interface between in situ and 
ex situ conservation programs allow the maintenance of biodiversity of 
endangered species from domestic and wild animals (Woelders e/ al. 2006; 
Andrabi and Maxwell 2007). 
1.4 CONVENTIONAL METHODS FOR CRYOPRESERVATI-
ON 
While the ability to freeze embryos has become standard practice in assisted 
reproductive technologies, cryopreservation of oocytes remains a challenge and 
has not been widely used despite significant research (Appendix B). The principles 
of cryopreservation are believed to be the same for all living cells; the most 
important consideration being the removal of most of the water from cells before 
they freeze intracellulary. Almost all cryopreservation strategies are based on two 
main factors: cryoprotectants (CPAs) and cooling-warming rates. Currently there 
are three strategies for oocyte and embryo storage; slow freezing, traditional 
(conventional) vitrification (vitrification in-straw), and ultra-rapid vitrification 
(Kasai 2002; Dinnyes e/ al. 2007; Fig 1.2 and Table 1.3). Storage, warming and 
re-hydration (Le. removal of CPAs) differ only slightly between the three 
protocols. The main differences between the three methods of cryopreservation 
exist in the addition ofCPAs and cooling rates (Vajta and Kuwayama 2006). 
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Figure 1.2 Schematic representation of an oocyte/embryo (circle) during slow 
freezing, conventional vitrification, and ultrarapid vitrification. White 
hexagons represent ice crystals. The concentration of cryoprotectant is shown by 
the darkness of shading (Adapted from Kasai 2002). 
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Table 1.3 Comparison of the three approaches for cryopreservation of oocytes 
(Adapted from Dinnyes et al. 2007) 
Parameters In-straw UItrarapid 
Freezing vitrification vitrification 
Oocyte storage Straw Straw Cryovial, straw, 
container special device or 
no container 
CPA concentration 1.3 -1.5 M 5.5-7.5 M 3.5 -5.5 M 
Time in CPA NA 2-5 min 2-5 min 
(concentration for 
equilibration 
Time in CPA 15 -20 min > 1 min > 10 sec 
(concentration for 
cooling 
Time required for 90-120 min 2-3 min <0.1 sec 
cooling 
Ice crystal Yes No No 
formation 
Osmotic injury Low risk High risk High risk 
Toxic injury Low risk High risk High risk 
Chilling injury High risk Low risk Low risk 
Warming rate Low to moderate Moderate to high High 
Cost High Low Low 
Commercial Extensive Limited Limited 
application 
1.4.1 Traditional slow rate/reezing 
Slow freezing was the first system used for embryo cryopreservation and this 
method has subsequently become highly standardized with considerable industrial 
and commercial background (Ledda et al. 2007). In this system, controlled cooling 
rates allow extra and intra-ceIlular fluid exchange without serious osmotic effects 
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and changes in cell shape. This fact is reflected in its alternative name; equilibrium 
freezing (Vajta 2000). Conventional slow freezing procedures have the following 
distinctive steps (Fig. 1.2); 1) oocytes exposed at room temperature (RT) to molar 
concentrations of low molecular weight permeating CPAs, such as ethylene glycol 
(EG), dimethylsulphoxide (DMSO, Me2S0) or propylene glycol until equilibrium 
is reached between CPAs and embryos; 2) induction of ice crystals (seeding) at -5 
to -7°C and holding at this temperature for 5-10 min; 3) controlled slow cooling 
around 0.2 to 2.0°C/min; 4) plunging at -30 to -70°C and storage in LN2 at -
196°C; 5) controlled thawing at around 250°C/min (e.g. 25°C water bath without 
stirring); 6) removal of CPAs at R T prior to culture or transfer (Palasz and 
Mapletoft 1996). In slow freezing, oocytes are immersed in hypertonic CPA 
solutions, and an outward flux of water is generated by osmosis because the cell 
membranes are more permeable to water than to the CPA. Cell volume is restored, 
at equilibration, however, cooling the cell to subzero temperatures causes a second 
volume variation due to the fact that, firstly water freezes extracellulary and salt 
concentration rises outside the oocytes (Ambrosini et aZ., 2006); water therefore 
leaves the cell again by osmosis (Jondet et af. 1984). Induction of ice crystals 
"seeding" is usually induced at -6°C, so the unstable state of supercooling of the 
water inside the cell, which will lead to sudden ice nucleation and consequently 
cell death, can be prevented (Ambrosini et af. 2006; Jain and Paulson 2006). Once 
ice crystals are induced, there is a tendency of smaller crystals to grow into larger 
ones, which is lethal to the cells and must be avoided (Knight and Duman 1986). 
The risk of intracellular ice formation increases when the temperature is changing 
either by cooling or re-warming. Hence, during thawing the temperature is usually 
raised very rapidly through the critical range (Todorw et af. 1989). The slow 
freezing technique has been used successfully to freeze oocytes and embryos of 
various mammalian species, especially those that are less sensitive to chilling such 
as mouse and cat (Ruppert-Lingham 2003; Luvoni et af. 1997, Luvoni 2006) and 
has also been used extensively to freeze human oocytes and embryos (Fabbri 
2006). Conversely, poor results have been reported for species more sensitive to 
chilling injuries including cattle, sheep, pigs, and horses (Martino el af. 1996b; 
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Isachenko et af. 1998; LeGall and Massip, 1999; Vajta et af 1998). Furthermore, 
an important constraint to the use of conventional slow freezing is the critical 
period of oocyte exposure to the CP As and the necessity to perform only in a 
laboratory equipped with an automated freezing system (Ledda et af. 2007) so that 
the cooling rate can be closely controlled (Kasai 2002). 
1.4.2 Conventional vitrification 
In 1985, Rail and Fahy devised an innovative method called vitrification (ice-free 
rapid solidification), in which oocytes/embryos suspended in a highly concentrated 
solution (20.5% DMSO, 15.5% acetamide, 10% propylene glycol and 6% poly-
ethylene glycol) were loaded in a straw and directly plunged into LN2 from a 
temperature above O°C (Rail and Fahy 1985). Significantly, higher levels of 
oocyte and embryo viability can be maintained through this technique. This is 
primarily attributed to the smaller chance of intracellular ice formation, although 
intracellular ice can be formed even in vitrification if the concentration of the 
CPAs in the cell is not high enough. The biggest obstacle to this approach is the 
toxicity of the CPAs, because high concentrations 5-8 mol/L are used to prevent 
ice formation (Kasai 2002). However, various improvements to this technique 
have been achieved, and many embryos in different species including mice (Rail 
and Fahy 1985; Kasai et af. 1990); rabbits (Kasai et af. 1992), cattle (Vajta et af. 
1998; Sommerfeld and Niemann 1999; Nedambale et af. 2004; Vieira et af. 2007); 
and sheep (Naitana et af. 1997; Leoni et af. 2003) have been preserved with 
minimal loss of viability. 
1.4.3 Ultrarapid vitrification 
In some species, consistently high survival of oocytes and embryos has not been 
obtained by either slow freezing or conventional vitrification (Kasai 2002). 
Therefore, improvement or development of the cryopreservation methods is 
necessary (Kasai 2002). The first reason for the low survival would be the 
sensitivity of oocytes and embryos to chilling, including porcine embryos, bovine 
oocytes and bovine embryos at early cleavage stages (Leibo et al. 1996). The 
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second reason would be lower permeability of the cell membrane, which would 
lead to the formation of intracellular ice and osmotic swelling. The third reason 
would be the toxicity of the cryoprotectant during exposure of the cells to 
concentrated vitrification solution (Kasai 2002). For instance, in blastocysts with a 
large fluid filled blastocoels cavity, a longer exposure would be necessary to make 
this space concentrated (Kasai 2002). Moreover, in some species (e.g. hamster 
embryos) oocytes and embryos are quite sensitive to an exposure just in an in vitro 
environment (Kasai 2002). A new strategy aiming to overcome these injuries is to 
markedly increase both cooling and warming rates. By this approach, critical 
temperatures at which the cells are injured could be passed quickly, so the 
formation of intracellular ice might be avoided even in less concentrated cells and 
the use of lower concentrations of ePAs could be possible (Kasai 2002). In fact, 
the concentration of permeating CPA in ultrarapid vitrification is lower than that 
adopted for conventional vitrification. In conventional vitrifictation, solutions with 
40% (or more) concentration of permeating CPA were widely used (Rail and Fahy 
1985; Kasai 1990; Nakagata 1989), whereas, in ultrarapid vitrification, solutions 
of 30% CPA were frequently used (Martino et af. I 996a). In ultrarapid methods, 
oocytes and embryos are pre-treated in a solution containing low concentration of 
permeating CPA before being suspended in a vitrification solution (Fig 1.2). This 
pre-treatment is effective to promote permeation of the CPA in less toxic 
conditions (Kasai 2002). The concentration of the permeating cryoprotectant used 
in the pre-treatment ranges from 2 to 3% (Papis et af. 2000) to 20% (Vajta et af. 
1997). The exposure time in vitrification solution should be the minimal required 
as long as intracellular ice formation is prevented and the toxic effect of the 
vitrification solution is avoided. The optimal time depends not only on the 
vitrification solution and the type of cell, but also on the temperature. In many 
cases, oocytes and embryos were exposed for only 25-30 sec at high temperature 
(35°e, Martino et af. 1996a; Vajta et af. 1998; Mukaida et af. 200 I). In all 
ultrarapid methods oocytes and embryos are warmed by immersing the sample as 
quickly as possible in a hypertonic solution containing sucrose or trehalose (Kasai 
2002). It has been reported that, by decreasing the volume of the solution and the 
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container, cooling and warming rates become much higher (Kasai 2002, Vajta and 
Kuwayama 2006). Various methods have been devised for handling oocytes and 
embryos with minimal volumes of solutions, these methods will be discussed later 
in detail. 
1.5 MECHANISMS OF CELL INJURY DURING CRYOPRE-
SERVATION 
Cells must be preserved at temperatures below the glass transition temperature of 
the cytoplasm and the suspending solution, which is approximately -130°C, at 
which effective cryopreservation without a decrease in survival could be obtained. 
In practice, LN2 (-196°C) is used to maintain the temperature. Not only during 
cooling but also during processing before cooling, during warming, and at 
recovery the cells are at risk of various types of injury. Therefore, all of these 
injuries must be prevented in order to minimize cell damage during 
cryopreservation. 
1.5.1 Types of cell injuries during cryopreservation 
I.S.I.IIce crystal/ormation 
Mammalian oocytes and embryos are large cell masses, a high proportion of which 
is occupied by water, when they are cooled to low temperatures intracellular ice is 
liable to form. This phenomenon is fatal because even a small amount of ice is 
likely to re-crystallize, become larger and have a destructive effect on the cellular 
structure. To avoid ice crystal formation, the cells must be concentrated and 
storage must occur below the glass transition temperature (Kasai 2002; Jain and 
Paulson 2006). In slow freezing, cells are concentrated gradually during slow 
cooling. whereas in vitrification, cells are concentrated upon direct suspension in a 
concentrated solution (Kasai 2002, Fig 1.2). Extra-cellular ice can be formed by 
slow cooling of oocytes or embryos, as the unfrozen fraction in which cells are 
located becomes smaller because the cells are large (Mazur 1977). On the other 
hand, when water is cooled to below its freezing point, it solidifies into a 
22 
Chapter 1 Literature review 
crystalline structure "ice" and these ice crystals occupy a greater volume than 
water and subsequently causes damage to the cells (Jain and Paulson 2006). 
Therefore, avoidance of ice crystal formation is one of the principal goals of 
successful cryopreservation. As the water transitions from liquid to ice, any solutes 
in the liquid phase are excluded from the solid. This will decrease the freezing 
point of unfrozen solutions, and result in an increase in the concentration of 
electrolytes and other solutes (Lovelock 1954). These high concentrations are 
toxic to the frozen oocytes and embryos, and the avoidance of these solution 
effects is a second major goal of successful cryopreservation (Jain and Paulson 
2006). 
1.5.1.2 Osmotic shock 
During re-warming the solid ice melts and releases free water resulting in a 
reduction of osmolarity of the surrounding solution (Jian and Paulson 2006). Slow 
re-warming can cause further cell damage by thawing and re-crystallization of free 
water. On the other hand, rapid re-warming leads to sudden drops in extracellular 
osmotic pressure and consequently rapid shifts of the water into the cell, which 
results in swelling and cell injury (Mazur 1980). This is called osmotic shock, and 
its avoidance is the third major goal of successful cryopreservation. Addition of 
CPAs into the solution could prevent these injuries (Kasai 2002; Jian and Paulson 
2006), but, higher concentrations of CPAs are toxic to the cells (Liebermann et al. 
2002). 
1.6 SLOW COOLING VS. VITRIFICATION 
Cryopreservation without ice formation (vitrification) could be beneficial in 
comparison to freezing methods for a number of reasons, firstly not least being 
cost as it does not require any expensive equipment. Secondly is much faster 
taking only few seconds for cooling and warming (Dinnyes e/ al. 2007). 
Vitrification is considered an alternative to conventional freezing and has been 
successfully used for the cryopreservation of spermatozoa (Saki et al. 2009), 
embryos (Vieira et al. 2007), oocytes (Vieira et al. 2002; Vieira et al. 2008) and 
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stem cells (Stachecki et al. 2008). Freezing includes the precipitation of water as 
ice; the resulting separation of the water from the dissolved substances poses 
problems. The physical definition of vitrification is the solidification of a solution 
in which water is rapidly cooled and formed into a glassy, vitrified state from the 
liquid phase at low temperature, not by ice crystallization but by extreme elevation 
in viscosity (MacFarlane 1978; Fahy et al. 1984). This phenomenon was described 
by Fahy (1986) as the viscosity ofthe sample becomes greater and greater until the 
molecules become immobilized and the sample is no longer a liquid, but rather has 
the properties of a solid. However, vitrification is a result of high cooling rates 
(2000-25000°C/min) associated with high concentrations of cryoprotectants (5-7 
M) which depress ice crystal formation and increase the viscosity at low 
temperature. The strategy of vitrification is basically different from that of slow 
cooling, a slow rate of cooling attempts to maintain a delicate balance between the 
various factors, which may result in damage, such as ice crystal formation, 
osmotic injury, cryoprotectant toxicity, concentrated intracellular electrolytes, 
chilling injury, zona and embryo fracture, and alterations of intracellular 
organelles, cytoskeleton and cell-to-cell contacts (Massip et al. 1995; Dobrinsky 
1996; Kasai 1996), whereas, vitrification totally eliminates ice crystal formation 
(Vajta 2000). Furthermore, the increased cooling rate during vitrification decreases 
chilling injury, i.e. damage of intracellular lipid droplets, lipid-containing 
membranes and the cytoskeleton, passing rapidly through the dangerous zone from 
+ 15°C to -5°C (Dobrinsky 1996; Martino et al. 1996 a; Isachenko et al. 1998). 
Vitrification as an ultra-rapid cooling technique is based on direct contact between 
the vitrification solutions containing the cryoprotectant agents and the liquid 
nitrogen. A comparison of the advantages and disadvantages of conventional 
freezing and vitrification is presented in Table 1.4. 
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Table 1.4 A comparison of vitrification with slow-cooling procedures 
(Adapted from Kuleshova and Lopata 2002) 
Accessibility and regulation 
Can be observed 
Can be anal ysed 
Interaction with oocytes and embryos 
Control of solute penetration 
Control of dehydration rate 
Maintenance of physiological temperature 
during equilibration procedure 
Duration of incubation 
Prolonged temperature shock 
Interference with oocyte or embryo 
Fracture of zona pellucida 
Formation of ice crystal 
1.6.1 Variables in Vitrification 
Vitrification 
Yes 
yes 
yes 
yes 
yes 
yes 
-10 min 
no 
low 
no 
no 
Slow cooling 
no 
no 
no 
no 
no 
no 
-3 h 
yes 
high 
possible 
possible 
Many variables have been reported to affect the efficiency of vitrification and 
survival rates of vitrified cells Table 1.5. 
Table 1.5 Variables in vitrification that can profoundly influence its 
effectiveness (Adapted from Liebermann et al. 2002) 
I. Type and concentrations of cryoprotectant 
2. Media used as base media (holding media) 
3. Temperature of the vitrification solution at exposure 
4. Time of exposure to cryoprotectants 
5. Volume of cryoprotectant solution 
6. Device used for vitrification 
7. Technical proficiency of the embryologist 
8. Quality and developmental stage of the tested cells/tissue 
9. Contamination of the sample by direct contact with LN2 
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1.6.1.1 Cooling and warming rates 
The success of cryopreservation depends on two main parameters: 1) the speed of 
freezing (Le. cooling rate) and 2) the effects of the dissolved substances (i.e. 
concentration of the cryoprotectants). Cooling rate is one of the principle 
determinants in the success and cell survival during vitrification. If the cooling rate 
is low, cytoplasmic water will flow out of the cell and freeze extracellulary and if 
the rate is too rapid, cytoplasm will not have sufficient time to dehydrate, resulting 
in the supercooling and eventual freezing (Rail 1987). In fact, cooling too slowly 
may kill the cells by exposing them to high concentrations of CPA for long time, 
whereas rapid cooling can cause cell death due to ice crystal formation. Mazur 
(1977) reported that the cell survival decreases at low cooling rates, increases to 
maximum at an optimal cooling rate which permits most of the water to move out 
from the cells and to vitrify extracellularly, and finally declines at high cooling 
rates. High cooling rates (from 15,000 to 30,000°C/min) can be achieved by using 
a small volume « 1 JlL) of highly concentrated CPAs (Martino et al. 1996a). 
Moreover, the use of high cooling rates combined with small sample volumes 
during vitrification reduces the CPA concentrations, exposure time and subsequent 
CPAs toxicity (Yavin and Arav 2007). Cooling the cells to subzero temperatures 
results in formation of extracellular· ice crystals and super-cooling of the 
cytoplasm, once cytoplasm is cooled to a temperature below -10 or -15°C, intra-
cellular ice abruptly forms. This phenomenon is called intracellular nucleation and 
is detrimental to the cell (Mazur 1970). However, if the cells are warmed very 
rapidly, this damage may be rescued. In addition to cooling, the warming rate is 
also very important for successful cryopreservation of mammalian cells. Following 
cryopreservation, the cell has to be re-hydrated and the cryoprotectant removed. 
The optimum warming rate for a given type of cell is highly dependent on the 
optimum cooling rate that preceded it. Warming of vitrified oocytes is critical, 
because transient formation of ice crystals might occur during de-vitrification, if 
the speed of warming is not adequate (RaIl 1987). Early investigators assumed that 
rapid warming of mammalian cells after cryopreservation was always better 
because cells had a shorter time to re-crystallize and were exposed to 
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cryoprotectants for less time. High warming rates could be achieved when vitrified 
oocytes were directly plunged into a warming solution (Le. from -196°C to 37°C), 
during this time, the warming rate reaches 4460°C/min (Liebermann et al. 2002). 
The rapid warming process allowed a very rapid dispersion of intracellular ice 
crystals, if any; the extracellular ice melts and permeated the cellular membrane in 
a liquid state to re-hydrate the oocytes (Friedler et al. 1988). 
1.6.1.2 Cryoprotectants 
Cryoprotectants are additional chemicals used in cryopreservation to avoid Ice 
formation and shock effects (Pereira and Marques 2008). They are divided into 
two categories, permeating and non-permeating. Permeating cryoprotectants are 
small molecules that have the ability to penetrate the cell membrane, form 
hydrogen bonds with intracellular water molecules, lower the freezing temperature 
of the resulting mixture and consequently prevent ice crystallization (Pereira and 
Marques 2008). At high concentrations, they inhibit the formation of ice crystals 
and lead to the development of a solid, glass like. so-called vitrified state in which 
water is solidified, but not expanded (Jain and Paulson 2006). Also, permeating 
CPAs protect the cells against solution effects by remaining in the solution and 
thus effectively diluting the residual electrolytes (Jain and Paulson 2006). 
Propylene glycol (I, 2-propanediol, PROH, Molecular weight MW- 76.1, Renard 
and Babinet 1984) is the most commonly used permeating CPA in oocyte and 
embryo freezing at concentration of 1.5 M (Jain and Paulson, 2006; Pereira and 
Marques 2008). At this concentration the toxicity is low, but its ability to prevent 
ice formation is limited (Pereira and Marques 2008). Other permeating 
cryoprotectants were commonly used, ethylene glycol (EG, MW- 62.07; 
Miyamoto and Ishibashi, 1977); glycerol (MW-92.1; Polge et al. 1949), 
dimethylsulfoxide (DMSO, Me2S0, MW-78.l3; Wilmut and Rowson 1973). EG is 
currently the most commonly used permeating CPA for oocyte vitrification, 
because its characteristic features of low molecular weight, high permeation 
ability, and low toxicity (Kuwayama et al. 2005). In contrast to the permeating 
cryoprotectants, non-permeating cryoprotectants remain extracellular. They act by 
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drawing free water from the cell, and subsequently causing dehydration of the 
intracellular space. They are used in combination with permeating cryoprotectant 
to increase the net concentration of permeating CPA inside the cell and also 
prevent ice crystal formation (Jain and Paulson 2006). Two categories of non 
permeating CPAs were reported I) low molecular weight non-permeating CPAs 
such as galactose (Mw- 180.2; Leibo and Oda 1993), glucose (Mw-181.1; Storey 
and Storey 1988), sucrose (Mw-342.3; Palasz and Mapletoft 1982); trehalose 
(Mw-378.3; Rudolph and Crowe 1985); 2) high molecular weight (> 50000 
Daltons) non-permeating CPAs like polyvinylpyrrolidone (PVP; Leibo and Oda 
1993), polyvinyl alcohol (PVA; Seidel et al. 1990); polyethylene glycol (PEG; 
O'Neil 1997), Ficoll (Shaw et af. 1997). Vitrification solutions are aqueous CPA 
solutions that do not freeze when cooled at high cooling rates to very low 
temperature (Liebermann et al. 2002). Therefore, CPA solutions are usually 
prepared in buffered media with a stable pH between 7.2-7.4. Although, 
Dulbecco's phosphate buffered saline (PBS) is most commonly used, other 
HEPES-buffered culture media such as TCM-199 have been used successfully. 
1.6.1.3 Cryodevices 
Various new techniques and types of carriers have been used with the overall aim 
of improving the survival of oocytes/embryos following cryopreservation. Until 
recently, 0.25 mL standard insemination straws were widely used for vitrification 
of oocytes and embryos. Relatively high cooling rate 2500°C/min could be 
achieved by direct plunging of the straw into LN2 (Palasz and Mapletoft 1996). 
However, using this method, oocytes suffered significantly from cryodamage 
(Martino et al. 1996a). 
Martino et al. (1996a) reported that bovine oocytes could be vitrified within a thin 
film « 1 J-lL) of vitrification solution placed on an electron microscope (EM) grid. 
Kasai (2002) reported that by using the EM grid the sample could be cooled 
instantly when plunged into LN2, however, because the grid is small in size (3.05 
mm in diameter and 0.037 mm thick), few oocytes or embryos could be loaded. 
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Therefore, Matsumoto et al. (2001) suggested the use of a triangular piece of 
nylon mesh (1.0 cm base and 1.3 cm height, with 60 flm meshes) so that many 
oocytes (65 bovine cumulus oocyte complexes) could be loaded. 
In 1998, Vajta et al. devised the open-pulled straw (OPS) method by heating and 
softening insemination straws (0.25 mL) and then shortening them manually until 
the inner diameter and the thickness of the wall decreased from 1.7 to 0.8 mm and 
from 0.15 to 0.07 mm, respectively. The straws were then, cut at the narrowest 
point with a razor blade. Embryos were loaded by means of the capillary effect 
with approximately 1 flL of vitrification solution; the estimated cooling rate in 
OPS was around 20000°C/min (Vajta et al. 1998). 
Lane et al. (1999a) then developed a refined system for embryo cryopreservation 
"the cryoloop", which consisted of a small nylon loop (20 flm wide and 0.5-0.7 
mm in diameter) mounted on a stainless steel pipe inserted into the lid of a 
cryovial. The oocytes or embryos were loaded over a thin film of vitrification 
solution into the loop. The loop containing the oocytes or embryos was then 
directly immersed into LNz. 
Another rapid approach which was used to achieve high cooling rate was 
completely containerless called "microdrops" (or "microdroplets'). This method 
was first demonstrated by Landa and Tepla in 1990, without intention to increase 
cooling/warming rates (Landa and Tepla 1990). Papis et al. (1999) reported that 
this method was more effective than conventional straw for vitrification of bovine 
embryos. In this approach, oocytes in small volumes of vitrification solution are 
dropped directly into LNz; this successfully eliminates the insulation effects of the 
container wall. An alternative way to avoid the vapour formation around the 
sample was the solid surface vitrification (SSV) method (Dinnyes et al. 2000). 
This technique makes a shortcut to exclude entirely the vapour formation by 
dropping the vitrification solution containing the oocytes onto a pre-cooled metal 
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surface in the LN2. SSV provided an efficient method of heat transfer in 
conjunction with containerless vitrification in microdrops. 
Alternative modification of the vitrification technique depends on the use of 
partially solidified liquid nitrogen (nitrogen slush); this is prepared by placing LN2 
in glass vacuum desiccators. The temperature of LN2 then decreases below the 
boiling point to almost -210°C, increasing the cooling rate to 24000°C/min 
(Martino et al. 1996a). 
Arav and Zeron (1997) developed another technique called minimum drop size 
(MOS), in which 0.1 to 0.5 ilL of vitrification solutions were cooled and warmed. 
This method was successfully used for vitrification of bovine oocytes (Arav and 
Zeron 1997). Another device was developed by the same group Arav et al. (2000), 
the VitMaster, this device producing vacuum in a reinforced LN2 container, so that 
a considerable part of LN2 evaporates but the remaining solution cools and even 
starts to solidify to form LN2 slush. 
The most recent development of uItrarapid vitri fication methods was based on the 
concept of minimum volume cooling (MVC, Kuwayama and Kato 2000). In the 
origin of the procedure, very small volumes of vitrification solution containing 
oocytes or embryos were loaded onto the inner wall of 0.25 mL standard 
insemination straws, after sealing, the straw was immersed directly into LN2. In 
the cryotop procedure, a thin plastic film strip attached to a plastic handle was the 
carrier tool; loading was performed by the use of a glass capillary under the 
control of a stereomicroscope. Before cooling almost all liquid was removed so 
that the embryos or the oocytes were only surrounded by a very thin layer of 
vitrification solution. Although all these methods result in high cooling and 
warming rates by using a minimal volume of freezing medium coupled with direct 
contact with LN2• most of these approaches have introduced a problem due to 
contamination by direct contact with LN2. To solve this problem some approaches 
such as VitSet technique performed the cooling in factory derived, and/or filtered 
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or UV-sterilized LN2, followed by wrapping the sample and the carrier tool into a 
sealable container before storage (Vajta et al. 1998). Recent alternative solutions 
to the problem of LN2 were the cryotip (Kuwayama et al. 2005) and super open 
pulled straw (SOPS, Isachenko et al. 2005). In fact, any technology in 
reproductive biology must ensure and guarantee the full protection of biological 
objects from microorganisms (Bielanski et al. 2000). Liquid nitrogen, which is 
used for storage of frozen material, can be a source of contamination by these 
microorganisms (Bielanski et al. 2000). Different types of viruses, which are 
simple and very cryo-stable structures, may increase their virulence after direct 
plunging and storage in liquid nitrogen, such as hepatitis virus (Hawkins et al. 
1996) and herpes virus (Jones and Darville 1989). So, the critical requirement in 
vitrification is a combination of high cooling rate and a safe procedure. 
1.7 OOCYTE STRUCTURE AND CRYOPRESERVATION 
DAMAGE 
Fundamental knowledge of cryobiological characteristics of each cell type is 
needed in order to develop an effective cryopreservation protocol (Critser et al. 
1997). Diverse strategies have been tested to minimize cooling induced cell injury. 
Irrespective of the efficiency of the above mentioned freezing strategies, it appears 
that oocytes pose specific problems because of their unique physical and 
biological proprieties that also vary between species. The oocyte is one of the 
largest mammalian cells ranging from 80 to 120 Ilm in diameter depending on 
species. Immature oocytes at the germinal vesicle (GV) stage are characterised by 
a large diploid nucleus (prophase I), a dense band of filamentous actin subjacent to 
the oolemma, and other organelles scattered throughout the ooplasm, including 
mitochondria, endoplasmic reticulum, and Golgi apparatus. The Golgi of the 
oocytes produces lysosome-like vesicles, the cortical granules that are randomly 
distributed throughout the cytoplasm. The mature oocyte (metaphase of the second 
meiotic division, MIl) is characterized by a large peripheral spindle apparatus with 
microtubules extending from pole to pole and from each pole to kinetochores of 
the chromosomes aligned along the metaphase plate. Abundant actin containing 
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microfilaments are distributed in the perinuclear and cortical ooplasm, where they 
direct organelle distribution and polar body extrusion during meiosis. In MIl 
oocytes cortical granules migrate to the periphery of the ooplasm just beneath the 
actin band, where they are ready to undergo exocytosis at the time of fertilisation. 
As first proposed by Mazur in 1963, one of the major factors that influences the 
response of a cell to freezing is the ratio of its surface area to volume. In general 
the larger the cell, the slower it must be cooled to survive freezing (Mazur 1963). 
For example in humans the flattened paddle shaped sperm cell has a surface area 
to volume ratio of 4.3, meanwhile the spherical oocyte has a surface area to 
volume ratio of only 0.05. Consequently, human oocytes require much longer to 
reach osmotic equilibrium when exposed to CPAs than do spermatozoa (Gilmore 
et al. 1997). Additionally, the lower surface area to volume ratio of the oocytes has 
an adverse effect on the transport of water and CPAs through plasma lemma 
(Leibo 1980). Apart from the size, the shape of the oocyte is problematic. The 
almost perfect sphere slows down formation of an equal distribution of any 
substance including permeable CPAs coming from outside or released from the 
oocyte (Kuwayama 2007). The third major factor responsible for oocyte 
cryodamage is the lowest possible cell number; from this point of view 
multicellular embryos can survive and compensate for as much as 50% loss of 
their cells as demonstrated by biopsies or bisection of the embryos, or even 
suboptimal culture conditions (Kuwayama 2007). Mammalian oocytes have a 
complex of organelles and subcellular structures, which are particularly sensitive 
to temperature and osmotic pressure. The effects of cryopreservation on oocyte 
structures and subsequent development will be discussed in later experimental 
chapters. 
1.8 CONCLUSIONS 
Despite considerable interest surrounding the application of oocyte 
cryopreservation as a tool for the treatment of infertility in women, which can 
overcome some of the ethical problems associated with embryo freezing, and 
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provide storage for future use as well as for preservation of genetic material from 
rare or valuable animals and use in NT, this technique cannot yet be considered as 
well-established. Low survival rates, the absence of comprehensive information of 
the status of essential biological attributes of oocytes after thawing and insufficient 
developmental rates, all contribute to the need for further improvement. The 
unique physical and biological properties of oocytes render them more sensitive to 
chiI1ing injuries. As previously discussed, many problems are associated with MIl 
oocyte cryopreservation including chilling injuries and toxicity to the CPAs which 
lead to considerable morphological and functional damage. Cryopreservation of 
GV-stage may provide an alternative approach for preservation of female gametes, 
due to the lack of the meiotic spindle which is one of the main targets for chilling 
injuries and cryodamage. More realistic advances could come from the 
optimization of freezing protocols for immature and matured oocytes using 
vitrification (ice-free cryopreservation) techniques which result in better 
preservation of viability and developmental potential, however many variables 
need to be considered in order to achieve effective vitrification. 
1.9 GENERAL AIMS OF EXPERIMENTAL CHAPTERS 
In this thesis, the recovery, viability and subsequent developmental potential of 
cryopreserved oocytes were studied. The overall aim for these studies was to 
establish a technique for oocyte cryopreservation which would support subsequent 
development following different in vitro techniques. Sheep were chosen as an 
experimental model due to their agricultural importance in Egypt and the 
availability of biological materials from mature ewes in Nottingham. To achieve 
this aim, the experimental chapters in this thesis were designed. 
Firstly, to evaluate viability and subsequent in vitro maturation of ovine GV-stage 
oocytes following exposure to different combinations of cryoprotectants. Oocyte 
viability was based on morphological evaluation, cumulus cell expansion and 
nuclear maturation following exposure of GV-stage oocytes to different 
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combinations of ethylene glycol, glycerol and DMSO (Chapter 3, Effect of 
exposure of immature ovine oocytes to different combinations of 
cryoprotectants on viability and subsequent in vitro maturation). 
Secondly, to evaluate the effects of vitrification using solid surface vitrification 
(SSV) technique on recovery, viability, cumulus cell expansion, nuclear 
maturation following IVM, frequencies of in vitro fertilisation, polyspermy and 
subsequent in vitro embryo development of vitrified/thawed ovine GV-oocytes 
(Chapter 4, In vitro fertilisation of ovine oocytes vitrified by solid surface 
vitrification (SSV) at germinal vesicle stage). 
Thirdly, to investigate the effects of Cryoloop vitrification on developmental 
potential of ovine GV-stage oocytes following vitrification and warming. The 
effects of cryoloop vitrification on recovery, viability, cumulus cell expansion and 
meiotic status following IVM, spindle and chromatin configuration, frequencies of 
in vitro fertilisation and polyspermy, first cleavage following IVF and subsequent 
development. Total cell numbers, numbers of apoptotic nuclei, and ploidy of day 7 
in vitro produced blastocysts were also evaluated (Chapter 5, Vitrification of 
immature ovine oocytes using the cryoloop: Effects on viability, in vitro 
maturation, in vitro fertilisation, and subsequent development). 
Fourthly, to elucidate the maturation promoting factor (MPF) and mitogen-
activated protein kinas (MAPK), in addition to in vitro embryo development 
following parthenogenetic activation (PA) and somatic cell nuclear transfer 
(SeNT) of ovine oocyte vitrified at GV-stage. Embryo quality based on 
morphological evaluation and detection of apoptotic nuclei and apoptotic index in 
day 7 in vitro produced blastocysts following PA or SCNT using TUNEL assay. 
Also, the ploidy of day 7 blastocysts was evaluated by karyotyping (Chapter 6, 
MPF/MAPK activities, parthenogenetic activation, and somatic cell nuclear 
transfer of ovine oocytes vitrified at germinal vesicle (GV) stage). 
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Fifthly, the effect of cytochalasin B pre-treatment as a cytoskeletal stabilizer on 
viability, frequencies of IVF and polyspermy, and subsequent development of 
ovine oocytes vitrified at GV-stage (Chapter 7, Vitrification of immature ovine 
oocytes with cryoloop: Effect of cytochalasin B pre-treatment on viability and 
subsequent development). 
The effect of caffeine treatment during IVM on spindle configuration, 
MPF/MAPK activities and subsequent in vitro embryo development folIowing 
IVF of ovine oocytes vitrified at GV-stage (Chapter 8, Effect of caffeine 
treatment on spindle configuration, MPFIMAPK activities, and subsequent 
development of ovine oocytes vitrified at germinal vesicle stage (GV) stage). 
Finally, the effect of demecolcine pre-treatment on viability, timing of first polar 
body extrusion, spindle configuration and subsequent development following IVF 
and parthenogenetic activation of ovine oocytes vitrified at GV-stage (Chapter 9, 
Effect of demecolcine pre-treatment on viability, timing of first polar body 
extrusion, spindle configuration, and subsequent development of ovine 
oocytes vitrified at germinal vesicle (GV) stage). 
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CHAPTER 2 
GENERAL MATERIALS AND METHODS 
All chemicals and reagents were purchased from Sigma-Aldrich, Dorset, United 
Kingdom, unless otherwise stated. Recipes of media and solutions not mentioned 
here are presented in Appendix A. 
2.1 ISOLATION OF OVINE CUMULUS OOCYTE COMPLEXES 
Fresh ovarIes from mature ewes were collected at a local slaughterhouse, 
immediately placed into pre-warmed phosphate-buffered saline (PBS) in a vacuum 
flask to maintain the temperature and then transported to the laboratory within 2-3 
hours (h) of collection at 25°C. In the laboratory, the ovaries were washed twice 
with fresh pre-warmed sterile PBS (37°C) in a sieve and then placed into a flask 
with 100-200 ml of warm PBS. In a laminar flow hood, antral follicles (2 to 3 mm 
diameter) were aspirated from individual ovaries using 21-gauge needle attached to 
a 10 ml syringe. The point of the needle was inserted into the ovary 2-3 mm away 
from the selected follicle; the follicle was then carefully penetrated from the 
underside to avoid loss of the oocyte. Aspirated follicular fluid was regularly 
transferred into a 50 ml conical polystyrene tube containing 20 ml of dissection 
medium, HEPES-butTered tissue culture medium (H-TCM 199 with Earle's salts; 
Gibco Life Technologies Inc., Paisley, UK) containing 10% heat inactivated foetal 
bovine serum (FBS; Gibco) in a hot box at 39°C, and allowed to settle for to min. 
After settling, % of the volume was removed and the remaining fluid transferred 
into a 92 x 10 mm Petri dish (Nun cion, Roskilde, Denmark). Cumulus oocyte 
complexes (COCs) were identified and collected on a warm stage at 39°C under a 
stereomicroscope (Leica MZ 12.5, Leica, Microsystems, Germany). Oocyte quality 
was determined on the basis of morphological features. Briefly, only good quality 
COCs showing an even granulated cytoplasm with at least three layers of cumulus 
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cells was selected. The selected COCs were washed three times in dissection 
medium at 39°C, and then transferred into 2 ml dissection medium in 35 mm Petri 
dish (Nunc, Rosklide, Denmark) at 39°C in a humidified atmosphere of 5% CO2 in 
air unti I use. 
2.2 VITRIFICATION OF OVINE COCs 
2.2.1 Exposure ofCOCs to different vitrification solutions (VS) 
Selected COCs were exposed for 10 min to equilibration solution, 10% ethylene 
glycol (EG) and 0.25 mol (M) trehalose (T), this solution was prepared in PBS 
supplemented with 10% heat inactivated FBS. After that, oocytes were exposed for 
60 sec to one of three different vitrification solutions (VS), all vitrification solutions 
were composed of PBS and 10% FBS in addition to different combinations of 
cryoprotectants, VSI (20% EG and 20% dimethylsulfoxide (DMSO), VSII (25% 
EG plus 25% DMSO) or VSIII (25% EG and 25% glycerol). After exposure, 
dilution of the cryoprotectants was performed by transfer of the oocytes to 10% EG 
and 1 M T, 0.5 M T in PBS and 10% FBS, and then finally to PBS/FBS for 3 min 
each at 39°C. After cryoprotectant dilution, oocyte viability was determined by 
morphological examination. COCs with normal appearance were washed twice in 
maturation medium and then matured in vitro for 24 h. 
2.2.2 Vitrification ofCOCs by solid surface vitrification ( S S ~ ~
Selected COCs were vitrified by solid surface vitrification (SSV) as previously 
described (Dinnyes et 01. 2000) with minor modifications. Briefly, COCs were 
handled for 2-3 min in a base medium (SSV BM) consisting of H-TCM 199 
supplemented with 20% heat inactivated FBS, and then suspended in the SSV 
equilibration medium (4% EG in SSV BM) for 6-10 min at room temperature (22-
24°C). Following equilibration, groups of 5-10 oocytes were rinsed three times in 
small drops (approximately 25 JlI) of SSV solution consisting of 35% EG, 5% 
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polyvinylpyrrolidone (PVP), 0.4 M T in BM on a warming plate at 39°C for less 
than 60 sec. The oocytes were then either processed through the warming solutions 
(toxicity control) or submitted to the complete vitrification process (Fig. 2.1). For 
vitrification, groups of 5- 10 oocytes with 1- 2 ~ I I of vitrification solution were 
aspirated into a glass pipette, then the solution containing the oocytes was expelled 
from the tip of the pipette onto the dry surface of a hollow metal cube pre-cooled by 
partial immersion in liquid nitrogen (LN2) maintaining its temperature between -
150 and -180°C. 
2.2.2.1 Warming of SSV oocytes 
Following vitrification, the vitrified droplets containing the oocytes were moved 
immediately using nitrogen-cooled forceps into a 35 mm Petri dish (Nunc, 
Rosklide, Denmark) containing 2 ml of 0.3 M trehalose solution in SSV BM for 1 
min at 39°C. After that, oocytes were consecutively transferred for 3 min intervals 
into 500 ~ I I of 0.15 M, 0.075 M, 0.0375 M trehalose solution in SSV BM, and 
fmally into SSV BM at 39°C in a four-well dish (Nunc, Denmark, Fig. 2.1). After 
warming, COCs were morphologically examined to evaluate their survival. 
Surviving vitrified-thawed oocytes were washed twice in maturation medium and 
matured in vitro for 24 h. 
-
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Figure 2.1 Vitrification of COCs using SSV. Diagram shows procedures of solid 
surface vitrification (SSV) of ovine oocytes. H-TCM 199: HEPES-Tissue Culture 
199 medium, FBS: Foetal Bovine Serum, BM: Base Medium, EG: Ethylene Glycol, 
Tr: Trehalose, LN2: Liquid Nitrogen, IVM: In vitro Maturation, IVF: In vitro 
Fertilisation, IVC: In vitro Culture. 
2.2.3 Vitrification ofCOCs using Cryoloop 
Following oocyte recovery, selected COCs were vitrified usmg the Cryoloop 
technique previously described by Lane e/ 01. (1999a). Cryoloops used for 
vitrification consisted of a nylon loop (20 Ilm wide; 0.5-0.7 mm diameter) mounted 
on a stainless steel tube inserted into the lid of a cryovial. The loops were purchased 
mounted with epoxide into vials (Hampton Research, Aliso Viejo, CA, USA). After 
washing three times in a base medium (cryoloop BM), H-TCM 199 supplemented 
with 10% heat inactivated FBS, COCs were transferred to 500 Ill-droplets of 
equilibration solution consisting of 10% EO plus 0.25 M trehalose in cryoloop BM 
for 3 min on a warm stage at 39°C (Fig. 2.2, A). The oocytes were then moved to a 
small drop (20 Ill) of vitrification solution which composed of 20 % EG and 20 % 
DMSO in BM at 39°C on a warming plate (Fig 2.2, B). After that, the oocytes were 
either processed through the warming solutions (toxicity control) or vitrified. For 
vitrification, the cryoloop was dipped into the vitrification solution to create a thin 
film by surface tension. A total of 3-5 oocytes were suspended on the film using a 
fine pulled glass mouth pipette. The cryoloop containing the oocytes was plunged 
into a cryovial previously submerged and filled with LN2. The transfer of oocytes 
into the vitrification solution and the vitrification process were performed within 1 
min. 
2.2.3.1 Warming of cryoloop vitrified oocytes 
To warm the cryoloop vitrified oocytes, the cryovial submerged under the LN2 was 
opened and the cryoloop containing the oocytes was removed from LN2 and placed 
39 
Chapter 2 Materials and Methods 
directly into a well of 500 )ll base medium containing 10% EG and 1 M trehalose. 
The oocytes immediately fell from the loop into the warming solution. The oocytes 
were then moved from this solution after 3 min and transferred to 500 )ll drop of 0.5 
M trehalose solution in BM and then to cryoloop BM for another 3 min. All the 
thawing procedures were conducted at 39°C. After thawing, COCs were examined 
microscopically to assess their viability. Viable oocytes were washed twice in 
maturation medium and then matured in vitro for 24 h. 
Figure 2.2 Cryoloop vitrification of immature ovine oocytes. (A) immature 
ovine oocytes exposed to equilibration solutions before cryoloop vitrification. (B) 
COCs in vitrification solutions. Scale bar = 50 )lm. 
2.2.4 Oocyte viability 
After exposure of COCs to different vitrification solutions, SSV, and cryoloop 
vitrification, oocyte survival was morphologically evaluated immediately after 
thawing and cryoprotectant dilution under a stereomicroscope (Leica MZ 12.5, 
Leica Microsystems, Germany). Oocytes with a spherical and symmetrical shape, 
evenly granulated cytoplasm and no signs of lysis, membrane damage, swelling, 
vacuolization, degeneration or leakage of the cellular content were recorded as 
viable (normal oocytes). Oocytes with ruptured zona pellucida, ruptured vitelline 
membrane or having dark or faint fragmented cytoplasm with signs of degeneration 
were assigned as non-viable (abnormal oocytes). 
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2.3 IN VITRO MATURATION OF VITRIFIEDITHAWED 
OVINE OOCYTES 
After thawing, morphologically normal COCs were washed twice in maturation 
medium, bicarbonate-buffered Tissue Culture Medium 199 (TCM 199 with Earle's 
salts, Gibco BRLlLife Technologies) supplemented with 10% FBS, 5 J.1g/ml FSH 
(Vetropharm, Ireland), 5 J.1g1ml LH (Vetropharm, Ireland), I J.lg/ml oestradiol-17P, 
0.3 mM sodium pyruvate, 100 J.1M cysteamine and 50 J.1g1ml gentamycin. 
Dissection and maturation media were sterilised by filtration through a 0.22 J.1m 
MiIlipore filter (Corning Inc, Germany) and equilibrated in a humidified 
atmosphere of 5% CO2 at 39°C for at least 2 h prior to use. For maturation, groups 
of 40-45 oocytes were transferred into four-well dishes (Nunc, Denmark) 
containing 500 JlI of maturation medium overlaid with 300 J.11 mineral oil to avoid 
evaporation, these dishes were pre-warmed at 39°C in a humidified atmosphere of 
5% CO2 in air before use. In most experiments except for nuclear transfer 
(Chapter 6) and caffeine treatment (Chapter 8), oocytes were matured in vitro 
(IVM) for 24 h at 39°C in a humidified atmosphere of 5% CO2 in air as previously 
described (Lee and Campbell 2006). 
2.3.1 Evaluation of cumulus cell expansion following IVM 
After 24 h IVM, cumulus expansion was evaluated under a stereomicroscope 
(Leica, MZ 12.5, Leica Microsystems, Germany) the percentage of oocytes with 
loosened layers of cumulus cells was noted. 
2.3.2 Assessment ofnuclear maturation using aceto orcein staining 
24 h post onset of maturation (hpm), cumulus cells were removed by repeated 
pipetting in H-TCM I 99/PVP containing 300 IU/ml hyaluronidase. Groups of 10-
15 completely denuded oocytes were mounted on a clean glass slide in a small drop 
of medium. The slide was prepared by placing four spots of Vaseline (96%) and 
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paraffin wax mixture (4%) in a position equal to the four comers of a cover slip to 
be used for holding the oocytes (18 mm x 18 mm, No. 1 BOH.). The cover slip was 
placed onto the Vaseline wax spots and gently pressed down until the oocytes were 
slightly compressed and not able to roll but remained intact. Slides were placed into 
a jar containing fixative (ethanol: acetic acid 3:1) for at least 24 h. Fixed oocytes 
were stained with 1.0% orcein by drawing the solution under the cover slips using a 
piece of filter paper (Whatman No. 1). The solution was prepared by boiling 1 gm 
of orcein in 45 ml acetic acid for two hours, after cooling, the solution was filtrated. 
The filtrate was then diluted with 55 ml of distilled water to give a 100 ml of a 45% 
of solution. The solution was stored at room temperature and only upper clear area 
of the stain was used. Excess orcein was removed by drawing ethanol under the 
cover slip again using filter paper. The slides were examined under phase contrast 
(Leica, Germany) to assess the state of nuclear maturation. Oocytes were classified 
into four stages based on nuclear chromatin configuration: germinal vesicle (GV), 
metaphase-I (MI), anaphase-I + telophase-I (AI/TI), and metaphase II (MIl). 
Oocytes at MIl were considered as matured. 
2.4 IMMUNOSTAINING FOR EVALUATION OF CHROMOS-
OME AND SPINDLE CONFIGURATION 
Meiotic spindle and chromatin status were evaluated by immunostaining of in vitro 
matured oocytes for tubulin and chromatin according to Bogliolo and colleagues 
(2007a) with some modifications. Following removal of cumulus cells as described 
(Section, 2.3.2); oocytes were fixed in 4% paraformaldehyde (PF A) for 30 min at 
room temperature. Fixed oocytes were then washed three times in phosphate-
buffered saline supplemented with 20% FBS (PBSIFBS) for 10 min each. The 
oocytes were then transferred into PBSIFBS containing 0.5% Triton X-IOO as a 
, 
permeabilizing agent for 30 min at room temperature. Subsequently, the oocytes 
were incubated overnight at 4°C with primary antibody; mouse monoclonal anti - a. 
- tubulin antibody (1 :200) in PBSIFBS plus 0.5% Triton X-IOO. After three washes 
in PBS/FBS, the oocytes were incubated with fluorescein isothiocyanate (FITC)-
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goat labelled secondary antibody (1 :200) at room temperature for 60 min. Oocytes 
were then washed three times in 500 ilL PBS/FBS and finally stained with a 
solution of 10 Ilg/ml bisbenzimide (Hoechst 33342) in PBS/FBS for chromatin 
labelling. Oocytes were then mounted on diagnostic microscope slides (Erie 
Scientific CO. Portsmouth, UK) in Vectashield mounting medium containing DAPI 
(Vector Laboratories, Inc. Burlingham, CA) under a cover slip. The slides were 
examined by epifluorescence (Leica DMR, Germany), images were captured using 
a digital camera (Hammamatsu, Japan) and analysed using Simple PCI software 
(Compix, CA, USA). The oocytes were assigned a quality score based on the 
morphological normality ofthe meiotic spindle and chromatin (Succu et al. 2007a). 
The oocytes were classified as normal when bearing the classical symmetrical 
barrel shape meiotic spindle or abnormal if oocytes showed disorganized, clumped 
or dispersed spindle elements, multiple spindle-like structures or absent (missing) 
not visible meiotic spindle. In addition, normal chromatin identified by two sets of 
chromatin aligned regularly along the equatorial plane of the meiotic spindle, 
abnormal showed clumping or dispersed chromatin from the centre of the spindle. 
2.5 IN VITRO FERTILISATION OF OVINE OOCYTES 
2.5.1 Sperm preparation 
Cryopreserved semen pellets from a Texel ram were purchased (Britbreed, UK) and 
stored under LN2. Approximately 1 h before fertilisation, a single 0.2 ml frozen 
semen pellet containing 400 x 106/ml progressively motile spermatozoa was thawed 
in a dry glass tube pre-warmed at 37°C in a hot box and then shaken in a beaker 
filled with warm water (30°C) for 30-60 sec. The thawed semen was prepared for 
in vitro fertilisation (lVF) by swim up technique, 80 III of thawed semen was placed. 
under 3 ml of sperm wash medium (Appendix A) in 15 ml centrifuge tubes pre-
warmed at 37°C. Spermatozoa were allowed to swim up by incubation of centrifuge 
tubes at 45° angle for 1 h at 37°C. Motile spermatozoa were collected by aspirating 
43 
Chapter 2 Materials and Methods 
and mixing the supernatant from each tube (1/3 volume) which was then 
centrifuged at 1700 rpm for 5 min. Following centrifugation. the supernatant was 
discarded leaving around 200 III of the medium above the pellet level. The sperm 
concentration was calculated by adding 10 J.lI of sperm suspension to 990 III of 
distilled water in small test tube and mixing well. 10 J.ll of sperm mix were loaded 
into an improved bright-line Neubauer counting chamber (Marien field. Germany), 
sperm were allowed to settle for two minutes and then counted microscopically. 
The sperm concentration was adjusted to 2.0 x 106 sperm Iml. The motility of the 
spermatozoa was also checked following swim up under phase contrast microscope 
(Leica). 
2.5.2 In vitro fertilisation 
Mature COCs (24 hpm) were washed once in pre-warmed fertilisation medium at 
39°C (Appendix A) containing 2% sheep serum. Groups of 40-50 oocytes were 
transferred into four-well dishes (Nunc) containing 500 III of fertilisation medium 
and 2.0 x 106 sperm Iml. Oocytes and sperm were co-incubated for 18 h at 39°C in a 
humidified atmosphere of 5% C02 in air. 
2.5.3 Evaluation of frequencies of in vitro fertilisation and polyspermy 
following IVF 
At 18 h post-insemination (hpi), presumptive zygotes were washed thoroughly and 
repeatedly pipetted in PBS supplemented with 4 mglml PVP (PBSIPVP) to remove 
all cumulus cells and attached spermatozoa. They were then fixed in 4% PF A in 
PBS/PVP for 20 min at room temperature and then washed three times in 500 J.ll 
PBS/PVP. After that, presumptive zygotes were transferred to 500 J.1l PBSIPVP 
containing 10 J.1g1ml Hoechst 33342 for 10 min at room temperature. Oocytes were 
washed three times in 500 J.1l PBS/PVP, then they were mounted on a clean glass 
slide in Vectashield mounting medium with DAPI (Vector Laboratories, USA) and 
then covered with a thin cover slip. Samples were examined using a fluorescence 
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microscope (Leiea DMR, Heidelberg, Germany) fitted with a digital camera 
(Hamamatsu, Japan) and image analysis software (Simple PCI, Compix Inc., USA). 
The inseminated oocytes were categorized as fertilised when they have 
sperm/swollen sperm head in ooplasm, or a male and/or female pronuclus, 
polyspermic fertilisation was characterized by presence of more than one sperm in 
ooplasm or more than two pronuclei, oocytes with no signs of sperm penetration 
were considered unfertilised. 
2.6 PARTHENOGENETIC ACTIVATION 
After removal of cumulus cells from in vitro matured oocytes at 24 hpm, oocytes 
were washed three times in HEPES-buffered synthetic oviduct fluid (H-SOF) 
medium supplemented with bovine serum albumin (BSA, 4mg/ml), non-essential 
amino acids, and sodium citrate. Oocytes at MIl stage with a visible first polar body 
(PBI) were selected and activated for 5 min in 5 ~ M M calcium ionophore (A 23187) 
in H-SOF-BSA at 39°C. Oocytes were then washed twiee in H-SOF-BSA and once 
in embryo culture medium (mSOFaaci, modified SOF medium supplemented with 
amino acids and fatty acid free-BSA 4 mg/ml), followed by incubation in embryo 
culture medium supplemented with 1 0 ~ g / m l l cycloheximide (CHX) and 7.5 ~ g / m l l
cytochalasin B (CB) for 4-5 h at 39°C in a humidified atmosphere of 5% CO2• 
Alternatively, oocytes were activated using a second method, selected Mil oocytes 
were washed 3 times in 500 ~ l l of calcium free CZB (Chatot, Ziomet, and Bavister) 
medium, oocytes were then activated by 10 mM SrCb (strontium chloride) and 7.5 
~ g / m l l CB in calcium free CZB medium for 4-5 h at 39°C in a humidified 
atmosphere of 5% CO2• The calcium free CZB was pre-warmed in the incubator at 
least 1 h before adding 100x strontium solution (1 0 ~ l I m l ) , , this was to avoid 
strontium precipitation during activation. 
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2.7 NUCLEAR TRANSFER 
At 15-16 hpm, enucleation was performed according to the method previously 
described (Lee and Campbell 2006). Briefly, maturing oocytes at anaphase I -
telophase I (AI-TJ) were stripped of cumulus cells as previously described (Section, 
2.3.2). Denuded oocytes with an extruding 151 polar body were selected and cultured 
in manipulation medium (HEPES-buffered synthetic oviduct fluid [H-SOF] 
containing non essential amino acids, sodium citrate and 4 mg/ml bovine serum 
albumin [BSA], pH 7.4) supplemented with Hoechst 33342 (5 /-lg/ml) for 15 min at 
39°C. Laser assisted enucleation (XY clone laser, Hamilton Thorne, USA) was 
carried out in manipulation medium containing 7.5 ~ g / m l l CB on a heated stage at 
39°C by aspirating a small amount of cytoplasm protruding from the protruding AI-
TJ containing the maternal chromosomes. Enucleation was checked by exposing the 
aspirated cytoplasm to V.V. light, whilst in the pipette, for the presence of the 
chromosomes. Enucleated oocytes were then returned to maturation medium under 
the same conditions (Section, 2.3) until transfer of the donor nuclei. 
For transfer of donor nuclei, enucleated oocytes were transferred from the 
maturation medium to manipulation medium H-SOF-BSA. A quiescent primary 
ovine foetal fibroblast cells used as nuclear donor (passage 3-5) were cultured in 
Dulbecco's modified Eagle's medium (DMEM) supplemented with 1.0% (v/v) 13-
mercaptoethanol, 2.0 mM L-glutamine, 1.0% (v/v) penicillin/streptomycin and 10% 
FBS until approximately 80-90% confluent, quiescence was then induced by 
reducing the concentration of FBS to 0.1 % for at least 3 days before to use. Donor 
cell was inserted under the zona pellucida of each enucleated oocyte, allowing the 
membrane of the donor cell to have contact with the oolema (Fig 2.3). The couplets 
(2-3) were placed and manually aligned in the fusion chamber containing 0.3 M 
mannitol without calcium ions. Fusion was induced by two D.C. pulses of 1.25 
kV/cm for 30 ~ s e c c using a multiporator (Eppendorf, Germany) between 22 and 24 h 
after onset of maturation. Couplets were then returned to culture medium (C.SOF, 
mSOFaaci containing BME-essential amino acid and MEM-non essential amino 
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acids and FAF-BSA 4 mg/ml) until activated. For activation, reconstructed embryos 
approximately 1 h post fusion (hpf) were washed three times in 500 ) ..t1 calcium-free 
CZB medium, then they were activated using 10 mM SrCh in calcium-free CZB 
with CB (7.5 ).1g/ml) for 4-5 h at 39°C in a humidified atmosphere of 5% CO2 in 
air. 
Figure 2.3 Production of oocyte somatic cell couplets from ovine oocyte 
vitrified at GV-stage. (A) Donor cell is positioned at the tip ofthe pipette. (B) The 
nuclear transfer pipette is inserted through the hole made during enucleation and the 
donor cell deposited in the perivitelline space. (C and D) Cells for transfer are 
pushed to ensure close contact with the oolema. 
2.8 IN VITRO CULTURE OF OVINE EMBRYOS 
At 18 hpi or 4- 5 h post activation (hpa), presumptive zygotes were washed three 
times in 500 ).11 H-SOF containing non essential amino acids and 4 mg/ml BSA at 
39°C. IVF embryos were repeatedly pipetted to remove any attached cumulus cells 
and adhered spermatozoa). After that, they were washed twice in embryo culture 
medium (C.SOF, mSOFaaci containing BME-essential amino acid and MEM-non 
essential amino acids and FAF-BSA 4 mg/ml). Following washing, the embryos 
(15- 20) were transferred into 50 ).11 drops of pre-warmed and equilibrated C.SOF-
BSA culture medium covered with mineral oil and incubated at 39°C in a 
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humidified atmosphere of 5% O2, 5% CO2 and 90% N2 until day 7 (Day 0 = Day of 
insemination or day of activation). 
2.8.1 Evaluation of the frequency of cleavage and subsequent embryo 
development 
The numbers of cleaved embryos were assessed at 24 and 48 hpi or hpa and cleaved 
embryos were transferred into fresh culture medium. Development to morula stages 
was evaluated on day 5. On day 7, development to blastocyst was recorded and 
morphologically evaluated under a stereomicroscope and divided into early, 
expanded or hatched blastocyst. 
2.8.2 Evaluation oftolal cell numbers 
Total cell numbers for day 7 in vitro produced blastocyts were evaluated using 
Hoechst stain. After washing in PBS supplemented with 4 mg/ml PVP, embryos 
were fixed in 4% PFA in PBSIPVB for 10 min at room temperature. After 
thoroughly washing in PBS/PVB, blastocyst embryos were incubated in PBSIPVP 
containing 10 Jlg/ml Hoechst 33342 for 5 min at room temperature. After washing 
in PBSIPVP, they were mounted on clean glass slides in Vectashield mounting 
medium with DAPI (Vector Laboratories, Inc. Burlingham, CA.) and covered with 
a cover slip. The samples were examined under epifluorescence (Leica DMR, 
Germany) fitted with a digital camera (Hamamatsu, Japan) and image analysis 
software (Simple PCI, Compix Inc., USA). 
2.9 TUNEL ASSAY TO DETERMINE DNA FRAGMENTATION 
Day 7 embryos were removed from embryo culture medium (mSOFaaci containing 
4 mg/ml F AF-BSA [C-SOFD and washed three times in 200 Jll drops of PBSIPVP 
at 39°C by passing the embryos through the drops. After washing, embryos were 
incubated in 4% PF A containing 10 Jlg/ml bisbenzimide (Hoechst 33342) for 30 
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min at room temperature, followed by two washes in 200 J..t1 PBSIPVP. Embryos 
were incubated in 500 ~ I I of freshly prepared permeabilization solution (0.1 % v/v 
Triton X-I 00 in PBS/PVP) for 5 min at room temperature, and then washed twice in 
200 ~ I I PBSIPVP. To detect DNA degradation in apoptotic cells, Terminal 
Transferase dUTP Nick End Labelling (TUNEL) was performed using an in situ 
cell death detection kit (Roche Diagnostics, Mannheim, Germany) according to 
manufacturer's instruction. The embryos were incubated in 50 ~ I I of the TUNEL 
reaction mixture (I: 10; dilution of enzyme, terminal deoxynucleotidyl transferase 
from calf thymus, in label solution, nucleotide mixture) at 39°C for 45 min in a 
humidified chamber to avoid evaporation of the reaction mixture (Choi 2008). 
Embryos were washed in 200 ~ I I PBSIPVP, and then mounted on glass slides in 
Vectashield mounting medium with DAPI (Vector Laboratories, Inc. Burlingham, 
CA.) under a cover slip. DNA fragmentation was visualised by epifluorescence 
microscope (Leica DMR, Germany) fitted with a digital camera (Hamamatsu, 
Japan) and image analysis software (Simple PCI, Compix Inc., USA). 
2.10 KARYOTYPING OF IN VITRO PRODUCED BLASTOC-
YSTS 
Day 7 blastocysts were prepared and examined for their cytogenetic compositions 
as described by King et af. (1979) with minor modifications. B1astomeres of the 
embryos were synchronised at metaphase by incubation of blastocysts in culture 
medium containing 0.05 ~ g / m l l demecolcine solution for 3h at 39°C in a humidified 
atmosphere of 5% 02, 5% C02 and 90% N2. After washing in PBS/PVP, blastocysts 
were transferred to hypotonic solution (0.8% sodium citrate) for 10 min at room 
temperature, and followed by 10 min incubation in a solution of 0.56% potassium 
chloride. The blastocysts were then fixed in a solution consisting of 1: 1.2 sodium 
citrate (0.8%) and methanol: acetic acid (2:1) for 15 min at room temperature. 
Subsequently, blastocysts were mounted individually in a marked frame onto a 
freshly cleaned glass microscope slide in a minimal volume of fixative. By 
observing the slides under stereomicroscope (Leica) and before evaporation of the 
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fixative drop, a freshly prepared solution of methanol: acetic acid (1: I) was dropped 
onto the embryo until complete cell spreads were obtained. After air drying, the 
slides were stained with 4% (v/v) Giemsa solution for 5 min. Slides were then 
washed with water and left to dry in air at room temperature. The ploidy was 
evaluated under phase contrast microscope (Leica, Germany) at x 100 under oil 
immersion. Embryos were classified as being normal when diploid chromosomes 
(54,2 n) or abnormal, when haploid (n) or polyploidy ( ~ 3 3 n). 
2.11 IN VITRO DOUBLE KINASE ASSAY 
2.11.1 Preparation of oocyte lysate 
The preparation of oocyte lysate and analysis of maturation promoting factor (MPF) 
and mitogen activated protein kinase (MAPK) activities were performed as 
previously described (Ye et ai, 2003) with some modifications. Briefly, groups of 
10 cumulus stripped oocytes were thoroughly washed in DPBS containing 0.1 % 
polyvinyl alcohol (PV A) at 39°C and then placed into 5 JlI of ice-cold lysis buffer 
containing 45 mM p-glycerophosphate (pH 7.3), 12 mM p-nitrophenylphosphate, 2 
mM 3-(N-morpholino)-propanesulfonic acid (MOPS), 12 mM MgCIz, 12 mM 
ethyleneglycol bis (2-aminoethyl-ether) tetraacetic acid (EGT A), 0.1 mM EDT A, 
20 mM Na3V04, 10 mM NaF, 2 mM dithiothreitol (OTT), 2 mM 
phenylmethylsulphonyl fluoride, 2 mM benzamidine, 20 Jlglml leupeptin, 20 Jlglml 
pepstatin A and 19.5 Jlglml aprotinin. The samples were frozen in LN2 and stored at 
-80°C until analysed. 
2.11.2 In vitro double kinase assay 
The activities of MPF and MAPK kinases were measured simultaneously using 
histone H I and bovine myelin basic protein (MBP) as their in vitro substrates, 
respectively. The oocyte lysate was thawed and then refrozen in liquid nitrogen 
(-196°C) once. The kinase reaction was started by adding the oocyte lysate to 5 JlI 
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kinase assay buffer containing 45 mM p-glycerophosphate (pH 7.3), 12 mM p-
nitrophenylphosphate, 20 mM MOPS, 12 mM MgCh, 12 mM EGTA, 0.1 mM 
EDTA, 2 mM Na3V04, 10 mM NaF, 4 mg/ml HI, 6 mg/ml MBP, 40 ~ M M protein 
kinase A (PKA) inhibiting peptide (Santa Cruz Biotechnology; Autogen Bioclear, 
Clane), 43 ~ M M protein kinase C (PKC) inhibiting peptide (Promega, Southampton) 
and 10 Ci/mmol [y)2p] ATP (PerkinElmer). The mixtures were incubated at 37°C 
for 30 min with gentle shaking. The reaction was stopped by adding I 0 ~ l l ice-cold 
2xSDS sample buffer which was made from [125 mM Tris-C1 (pH 6.8) (Fisher 
Scientific), 200 mM DTT, 4% (w/v) SDS (Fisher Scientific), 0.01% (w/v) 
bromophenol blue and 20% (w/v) glycerol]. After boiling for 5 min, the substrates 
were separated by standard polyacrylamide gel electrophoresis (SDS-PAGE, 15% 
gels) using a Mini-Protean II dual slab cell (Bio-Rad, Hercules, CA) at 140 V for 
1.5 h. Gels were dried on 3 mm filters and exposed to phosphor-screens (Fuji film). 
The phosphor images of gels (screens) were captured and the kinase activities were 
quantified using an FX phosphor image analysis system (Bio-Rad). 
2.12 STATISTICAL ANALYSIS 
At least three replicates were carried out for each experimental group. Data were 
analysed using Chi square test and un-paired student's (-test. All results are 
considered to be statistically significant at P< 0.05, unless otherwise stated. The 
statistical analysis was performed using Graph Pad Software 
(http://www.graphpad.com). 
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CHAPTER 3 
EFFECTS OF EXPOSURE OF IMMATURE OVINE 
OOCYTES TO DIFFERENT COMBINATIONS OF CR-
YOPROTECTANTS ON VIABILITY AND SUBSEQ-
UENT IN VITRO MA TURA TION 
3.1 INTRODUCTION 
Maintaining the viability and potential developmental ability of living 
reproductive cells and tissues of several mammalian species after long-term 
storage represents an important tool in human and animal reproduction (Ledda et 
al. 2007). Although the viability of cryopreserved mammalian oocytes was first 
demonstrated about 30 years ago (Whittingham 1977) and the first domestic 
offspring was reported nearly 20 years ago (Hamano et al. 1992), this technology 
is still considered to be at an early stage. Slow freezing protocols have been 
replaced by the most recent vitrification approaches. Vitrification is a physical 
process in which cryoprotectant solutions fonn a glassy solid state, this can be 
achieved by elevation in the viscosity of the solution, through using high cooling 
rates in association with high concentrations of cryoprotectant (Rail and Fahy 
1985; Vajta et al. 1998). So, the vitrification solution must be sufficiently 
concentrated to avoid crystallization during cooling (Kasai et al. 2002). However, 
high concentrations of cryoprotectant are toxic and may cause osmotic injury to 
the oocytes (Liebennann et al. 2002) which is responsible for low developmental 
potential of cryopreserved oocytes (Fahy et al. 1984). Many suggestions have been 
reported to minimize the toxicity of vitrification solutions such as use of less toxic 
cryoprotectants, combinations of different cryoprotectants, prior exposure to less 
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concentrated cryoprotectants and reduction of exposure time to vitrification 
solution (Vajta et al. 2000). 
Different cryoprotectants like ethylene glycol (EG), glycerol (GL Y), 
dimethylsulfoxide (DMSO), propylene glycol and 1, 2-propanediol (PROH) have 
been used in different combinations for vitrification of mammalian oocytes and 
embryos (Liebermann and Tucker 2002; Yamada et al. 2007). Several studies 
demonstrated that EG would be an ideal cryoprotectant (Shaw et al. 1997; Cetin 
and Bastan 2006), because of its ability to penetrate cell membranes faster than 
other cryoprotectants (Shaw et al. 1997), also EG was proven to be less toxic than 
other permeable cryoprotectants (Martino et al. 1996a; Dinnyes et al. 2000). 
DMSO was reported to have toxic effects on bovine oocytes (Arav and Zeron 
1997) causing disassembly of the spindle microtubules and movement of 
pericentrioler material to the centre of the oocytes. However, other studies 
reported successful oocyte vitrification with DMSO alone (Wani et al. 2004a, b) or 
in combination with other cryoprotectants (Vieira et al. 2002; Yamada et al. 
2007). It has been reported that, vitrification solution containing DMSO and EG 
could parthenogenetically activate in vitro matured ovine oocytes, also it caused 
zona pellucida hardening and subsequent decreased sperm penetration (Tian et al. 
2007). Few studies have reported the use of glycerol as a permeable cryoprotectant 
in oocyte vitrification. Wani and colleagues obtained 23.5% maturation rates 
following vitrification of immature buffalo oocytes with 7 M glycerol (Wani et al. 
2004a). Moreover, lower maturation rates (54.3%) were reported foHowing 
exposure of immature bovine oocytes to vitrification solutions containing 25% EG 
in combiriation with 25% DMSO (Yamada et al. 2007). In buffalo, a severe 
reduction in the frequency of in vitro maturation was reported following exposure 
of germinal vesicle (GV) oocytes to a combination of 3 M EG and 3 M glycerol 
(Mahmoud et al. 2009). However, evaluation of the effects of different 
cryoprotectants with varying concentrations on survival of immature ovine oocytes 
is lacking. 
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Thus, the present study of cryoprotectant combinations is important to improve the 
efficiency of ovine oocyte vitrification, aiming to minimize the toxic effect of 
cryoprotectant solutions. The objectives of these studies were to evaluate the 
survival rates and subsequent in vitro maturation of ovine GV-stage oocytes 
following exposure to different vitrification solutions containing three different 
combinations ofEG, DMSO, and GLY. 
3.2 MATERIALS AND METHODS 
3.2.1 Exposure of COCs to different vitrification solutions 
Recovery of ovine oocytes was carried out as previously described (Chapter 2.1). 
Selected oocytes were washed three times in washing medium and randomly 
assigned into four groups, I) control groups (directly subjected to in vitro 
maturation), 2) VSI group (exposed to vitrification solution I), 3) VSII group 
(exposed to vitrification solution II), and 4) VSIII group (exposed to VIII). 
Exposure of COCs to different combinations of cryoprotectants was carried out as 
described (Chapter 2.2.1). After cryoprotectant dilution, oocyte viability was 
determined as described in (Chapter 2.2.4). 
3.2.2 Evaluation of cumulus cell expansion and nuclear maturation 
COCs with morphologically normal appearance were washed twice in maturation 
medium and then matured in vitro as demonstrated (Chapter 2.3). Following 24 h 
post onset of maturation (hpm), cumulus cell expansion and meiotic maturation 
were evaluated as previously described (Chapter 2.3.1 and 2.3.2). 
3.2.3 Statistical Analysis 
Data were analysed by using Chi square test. All results are considered to be 
statistically significant at P< 0.05, unless otherwise stated. 
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3.3 RESULTS 
3.3.1 Effects of different cryoprotectants on oocyte viability 
The effects of exposure of immature ovine oocytes to different vitrification 
solutions containing different combinations of cryoprotectants (YSI: 20% EG + 
20% DMSO; YSJI: 25% EG + 25% DMSO; YSIII: 25% EG + 25% glycero l) on 
oocyte viability based on morphological evaluation are illustrated in Table 3.1 and 
Fig 3.1. No significant differences (P> 0.05) were observed in the proportions of 
oocytes with normal morphology (viable oocytes) between three different 
vitrification solutions (81.9, 75 .3, and 81.8% for YS1 , YS[] , and YSIII , 
respectively, Fig. 3.1). 
Table 3.1 Effects of exposure of immature ovine oocytes to different 
vitrification solutions on survival rates. 
Treatment No.Oocytes No. Normal % 
VSI 215 176 81.9% 
VSII 162 122 75.3% 
VSIII 214 175 81 .8% 
100 • Normal 
80 
~ 6 0 0
e 
40 
20 
0 
VSI VSII VSIII 
Figure 3.1 Effects of exposure of immature ovine oocytes to different 
vitrification solutions on survival rates. The graph represents the proportions 
(±SEM) of viable (with normal morphology) ovine COCs following exposure to 
different combinations of cryoprotectants: YSI (20% EG + 20% DMSO), YSJ[ 
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(25% EG + 25% DMSO), VSIIl (25% EO + 25% Gly). Four replicates were 
performed. 
3.3.2 Effects of different vitrification solutions on cumulus cell expansion 
following IVM 
The effects of different cryoprotectants on the numbers of oocyte with expanded 
cumulus cells following IYM are presented in Fig 3.2. The percentages of cumulus 
cell expansion following IVM were significantly decreased (P< 0.0 I) in oocytes 
exposed to VSI (20% EG + 20% DMSO) and VSIl (25% EG + 25% DMSO) as 
compared to the control group (66.2 and 66.5 vs 93.3%, respectively). However, 
these values were not significantly different (P> 0.05) from oocytes exposed to 
VSIlI (25% EG + 25% glycerol, 77.7%, Fig. 3.2) . 
100 
• Cumulus expansion b 
ab 
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a a 
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~ ~0 
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20 
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VSI VSII VSIII Control 
Figure 3.2 Cumu lus cell expansion following IVM of ovine oocytes exposed to 
different vitrification solutions at GV-stage. The graph represents the 
percentages (±SEM) of oocytes with expanded cumulus cells following IVM of 
COCs exposed to different vitrification solutions. Different letters are significantly 
different (P< 0.01). Four replicates were performed. 
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3.3.3 Effects of different cryoprotectants on meiotic maturation following IVM 
Nuclear status of ovine oocytes from different groups· was evaluated 24 hpm. 
Oocytes were categorized into four groups according to nuclear appearance; GV, 
MI, AIrrI, and MIl stages. Oocytes at MIl were recorded as matured. The results 
are presented in Table 3.2 and Fig 3.3. 
Numbers of oocytes remaining at the GV-stage (75.9%, 85/112) were significantly 
higher (P< 0.001) in oocytes exposed to VSII (25% EG + 25% DMSO) than other 
groups (20.3, 26.8, and 11.0% for VSI, VSIII and control, respectively, Table 3.2 
and Fig. 3.3 A). Also, a significant difference (P< 0.05) was observed between 
VSIII and control oocytes. On the other hand, the frequency of nuclear maturation 
(oocytes at MIl-stage) was the lowest (P< 0.001) for oocytes exposed to VSII 
(16.1%, 18/112) than those exposed to VSI (50.0%, 64/128), VSIII (45.1%, 
74/164) as well as control oocytes (61.4%, 781127), with no significant differences 
between the later groups (Table 3.2 and Fig. 3.3 D). 
A significant (P< 0.001) decrease was observed in the proportion of AIrrI oocytes 
in VSII exposed group (2.7%) than other groups (21.9, 17.1, and 16.5% for VSI, 
VSIII, and control, respectively, Table 3.2 and Fig. 3.3 C). No significant 
differences (P> 0.05) were observed in the numbers of MI oocytes between 
treated and control groups (7.8, 5.4, 10.8 and 11.0%, for VSI, VSII, VSIlI, and 
control, respectively, Table 3.2 and Fig. 3.3 B). 
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Table 3.2 Effect of exposure to different vitrification solutions on subsequent 
nuclear maturation of immature ovine oocytes 
Treatment No. Meiotic maturation No. (%) 
Oocytes GV MI Al/J'I MIl 
VSI 128 26 (20.3%t 10 (7.8%)a 28 (21.9%)a 64 (50.0%t 
VSII 112 85 (75.9%t 6 (5.4%t 3 (2.7%)b 18 (16.1%)b 
vsm 164 44 (26.8%)d 18 (10.8%)a 28 (l7.1%t 74 (45.1%)a 
Control 127 14 (ll.O%t 14 (11.0%)a 21 (16.5%t 78 (61.4%t 
Values with different superscripts in the same column are significantly different (a, 
c, b P< 0.001; a, d P < 0.05). GV (Germinal Vesicles), MI (Metaphase-I), AliT! 
(Anaphase-l + Telophase-I), MIl (Metaphase-II), VSI (20% EG + 20% DMSO), 
VSII (25% EG + 25% DMSO), VSIII (25% EG + 25% Gly). 
Figure 3.3 Nuclear maturation of ovine oocytes. The figure shows different 
stages of nuclear maturation of ovine oocytes following 24 h IVM and orcein 
staining, (A) Oocyte at GV-stage, (B) MI stage, (C) AlITI stage, (D) MIl stage, 
scale bar = 50 ~ m . .
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3.4 DISCUSSION 
The major problem associated with cooling and cryopreservation of oocytes is the 
low percentage' of oocytes retaining the ability to undergo normal maturation and 
fertilisation (LeGal and Massip 1999). This may be attributable to the exposure to 
cryoprotectants and cooling process (Mahmoud et al. 2009). Therefore, research 
on different cryoprotectants and combinations here is important for successful 
vitrification, since greater concentrations of vitrification solution may be toxic to 
the oocytes (Yamada et al. 2007). In this study the effects of different vitrification 
solutions with various combinations of cryoprotectants on viability and subsequent 
in vitro maturation of GV-stage ovine oocytes were determined. 
Until recently, attention has been focused on the cryopreservation of mature 
oocytes, however, at this stage; the microtubular spindles are highly sensitive to 
cooling and cryoprotectant agents resulting in damage which may include 
chromosomal abnormalities (Men et al. 2003b). Therefore, the development of an 
efficient protocol for the cryopreservation of immature oocytes with their cumulus 
i 
cells would offer an alternative to the storage of mature oocytes (Silvestre etal. 
2006). In this study, the viability (based on morphological observation) of 
immature ovine oocytes exposed to different vitrification solutions was not 
affected by the types and concentrations of the cryoprotectants ranging from 75 to 
82%. However, following in vitro maturation, significantly lower maturation rates 
(16.1%) were observed in oocytes exposed to VSII (25% EG + 25% DMSO) as 
compared with other groups. In similar studies in bovine oocytes Yamada and 
colleagues (2007), reported that exposure of immature oocytes to the same 
vitrification solutions with the same concentrations for 30 sec did not affect the 
frequencies of in vitro maturation as compared to control, indicating that this 
exposure time, irrespective of vitrification solution had no effect on oocyte 
maturation ability. However, when they increased the time of exposure to 60 sec, 
they found a significant decrease in the frequency of in vitro maturation of oocytes 
exposed to VSII and VSIII. Based on these observations, the results suggest that 
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for this exposure period (60 sec) these cryoprotectants (VSII: 25% EG 25% 
DMSO) have toxic effects on the oocytes (Yamada et al. 2007). In sheep, Silvestre 
et al. (2006) demonstrated that, exposure of immature oocytes obtained from pre-
pubertal ewes to 20% EG plus 20% DMSO significantly decreased the maturation 
rates as compared to control (41.1 % vs 79.9%). In buffalo, Mahmoud et al. (2009) 
reported that maturation rates were severely affected by exposure of GV-oocytes 
to different cryoprotectants. They reported highest maturation rates after exposure 
to EG (54.3%) and EG plus DMSO (47.5%), but the lowest maturation rates were 
observed in EG with glycerol (36.8%) and DMSO with glycerol (29.9%). In 
agreement with the results reported in this study, Albarracin et al. (2005a) reported 
that bovine oocytes exposed to 20% EG and DMSO showed a similar maturation 
frequency as control. Moreover, Wani et al. (2004a) observed that exposure of 
immature buffalo oocytes to 7 M concentrations ofDMSO, EG or PROH followed 
by removal of cryoprotectants in descending concentrations of sucrose did not 
affect the survival and maturation rates as compared to control. In cattle, Cetin and 
Bastan (2006) reported very low maturation rates (14.9%) following vitrification 
of immature oocytes using 40% DMSO. 
COCs have some characteristics that are adverse to cryoprotectant equilibrium 
between intra and extracellular environments. Factors that influence the passage 
velocity of cryoprotectants through the cell membrane and entrance into the 
ooplasm are important in oocyte vitrification (Yamada et al. 2007). The oocyte is a 
large single cell, with a small surface/volume ratio, and surrounded by compact 
cumulus cell layers. The role of cumulus cells during oocyte vitrification is still 
controversial. It has been reported that the presence of compact layers of cumulus 
cells surrounding immature mouse oocytes blocked the permeation of the high 
toxic cryoprotectant and might help to prevent swelling of oocytes during removal 
of the cryoprotectant (Miyake et al. 1993). Vajta et al. (1998) showed that, the 
cumulus layers and accumulated glycoproteins may reduce the speed of 
cryoprotectant penetration. Bogliolo et al. (2007a) reported that denudation of 
immature ovine oocytes before IVM and prior to vitrification increased the 
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frequencies of oocyte viability and subsequent maturation. Ohali et of. (2000) 
reported that, the presence of compact cumulus cell mass could reduce the rate of 
EG or DMSO passage into the oocytes. 
The maturation rate obtained in the present study (SO%, in VSI group) was similar 
to that reported by Silvestre et of. (2006) for pre-pubertal ovine immature oocytes 
following exposure to the same concentrations of cryoprotectants (20% EG + 20% 
OM SO). Although, the maturation rate was similar in oocytes recovered from pre-
pubertal or adult sheep, a previous report showed that oocytes recovered from pre-
pubertal sheep had significant biological differences compared with oocytes 
obtained from adult animals (Ledda et 01. 200 I). The higher viability and 
maturation reported here following exposure to VSI could be ascribed to multiple 
step-wise exposures of immature oocytes to cryoprotectants which resulted in less 
harmful effects than a single step exposure (Isachenko et 01. 1998; Abe et 01. 
200S). 
It has been reported that exposure of mouse oocytes to the three commonly used 
cryoprotectants (propanediol, EG, and OMSO) induces an immediate increase in 
intracellular calcium (Cat+). The magnitude and duration of (Cat) transient 
induced varied between the cryoprotectants with EG giving the smallest and 
shortest increase, and propanediol giving the highest level. However, DMSO 
affects (Catl stores directly, possibly by permeabilizing mitochondria andlor the 
endoplasmic reticulum (ER) (Larman et of. 2006; Gardner et of. 2007). In these 
studies, very low maturation rate (16.1%) was reported after exposure of oocytes 
to vitrification solution (VSII) containing higher concentrations of EG (2S%) and 
DMSO (2S%). This lower value seems to be associated with the use of this 
concentration of DMSO, because, the maturation rate (45.1 %) was not affected in 
oocytes exposed to VSIII (2S% EG + 2S% glycerol) as compared to control. 
Glycerol in combination with either EG or DMSO has been used as cryoprotectant 
for oocyte vitrification in buffalo (Wani et 01. 2004a, b; Mahmoud et 01. 2009), 
cattle (LeGal and Massip 1999; Yamada et 01. 2007) but with lower maturation 
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rates. Glycerol has been widely used for freezing of bovine embryos because of its 
low cytotoxicity. However, glycerol can induce severe osmotic damage to the 
cytoplasm due to its low membrane permeability (Szell et al. 1989). The low 
permeability of the cells to glycerol may increase the risk of osmotic stress during 
thawing and dilution as the water enters the cells more quickly than the glycerol. 
This may explain the poor results obtained following vitrification of oocytes by 
glycerol (Wani et al. 2004a). 
In the present study, a combination of 20% EG and 20% DMSO can be used 
effectively for the cryopreservation of oocytes. Because of their low molecular 
weight, these components can easily permeate through cell membranes rapidly to 
achieve concentration equilibrium across the membranes. Moreover, EG, because 
of its high permeability and low toxicity has been found to be convenient for 
vitrification of immature human (Liebermann and Tucker 2002), cattle (Cetin and 
Bastan 2006), horses (Hurtt et al. 2000), pigs (Somfai et al. 2007), buffalo 
(Mahmoud et al. 2009) and sheep (Bogliolo et al. 2007a) oocytes. 
In conclusion, exposure of immature ovine oocytes to vitrification solution 
containing higher concentrations of the permeating cryoprotectant DMSO has an 
adverse effect on subsequent in vitro maturation. However, a combination of EG 
plus DMSO at a concentration of 20% each can be used effectively as a 
vitrification solution for ovine GV-oocytes. Further studies are required to 
evaluate the effects of different exposure times to various cryoprotectants on 
viability and subsequent development of immature ovine oocytes. Also, further 
studies are required to test the effects of different vitrification solutions on 
development of immature oocytes during vitrification by different techniques. 
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CHAPTER 4 
IN VITRO FERTILISATION OF OVINE OOCYTES 
VITRIFIED BY SOLID SURFACE VITRIFICATION 
(SSV) AT GERMINAL VESICLE STAGE 
4.1 INTRODUCTION 
Oocyte cryopreservation has become one of the most challenging approaches to 
restore fertility of chemo-and radiation therapy treated women with compromised 
ovarian function (Fabbri et 01. 2001; Fabbri 2006). In livestock, where large 
numbers of ovaries can be easily obtained from a slaughterhouse, many oocytes 
can be collected, preserved and then incorporated in an in vitro production (lVP) 
system when considered appropriate, diminishing seasonal variations or sanitary 
constraints. Increasing cooling and warming rates as well as high concentrations of 
cryoprotectant are the critical factors which determine the success of vitrification. 
To achieve high cooling rates, the sample size and the volume of vitrification 
solution should be decreased. So, the sample has chance to be surrounded by 
liquid phase not vapour. Special carriers have been used to minimize the volume 
of vitrification solutions (see Chapter 1.6.1.3). In an alternative technique called 
Solid Surface Vitrification (SSV), oocytes in a small droplet of solution are 
vitrified upon contact with a metal surface partially immersed into liquid nitrogen 
(LN2) and pre-cooled to -180°C (Dinnyes et 01. 2000). SSV was used effectively 
for the cryopreservation of in vitro matured cattle (Dinnyes el 01. 2000; Sripunya 
et 01. 2010), goat (Begin et 01. 2003), pig (Somfai et 01. 2006), buffalo (Boonkusol 
et 01.2007; Gasparrini et 01. 2007), sheep (Zhang et 01. 2009) oocytes. Moreover, 
this method was used for vitrification of immature pig oocytes (Gupta et 01. 2007). 
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It has been previously described that the meiotic stage of oocyte influences its 
ability to survive cryopreservation. Until recently, attention has been focused on 
the cryopreservation of mature Mil oocytes, despite, the fact that various kinds of 
cryoinjury and severe malfunctions can be caused to the oocytes at this stage, such 
as spindle disorganization (Mandelbaum et al. 2004), loss or clumping of 
microtubules resulting in some scattering of chromosomes (Sathananthan et a/. 
1988), increased polyploidy after fertilisation (AI-Hasani et al. 1987; Carroll et al. 
1990) and subsequent decrease in fertilisation rates (Mandelbaum et al. 2004; 
Somfai et al. 2007). Conversely, vitrification of immature oocytes at the germinal 
vesicle (a V) stage might circumvent these problems due to fact that the genetic 
material is held within the contours of a nuclear envelope. However, there are few 
studies that have reported the development of immature oocytes following 
vitrification (Somfai et al. 2010). 
The objectives of this study were to evaluate the effects of SSV and exposure to 
SSV solutions (35% EO, 5% PVP, 0.4 M trehalose for less than 60 sec) without 
freezing (Toxicity control) on the viability and subsequent development of ovine 
oocytes vitrified at GV-stage. Following parameters were assessed 1) recovery 
and survival rates following SSV, 2) cumulus celI expansion and nuclear 
maturation following in vitro maturation (IVM), 3) frequencies of in vitro 
fertilisation (IVF) and polyspermy, 4) kinetics of first cleavage following IVF, 5) 
in vitro embryo development f o l ~ o w i n g g IVMlIVF. 
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4.2 MATERIALS AND METHODS 
4.2.1 Vitrification ofCOCs hy solid surface vitrification (SSV) 
COCs obtained from slaughtered sheep ovarIes were washed three times in 
washing medium (see Chapter 2.1) and randomly assigned into three groups, 1) 
control group (directly subjected to in vitro maturation, IVM), 2) Exposed group 
(EXP, exposed to SSV vitrification solution without plunging into LN2), 3) SSV 
group (vitrified by SSV, Chapter 2.2.2). Following vitrification and warming, 
viable oocytes were matured in vitro for 24 h (Chapter 2.3). 24 h post onset of 
maturation (hpm), cumulus cell expansion and meiotic maturation were evaluated 
as previously described (Chapter 2.3.1 and 2.3.2). 
4.2.2 In vitro fertilisation (IVF) and Culture (IVe) 
Matured oocytes were fertilised in vitro usmg frozen thawed ram semen as 
previously described (Chapter 2.5). 18 hpi (hours post insemination); frequencies 
of in vitro fertilisation and polyspermy were evaluated as previously described 
(Chapter 2.5.3). Presumptive zygotes were cultured in vitro as described in 
(Chapter 2.8). Frequencies of cleaved embryos were assessed at 24, 30 and 48 
hpi. On day 7, developmental rates to blastocyst stage embryos were recorded and 
morphologically evaluated under stereomicroscope and divided into early, 
expanded and hatched blastocysts. 
4.2.3 Statistical Analysis 
At least three replicates were carried out for each experimental group. Data were 
analysed using Chi square test. All results are considered to be statistically 
significant at P< 0.05, unless otherwise stated. 
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4.3 RESULTS 
4.3.1 Recovery rates and oocyte viability following SSV 
The effects of SSV of immature ovine oocytes on recovery rates and viability 
based on morphological evaluation are illustrated in Table 4.1 and Figs 4.1, 4.2 
and 4.3. No significant differences (P> 0.05) were observed in the proportions of 
recovered oocytes following SSV (75.7%, ] 43/189) or exposure to SSV 
vitrification solution (EXP, 90%, 108/120, Fig 4.1). Of those oocytes recovered 
74.8%, 1071143 and 82.4%, 89/108 were recorded as morphologically normal 
(viable) in SSV and EXP groups, respectively (Fig 4.2), the difference between the 
two groups was not significant. Also, no significant differences were observed in 
the numbers of recovered oocytes with abnormal morphology (damaged, non 
viable) following SSV and EXP (25.2 vs 17.6%, respectively, Figs 4.2 and 4.3). 
Table 4.1 Recovery rates and viability of ovine oocytes vitrified at GV-stage 
by Solid Surface Vitrification (SSV). 
Treatment 
SSV 
EXP 
100 
80 
60 
~ ~
Q 40 
20 
Total No. Oocytes No. Recovered (% 
of to 10 I oocytes) 
189 143 (75.7%) 
120 108 (90.0%) 
- Recovered 
No. Normal (% of 
recovered oocytes) 
107 (74.8%) 
89 (82.4%) 
o + - - - - - - ~ - - - - - - - - , - - - - - - - - ~ ~ - - - - - - ~ ~
SSV EXP 
Figure 4.1 Recovery rates of ovine oocytes vitrified at GV -stage by Solid 
Surface Vitrification (SSV). The graph represents the proportions (±SEM) of 
recovered oocytes following SSV of ovine COCs and exposure to vitrification 
solution (EXP). 
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- Normal 
100 
80 
~ ~ 60 
40 
20 
0 
SSV EXP 
Figure 4.2 Viability of ovine oocytes vitrified at GV-stage by Solid Surface 
Vitrification (SSV). The figure represents the percentages (±SEM) of recovered 
oocytes with normal (viable) morphology following SSV and exposure to 
vitrification solution (EXP). Three replicates were carried out. 
Figure 4.3 Degenerated oocyte recovered following SSV of ovine COCs. The 
figure shows an oocyte with damaged zona pellucida and degenerate cytoplasm 
following SSV. Scale bar = 50 ).lm. 
4.3.2 Cumulus cell expansion and meiotic maturation folio wing IVM 
The effects of SSV on cumulus cell expansion following IVM of ovme 
vitrified/thawed GV-oocytes is presented in Figs 4.4 and 4.5. Vitrification of 
immature ovine oocytes with SSV and exposure to vitrification solution 
significantly (P< 0.01) decreased the proportions of oocytes with expanded 
cumulus cells as compared with control (41.3 and 58.3 vs 80.9% for SSV, EXP, 
and control, respectively, Figs 4.4 and 4.5). 
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The nuclear maturation of ovine oocytes vitrified at GV-stage using SSV and 
exposed to SSV vitrification solution is presented in Table 4.2 and Fig 4.6. 
Frequencies of in vitro maturation (oocytes at MIl stage) were sign ificantly 
decreased (P< 0.01) in both SSV and EXP groups as compared to control (23.7 
and 35.6 vs 71.9%, respectively). In contrast, at 24 hpm, numbers of oocytes that 
remained at the GV-stage were significantly higher (P< 0.01) in both SSV and 
EXP groups than in control (62.9 and 51.7 vs 9.6% respectively). No significant 
differences were observed between treated and control groups in terms of MI and 
AIITI stages. These values ranged from 4.6 to 10.2% Table 4.2 and Fig 4.6 . 
• Cumulus expansion 
100 
b 
v EXP Control 
Figure 4.4 umulu cell expansion following IVM of ovine oocytes vitrified at 
GV-stagc u ing V. The figure represents the percentage (±SEM) of oocytes 
with expanded cumulus cells following IYM of COCs vitrified by SSV or exposed 
to S V olution ( XP). Different letters indicate significant differences (P < 0.0 I). 
Three replicates were performed. 
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Figure 4.5 Oocytes with expanded cumulus cells. The figure reveals cumulus 
cell expansion following 24 h IVM of ovine oocytes (A) vitrified at GV-stage 
using SSV, (B) exposed to SSV solution or (C) non treated (control) group, scale 
bar = 50 )lm. 
Table 4.2 Nuclear maturation of ovine oocytes vitrified at GV-stage by SSV 
Treatment 
SSV 
EXP 
Control 
No. 
Oocytes 
97 
87 
135 
GV 
61 (62.9%)3 
45 (51.7%)3 
13 (9.6%)b 
Meiotic maturation No. (%) 
MI AIITI MIl 
5 (5.2%)3 8 (8.3%)3 23 (23.7%t 
4 (4.6%t 7(8.1%t 31 (35.6%t 
II (8.2%t 14 (10.4%t 97 (71.9%)b 
Values with different superscripts in the same column are significantly different (a, 
b P< 0.01). GV: Germinal Vesicles, MI: Metaphase-I, AliT!: Anaphase-II 
Telophase-I, MIl: Metaphase-II, SSV: Solid Surface Vitrification, EXP: Exposed 
to vitrification solution without freezing. Three replicates were performed. 
Figure 4.6 Meiotic maturation of ovine oocytes. The figure shows stages of 
nuclear maturation following 24 h IVM of ovine oocytes vitrified at GV-stage 
using SSV. Oocytes were examined after orcein staining (A) oocyte at GV-stage, 
and (B) MIl stage. Scale bar = 50 )lm. 
69 
Chapter 4 SSV and subsequent development 
4.3.3 Frequencies of in vitro fertilisation and polyspermy following IVF 
The effects of SSV or exposure to vitrification solution on in vitro fertilisation 
following IVF of ovine oocytes vitrified at GV-stage are presented in Table 4.3 
and Fig 4.7. Vitrification of immature ovine oocytes with SSV significantly (P< 
0.01) decreased the in vitro fertilisation rates (39.3%) as compared to non treated 
control group (64.7%). However, exposure to SSV solution alone did not 
significantly affect fertilisation (56.4%) as compared to control. In terms of 
polyspermy (presence of more than one sperm in ooplasm or more than two 
pronuclei), SSV resulted in lower percentages (5.4%) than EXP (11.7%) or control 
(15.3%), however the differences were not significant between three groups. 
Significantly higher (P< 0.01) percentages of oocytes remained unfertilised in 
SSV group (55.4%) compared to EXP (31.9%) and control (20.0%, Table 4.3 and 
Fig 4.7). 
Table 4.3 Frequencies of in vitro fertilisation and polyspermy following 
IVMIIVF of ovine oocytes vitrified at GV-stage by SSV. 
No. Fertilisation No. (%) 
Treatment 
Oocytes Fertilised Polyspermic Unfertilised 
SSV 56 22 (39.3%t 3 (5.4%t 31 (55.4%t 
EXP 94 53 (56.4%)b 11 (11.7%t 30 (31.9%)b 
Control 85 55 (64.7%)b 13 (15.3%)8 17 (20.0%)b 
Values with different superscripts in the same column are significantly different (a, 
b P< 0.01). Fertilised oocytes (characterised by presences of spermlswolIen sperm 
head in ooplasm, or a male andlor female pronuc1us), polyspermy (oocytes have 
more than one sperm in ooplasm or more than two pronuclei), unfertilised oocytes 
(with no signs of sperm penetration), SSV (Solid Surface Vitrification), EXP 
(Exposed to vitrification solutions without freezing). Three replicates were carried 
out. 
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ssv Control 
Figure 4.7 Fertilisation events in ovine oocytes. The figure illustrates IVMlIVF 
oocytes at 18 hpi stained with Hoechst. (A and B) fertilised oocytes with male and 
female pronuclei, (C and D) oocytes with polyspennic fertilisation, and (E and F) 
unfertilised oocytes with no signs of spenn penetration. Scale bar = 50 ~ m . .
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4.3.4 Kinetics of first cleavage following IVF 
Timing of first cleavage following IVF of ovine oocytes vitrified at GV-stage 
using SSV was evaluated at 24 and 30 hpi. The results of this experiment are 
presented in Table 4.4. The total cleavage was calculated from total oocytes used 
for IVF, while kinetics of first cleavage was recorded based on total cleavage. 
Significantly (P< 0.001) lower frequencies of cleaved embryos were observed in 
vitrified group compared to EXP and control (4.1 vs 50 and 52.5%, respectively). 
Assessment between 24 and 30 hpi indicates that most of vitrified oocytes (75%) 
cleaved late as compared to EXP (58.6%) and control (43.8%) groups. At 24 h, 
only 25% of cleaved oocytes were recorded in SS V groups, while 41.4 and 56.3% 
were observed for EXP and control oocytes, respectively (Table 4.4). 
Table 4.4 First cleavage following IVMlIVF of ovine oocytes vitrified at GV 
stage 
No. No. 
Treatment No. Cleaved(%) Total cleaved Oocytes hpi (%) 24 30 
SSV 97 1 (25.0 %)8 3 (75.0 %t 4 (4.12%)8 
EXP 58 12 (41.4%t 17 (58.6 %t 29 (50.0%)b 
Control 61 18 (56.3 %)8 14 (43.8 %)8 32 (52.5%)b 
Values with different superscripts in the same column are significantly different (a, 
b P< 0.001). Total cleavage rate is calculated on IVF oocytes while kinetic 
cleavage rates are based on total cleaved oocytes, hpi (hours post insemination). 
Three replicates were performed. 
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4.3.5 In vitro embryo development following IVF 
The effects of SSV and exposure to vitrification solution on the frequencies of 
oocyte cleavage at 48 hpi and subsequent in vitro embryo development up to 
blastocyst stages are presented in Table 4.5 and Fig 4.8. 
Vitrification of immature ovme oocytes using SSV significantly (P< 0.00 I) 
decreased the frequency of cleavage at 48 hpi as compared to EXP and control 
groups (9.6 vs 55.9 and 76.6%, respectively). Also, exposure to vitrification 
solution alone (EXP) significantly reduced cleavage. 
A similar trend was observed for day 7 blastocyst development. Significantly (1'< ~ ~
-.............. __ ~ r ~ ~
0.00 I) lower percentages of oocytes developed to blastocyst stage embryos 
following SSV (0.5%) as compared to EXP (20%) and control (45.3%) groups 
(Table 4.5 and Fig 4.8). The difference between EXP and control groups was also 
significant at (P< 0.01). Based on the numbers of cleaved oocytes, 5.4% of the 
cleaved embryos had developed to the blastocyst stage at day 7 following IVF in 
SSV group compared to 35.2 and 59.2% for EXP and control groups (Table 4.5). 
Morphological evaluation of in vitro produced blastocysts revealed that, no 
blastocysts at early and expanded stages were observed in SSV groups, but 6.2 vs 
13.1 % were recorded as early and 6.6 vs 13.1 % as expanded blastocysts for EXP 
and control (Table 4.5 and Fig 4.8). In terms of hatched blastocysts, all in vitro 
produce blastocysts from SSV were hatched and represented 0.5% of the total 
oocytcs vitrified. This value was significantly lower (P< 0.00 I) than those 
observed in EXP (7.2%) and control (18.7%) groups. 
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Table 4.5 In ,"itro embryo development following IVF oh"itrifiedJthawed ovine COCs using SSV 
Treatment 1\'0. No. Cleaved No. Blastocysts (% of ooc)'tes) Total Blastocysts 
Oocytes 48 hpi(%) (% of cleaved) 
Early Expanded Hatched Total 
SSV 385 37 (9.6%t 0 0 2 (0.5%t 2 (0.5%t (5.4%t 
EXP 290 165 (55.<)010)" 18 (6.2%t 19 (6.6%t 21 (7.2%t 58 (20.0%t (35.2%)" 
Control 278 213 (76.6%t 37 (13.I%t 37 (13.1%)D 52 (18.7%t 126 (45.3%t (59.2%t 
Values with different superscripts in the same column differ significantly (a vs b and a vs c P< 0.001 while b vs c P< 0.01). hpi (hours 
post insemination). Seven replicates were carried out. 
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Figure 4.8 Developmental stages of ovine embryos produced by IVF of ovine 
oocytes vitrified at GV-stage using SSV. Examples of embryos produced 
following IVF (A) SSV. (B) Day 7 early blastocyst produced following IVMlIVF 
of ovine oocytes exposed (EXP) to SSV solution without freezing. (C) Day 7 
hatched blastocysts produced by IVF of ovine oocytes exposed to SSV solution, 
and (D) vitrified using SSV technique. Scale bar = 50 ~ ~ . .
4.4 DISCUSSION 
Vitrification, as a simple cryopreservation method of directly submerging a cell in 
liquid nitrogen after brief exposure to a cryoprotectant agent, is substantially less 
harmful to cells such as oocytes and embryos that have high chilling sensitivities 
than are conventional cryopreservation methods using traditional slow-freezing 
(Martino et al. 1996a; Vajta et al. 1998). The advantage to the cells of vitrification 
over conventional cryopreservation procedures is that the 'open system' lacks an 
insulating layer around the sample. The vapour surrounding the cells can create 
effective insulation that reduces temperature transfer, resulting in a decreased 
cooling rate and possibly crystallization (Liebermann and Tucker 2002). The 
volume of the vitrification solution should be minimized as much as is practical to 
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ensure that the cells are surrounded with liquid nitrogen and not vapour. Thus the 
duration of any coating vapour is reduced and the rate of cooling is increased. 
Combination of direct contact with liquid nitrogen and small volume of 
vitrification solution allows higher cooling rates to be achieved, because heat 
conduction in liquid is much faster than in vapour. SSV as a containerless system 
which favours rapid heat exchange during cooling was effectively used for 
cryopreservation of in vitro matured bovine oocytes (Dinnyes et al. 2000), 
however its application in vitrification of IVM ovine oocytes resulted in very low 
(2%) blastocyst rates following IVF (Zhang et al. 2009). The present study 
investigated the effects of SSV on viability and subsequent developmental 
potential after IVMlIVF of vitrified/thawed ovine GV -oocytes. 
SSV is a very cheap method that enables preservation of several microdrops of 
vitrification solution within a short period of time, each containing a large number 
of oocytes (Somfai et af. 2010). On the other hand, controlling the droplet size by 
this method requires extensive practice and there is a constant chance of oocyte 
loss through sticking of oocytes to the inner surface of the glass capillary or due to 
random drop dispersion caused by the flipping movement (Begin et af. 2003). The 
recovery rate is the number of remaining oocytes after expulsion of solution from 
the container during warming. Its analysis is important because cells must tolerate 
a sequence of volumetric concentrations and expansions which are related to 
different concentrations of the solution, and they can lose or rupture during this 
process (Gomes et al. 2008). The recovery rate following SSV (75.7%) reported 
here was slightly lower than that obtained by (Begin et al. 2003, 83%) and (Gupta 
et al. 2007, 91%) following SSV of IVM goat and pig oocytes. These variations 
might be ascribed to differences in protocols and technical approaches. In the goat 
study, the authors used a hollow metal cube covered with aluminium foil 
immersed in liquid nitrogen, however, in pig experiments; a piece of aluminium 
foil floating on liquid nitrogen was used as a cooling surface. Somfai et al. (2007) 
compared the two methods for vitrification of pig oocytes and they reported higher 
survival rates with aluminium foil than metal cube. Nevertheless, it must also be 
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emphasized that use of aluminium foil might add a technical variable and would 
require technical skill in controlling the size of the droplets formed on the cold 
surface, to keep the metal surface dry and to avoid setting of liquid nitrogen 
vapour on the surface of the droplet whilst being placed onto the metal surface. 
The frequencies of viable oocytes based on morphological evaluation reported in 
this study (74.8%) were slightly lower than those reported by Al-aghbari and 
Menino (2002, 88.9%) and Bogliolo et al. (2007a, 84.3%). The differences 
between studies may be due to the cryodevices used for vitrification (cryotops in 
Bogliolo et al. 2007a versus SSV). However, Al-aghbari and Menino (2002) used 
the same method (SSV), so the differences in the results were not clear. But, the 
objective of Al-aghbari and Menino study was to develop an effective technique 
for vitrification of sheep ovarian tissues and they collected ovine COCs by 
slashing of the ovaries with a scalpel. Moreover, they evaluated oocytes survival 
using hematoxylin and eosin staining. SSV was used successfully for 
cryopreservation of IVM sheep oocytes with high survival rates (84.6%, Zhang et 
al. 2009). In pig, high survival (80%) was also reported following SSV of GV and 
MIl oocytes (Gupta et al. 2007). In contrast, Somfai et al. (2010) r e p o ~ e d d lower 
viability (27.7%) following SSV of pig GV oocytes. Following exposure to SSV 
solution (EXP, toxicity test), -80% of oocytes were viable. Similarly, Dinneys et 
al. (2000) and Somfai et al. (20 I 0) reported 90-94% survival following exposure 
of cattle MIl and pig GV oocytes to the same cryoprotectants. 
Oocyte maturation provides an indication of the impairment of oocytes following 
exposure to cryoprotectant or vitrification. In the present study, the degree of 
cumulus cell expansion was significantly decreased in both treatment groups (SSV 
and EXP, 41.3 and 58.3%, respectively) as compared to control (80.9%). In 
contrast, a study by Isachenko et al. (200 I) reported excellent expansion of 
cumulus cells following IVM of vitrified/thawed ovine GV oocytes. They 
suggested that this could be due to the presence of light unsaturated lipids in 
cumulus cells. Also, Gupta et al. (2007) observed significantly decreased (31 %) in 
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cumulus ceJl expansion after IVM of porcine oocytes vitrified by SSV at GV-stage 
using DMSO as a cryoprotectant. This observation could be attributed to the 
damage and interruption that occur to the cumulus ceJls during vitrification. 
Bogliolo et al. (2007a) observed that most of the cumulus cells surrounding 
vitrified/thawed immature ovine oocytes had numerous cytoplasmic vacuoles and 
damaged cell projections. In addition, exposure to the cryoprotectants has been 
found to disorganize the actin filaments within transzonal processes through which 
cumulus cells establish physical contact with the oocytes (Younis et al. 1996). In 
the present study, vitrification of ovine GV oocytes and exposure to 
cryoprotectants significantly decreased the frequencies of in vitro maturation 
(oocytes at MIl stage, 23.7 and 35.6%) as compared to the control group (71.9%). 
Lower maturation rates were also reported by Isachenko et al. (2001, 27.5%), 
Bogliolo et al. (2007a, 31.2%) following vitrification of ovine GV-oocytes. 
Moreover, vitrification of immature oocytes resulted in lower maturation rates in 
other species such as goats (Kharche et al. 2005, 27.5%); cattle (Kim et al. 2007, 
41.1%); buffalo (Wani et al. 2004b, 29.2%; Sharma and Purohit 2008, 39.2%), and 
horses (Tharasanit et al. 2006a, 27.6%) as compared to the control groups. 
FoJlowing IVM of ovine vitrified/thawed GV-oocytes, many oocytes (62.9%) did 
not resume meiosis and remained at GV stage. This block in oocyte development 
may be due to aberrant protein synthesis after freezing (Kharche et al. 2005). 
Different lines of evidence clearly indicate that surrounding cumulus cells playa 
fundamental role in the maturation process (Li et al. 2006). These cells and the 
oocyte are functionally and physically connected, establishing a sophisticated 
network of mutual interaction, which ultimately confers fuJI developmental 
competence to the oocyte (Bogliolo et al. 2007a). 
It has been reported that cooling affects spindle fibre integrity (Chen et al. 2003) 
and cortical granule vesicles (Vincent and Johnson 1992). Depolymerization of the 
spindle fibres is likely to lead to aneuploidy (AI-Hasani el al. 1987) and premature 
release of the cortical granules is likely to lead to zona hardening (Vincent and 
Johnson 1992). Alterations of zona pellucida glycoproteins, especially ZP2, are 
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reported to be responsible for zona hardening in mouse oocytes (Moller and 
Wassarman 1989). The frequencies of in vitro fertilisation reported here were 
significantly lower in vitrified oocytes as compared to EXP and control groups and 
higher numbers of oocytes remained unfertilised (with no signs of sperm 
penetration) in vitrified groups as compared to EXP and controls (Table 4.3). In 
cattle, lower fertilisation rates were also reported following IVF of 
vitrified/thawed GV-oocytes (Kim et al. 2007, 78.6%). In contrast to these results, 
Somfai et al. (2010) reported high fertilisation rates (91.7%) after IVF of 
vitrified/thawed porcine GV oocytes, suggesting that normal cytoplasmic 
maturation had occurred. 
The deleterious consequences arising from cryodamage may also appear during 
cleavage or pre-implantation development (Coticchio et al. 2004). In fact, it has 
been well documented that, vitrified-warmed oocytes cleave and reach blastocyst 
stage in significantly lower proportions as compared to control (Kelly et al. 2006; 
Kim et al. 2007; Succu et al. 2008,). This study investigated the effect of SSV on 
kinetics of first cleavage and subsequent in vitro embryo development following 
IVM/IVF/IVC of ovine oocytes vitrified at GV stage. Vitrified warmed oocytes 
displayed a delay in cleavage compared to control, but the differences were not 
significant. Similarly, Sucuu et al. (2008) reported a delay in cleavage following 
IVF of vitrified/warmed ovine Mil oocytes. The delay in cleavage rates observed 
in vitrified oocytes, may suggest a decrease in gamete competence caused by 
cryopreservation procedures (Succu et al. 2008). In the present study, the 
frequencies of cleaved embryos (48 hpi) and blastocyst development (Day 7 pi) 
were significantly lower in vitrified oocytes as compared to EXP and control 
groups (Table 4.5). Cleavage (9.6%) and blastocyst development (5.4%) reported 
here were lower than those obtained by Succu et al. (2007a, 12.5%) and Succu et 
al. (2008, 17%) following IVF of vitrified/thawed ovine Mil oocytes. These 
differences may be due to the cryodevices used (cryoloop and cryotop versus 
SSV); or to differences in the meiotic stage (MIl versus GV) of oocytes when 
vitrified. Higher percentage of blastocysts development (35.2%) was reported 
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following exposure of immature ovine oocytes to vitrification solutions alone 
indicating that the use of a mixture of a relatively low molecular weight and highly 
penetrated cryoprotectant (Le. EG), a viscosity-increasing compound (PVP), and a 
membrane-protective sugar (trehalose) is efficient for oocyte vitrification (Oinnyes 
et 01. 2000). Although lower rates of blastocyst development were obtained from 
the vitrified oocytes, morphological evaluation of those blastocysts suggested them 
to be of good quality (hatched), however further studies are required to evaluate 
total cell numbers in these blastocysts. The low frequency of blastocyst 
development reported here may be associated with the changes in lipid content 
(mainly phospholipids) and fatty acid composition in frozen-thawed oocytes (Kim 
et of. 2001). Also, oocyte vitrification has been reported to be accompanied with 
alterations in mitochondrial activity such as loss of activity or abnormal 
distribution (Abe et 01. 2005). More recently, it has been speculated that oocyte 
vitrification may also affect embryo development on a molecular level by 
decreasing the levels of maternal mRNAs in ovine oocytes (Succu et 01. 2008). 
In conclusion, these results indicate that immature ovine oocytes vitrified with 
SSV as a simple and rapid procedure can survive and subsequently be matured, 
fertilised and develop in vitro up to the blastocyst stage, although the frequency of 
development is low. The results also show that the high concentrations of 
cryoprotectants per se applied in SSV were not detrimental for in vitro 
development. The vitrification protocol described here is not a definitive protocol; 
rather, it provides direction for further investigations into the cryopreservation of 
ovine oocytes, which may lead to more effective techniques. Therefore, further 
studies are required to improve the survival and developmental potential of 
vitrified/thawed ovine oocytes. 
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CHAPTERS 
VITRIFICATION OF IMMATURE OVINE OOCYTES 
USING THE CRYOLOOP: EFFECTS ON VIABILITY, 
IN VITRO MATURATION, FERTILISATION AND 
SUBSEQUENT DEVELOPMENT 
5.1 INTRODUCTION 
Oocyte cryopreservation represents one of the most recent developments in the 
field of reproductive technologies and will become an important tool for the 
creation of genetic resources banks in domestic animals (Ledda et al. 2007). 
Despite some success with different species and the publications in the past years 
of several fundamental cryobiology studies, oocyte cryopreservation as an 
established procedure, able to compete with the efficiency of sperm and embryo 
freezing, remains largely unaccomplished (Shaw et al. 2000). The cryopreserved 
Iwarmed oocytes normally show several ultrastructural (Abe et al. 2005) and 
structural alterations, such as phase change of lipid bilayers, lysis of cytoplasmic 
membrane (Agca el al. 1998) and nuclear fragmentation (Men el al. 2003a). As 
early as 1985, ice-free cryopreservation of mouse embryos at -196°C by 
vitrification was reported (Rail and Fahy 1985) as an alternative approach to 
cryostorage. The key aim of any vitrification protocol is to achieve high cooling 
rates in association with high concentrations of cryoprotectant. High cooling rates 
allow reduction in the concentration of the cryoprotectants used and subsequent 
reduction in their toxic and osmotic effects. Special carriers have been used to 
minimize the volume of vitrification solution (see Chapter 1.6.1.3), Vitrification 
of oocytes using the cryoloop has advantages over conventional vitrification in 
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that, the open system lacking any thermo insulating layer, coupled with the small 
volume of less than 1 Ill, results in both rapid and uniform heat exchange during 
cooling (Lane et al. 1999a, b; Saki and Dezfuly 2005). So far, the cryoloop has 
been used effectively for vitrification of human, mouse (Lane et al. 1999a, b) 
blastocysts with high survival rates. Furthermore, Mavrides and Morroll (2002) 
obtained high survival and cleavage rates similar to fresh oocytes following 
intracytoplasmic sperm injection (ICSI) of vitrified bovine oocytes using 
cryoloop. Cryopreservation of germinal vesicle (GV) oocytes would generate a 
readily available source of oocytes for research and allow experiments to be 
performed at a convenient time. However, data obtained to date, indicate that 
immature oocytes are more susceptible to cryoinjury and the survival and 
subsequent developmental potential are greatly impaired in comparison to fresh 
oocytes (Hochi et al. 1998). Structural modifications of cytoskeleton, 
mitochondria, cortical granules and nucleoli have been described to be associated 
lower efficiency of vi trifiedl warmed GV oocytes. 
The aims of these studies were to investigate the effects of Cryoloop vitrification 
on viability and subsequent developmental competence of ovine oocytes vitrified 
at GV-stage. Following categories were examined, 1) recovery and survival rates 
following vitrification and warming, 2) cumulus expansion and nuclear 
maturation following in vitro maturation (IVM), 3) Spindle and chromosome 
configuration, 4) fertilisation events following in vitro fertilisation (IVF), 5) in 
vitro embryo development following IVM/IVF/IVC. Total cell numbers, numbers 
of apoptotic nuclei, and chromosomal constituents of in vitro produced blastocysts 
were evaluated. 
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5.2 MATERIALS AND METHODS 
5.2.1 Vitrification of cumulus oocyte complexes (COCs) using cryoloop 
COCs obtained from slaughtered sheep ovaries were washed three times in 
washing medium (see Chapter 2.1) and then randomly divided into three groups, 
1) control (directly matured in vitro), 2) toxicity (COCs exposed to cryoloop 
vitrification solutions without freezing), 3) vitrified (COCs were vitrified using 
cryoloop, Chapter 2.2.3) groups. Following vitrification and warming, oocyte 
viability was determined as previously described (Chapter 2.2.4). Viable oocytes 
were matured in vitro for 24 h (Chapter 2.3). At 24 hpm (hours post onset of 
maturation), maturation status, spindle and chromatin configuration were 
evaluated as described in (Chapter 2.3.1,2.3.2 and 2.4). 
5.2.2 In vitro fertilisation (IVF) and culture (IVC) 
In vitro matured oocytes were fertilised using 2.0 x 106 frozen/thawed ram semen 
as previously described (Chapter 2.5). 18 hpi (hours post insemination), 
fertilisation events were examined by staining with 10 Ilg/ml Hoechst 33342 
(Chapter 2.5.3). In vitro culture of presumptive zygotes and embryo evaluation 
were carried out as previously described (Chapter 2.8 and 2.8.1). Total cell 
numbers and number of apoptotic nuclei were determined using Hoechst and 
TUNEL assay as described in (Chapter 2.9). Cytogenetic analysis of day 7 
blastocyst embryos was evaluated according to the method described in (Chapter 
2.10). 
5.2.3 Statistical Analysis 
Data were analysed by Chi square test. Total cell numbers and apoptotic cells 
were analysed using un-paired student's I-test. All results were considered to be 
statistically significant at P< 0.05, unless otherwise stated. 
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5.3 RESULTS 
5.3.1 Recovery rates and oocyte survival 
The recovery rates and subsequent oocyte viability following cryoloop 
vitrification or exposure to vitrification solutions are presented in Figs 5.1, 5.2, 
and 5.3. After cryoloop vitrification (82.6%, 161/195) ofvitrified/warmed oocytes 
were recovered. These proportions did not differ significantly (P> 0.05) from 
those obtained' following exposure to vitrification solutions without cooling 
(Toxicity, 96.6%, 172/178, Fig 5.1). However, numbers of lost oocytes were 
significantly (P< 0.05) higher in vitrified group than toxicity (17.4 vs 3.4%, 
respectively). Based on morphological evaluation, the percentages of normal 
(viable) oocytes did not differ significantly (P> 0.05) between vitrified (72.6%, 
61/84) and toxicity groups (93.2%, 96/103, Fig 5.2). However, the proportions of 
recovered oocytes with abnormal morphology (non viable) were significantly (P< 
0.01) higher in vitrified group as compared to toxicity controls (27.4 vs 6.8%, 
respectively) as illustrated in Fig 5.3. 
Table 5.1 Recovery rates and viability of ovine oocytes vitrified at GV-stage 
using the cryoloop. 
Treatment No. Recovered (%) No. Normal (%) 
Vitrified 161/195 (82.6%) 61/84 (72.6%) 
Toxicity 172/178 (96.6%) 96/103 (93.2%) 
No significant differences were observed in the frequencies of recovered and 
viable oocytes (morphologically normal) between vitrified and toxicity groups. 
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Figure 5.1 Recovery rates of ovine oocytes vitrified at GV-stage using the 
cryoloop. The graph represents the percentages (±SEM) of oocytes recovered 
following vitrification of COCs using cryoloop or exposure to vitrification solution 
(Toxicity). Four replicates were performed. 
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Figure 5.2 Survival of ovine oocytes vitrified at GV-stage by the cryoloop. 
The graph represents the percentages (±SEM) of recovered oocytes with normal 
(viable) morphology following cryoloop vitrification (vitrified) or exposure to 
vitrification solution (Toxicity). Four replicates were performed. 
Figure 5.3 Damaged oocytes recovered following cryoloop vitrification. The 
figure shows oocytes with cracks in zona pellucida and degenerated cytoplasm 
obtained following vitrification of ovine COCs. Scale bar = 50 ).Lm. 
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5.3.2 Cumulus cell expansion and nuclear maturation following IVM 
The effect of cryoloop vitrification on cumulus cell expansion following IYM of 
vitrified/thawed ovine GY-oocytes is presented in Figs 5.4 and 5.5. The 
percentage of oocytes with expanded cumulus cells was significantly (P< 0.0 I) 
decreased following vitrification (70.4%) as compared to control grou p (95.2%). 
However, these values did not differ significantly (P> 0.05) from toxicity group 
(91.8%, Figs 5.4 and 5.5). The meiotic maturation of oyine oocytes vitrified at 
GY-stage using cryoloop is presented in Table 5.2 and Fig 5.6. No significant 
differences were observed in the freq uenc ies of in vitro maturation (oocytes at 
Mil stage) between treatment and control groups (43.4 and 60.0% vs 63.2%, in 
vitrified, toxicity, and control respectively). Similar trends were observed in the 
proportions of oocytes reaching MI and AIITI stages (values ranged 7.5 to 10.3% 
and 5.7 to 13.8%, respect ively, Table 5.2). The numbers of oocytes remaining at 
GY-stage were significant ly higher (P< 0.01) in vitrified group as compared to 
toxicity and contro l (34.4 vs 18.5 and 12.6%, respectively Table 5.2 and Fig 5.6) . 
• Cumulus expansion 
100 ab b 
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Figure 5.4 umulu cell expansion following IVM of ovine oocytes vitrified at 
GV- tagc using cryoloop. The graph represents the percentages (±SEM) of 
oocytes with expanded cumulu cell following IYM of COCs vitrified by 
cryo l op or exposed to vi trification olutions without freezi ng (Tox icity). 
Different letter are significant different (P< 0.0 I). Four rep li cates were carried 
out 
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Figure 5.5 Oocytes with expanded cumulus cells. The figure shows comparative 
cumulus cell expansion following 24 h IVM of ovine oocytes (A) vitrified at GV-
stage using cryoloop, (8) exposed to vitrification solution (toxicity) or (C) non-
treated (control) group. Scale bar = 50 )lm. 
Table 5.2 Nuclear maturation of ovine oocytes vitrified at GV-stage using 
cryoloop 
Treatment No. Meiotic maturation No. (%) 
Oocytes GV Ml AIlTI Mll 
Vitrified 53 23 4 3 23 
(43.4%)a (7.5%)a (5.7%)a (43.4%t 
Toxicity 65 12 8 6 39 
(18.5%)b (12.3%t (9.2%t (60.0%)a 
Control 87 II 9 12 55 
(12.6%)b (10.3%t (13.8%)a (63.2%)a 
Values with different superscripts in the same column are significantly different 
(a, b P < 0.01). V (Germinal Vesicle), MI (Metaphase-I), AlffI (Anaphase-l + 
Telophase- I), Mil (Metaphase-II). Four replicates were performed for each 
experimental group. 
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Figure 5.6 Meiotic maturation of ovine oocytes. The figure shows chromatin 
status in orcein stained oocytes following 24 h IVM after vitrification at GV-stage 
using cryoloop. (A) GV-stage, and (B) MIl stage. Scale bar = 50 11m. 
5.3.3 Spindle and chromosome organization 
Spindle configuration and chromosome organization was examined in control, 
vitrified and toxicity control oocytes at 24 hpm (Table 5.3 and Fig 5.7). No 
significant differences (P> 0.05, l) were observed in the frequencies of oocytes 
with normal spindle and chromatin configuration between treated (vitrified and 
toxicity) and control groups (50.0, 54.9 and 70.4%, respectively). Also, simi lar 
trends were noticed in the percentage of oocytes with missing spindle and the 
values ranging (from 22 to 29%). However, although the proportion of oocytes 
with abnormal spindle morphology was higher in both vitrified and toxicity 
groups as compared to control, the differences were not significant (20.8, 19.6 vs 
7.4%, P = 0.067). Similarly the proportions of oocytes t ~ a t t exhibited abnormal 
chromosome configuration between these groups (50.0, 45.1 and 29.6%) were not 
significant (Table 5.3 and Fig 5.7). 
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Table 5.3 Effect of vitrification of immature ovine oocytes on spindle and chromosome configuration following IVM 
Spindle configuration Chromosome configuration 
No. Treatment No. No. No. No. No. Oocytes Normal Abnormal Missing Normal Abnormal 
(%) (%) ~ ) ) (f%) (%) 
Vitrified 48 24 (50.0%) 10 (20.8%) 14 (29.2%) 24 (50.0%) 24 (50.0%) 
Toxicity 51 28 (54.9%) 10 (19.6%) 13 (25.5%) 28 (54.9%) 23 (45.1%) 
Control 54 38 (70.4%) 4 (7.4%) 12 (22.2%) 38 (70.4%) 16 (29.6%) 
Oocytes were immunostained using mouse monoclonal anti - a - tubulin antibody (1 :200) at 24 hpm to evaluate spindle and 
chromosome configuration in three different groups (vitrified, toxicity (oocytes exposed to vitrification solutions without freezing) 
and fresh control). No significant differences were observed in the frequencies of oocytes with normal spindle and chromosome 
configuration between three groups. Four replicates were carried out for each experimental group. 
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Figure 5.7 Examples of spindle and chromosome organization in ovine 
oocytes. The figure shows spindle (green) and chromatin (blue) morphology in 
ovine oocytes following irnmunostaining at 24 hpm. (A, B, and C) show normal 
morphology (symmetrical barrel shape meiotic spindle with chromatin aligned 
regularly along the equatorial plane of spindle), while (D, E, and F) illustrates 
abnormal morphology in vitrified, toxicity and control oocytes, respectively. 
Scale bar = 50 J.lm. 
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5.3.4 In vitro fertilisation and polyspermy 
The frequencies of in vitro fertilisation and polyspermy following IVM/IVF of 
ovine oocytes vitrified at GV-stage using cryoloop are presented in Table 5.4 and 
Fig 5.8. Interestingly, no significant differences were observed in the percentages 
of fertilised oocytes among three groups (54.0, 75.0, and 74.1 %, in vitrified, 
toxicity and control, respectively). Moreover, no differences were detected in the 
frequency of unfertilised oocytes (17.5 to 29.0%). However, cryoloop 
vitrification resulted in significantly (P< 0.001) higher percentages of oocytes 
with polyspermic fertilisation as compared to controls (17.0 vs 3.5%). These 
values did not differ significantly from those reported in toxicity oocytes (7.5%, 
Table 5.4 and Fig 5.8). 
Table 5.4 In vitro fertilisation of ovine oocytes vitrified at GV-stage using 
cryoloop 
Treatment No. Fertilisation No. (%) 
Oocytes Fertilised Polyspermic Unfertilised 
Vitrified 100 54 (54.0%)a 17 (17.0%t 29 (29.0%)a 
Toxicity 80 60 (75.0%t 6 (7.5%t6 14 (17.5%t 
Control 143 106 (74.1 %)a 5 (3.5%)6 32 (22.4%t 
Values with different superscripts in the same column are significantly different 
(a, b P< 0.001). Four replicates were carried out. 
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Figure 5.8 Fertilisation status of ovine oocytes following IVF. The figure 
shows IVMlIVF oocytes at 18 hpi stained with Hoechst 33342 and examined 
under a fluorescence mjcroscope (Leica, Germany). (A) Fertilised oocytes with 
male and female pronuclei (arrows) obtained in control group, (B and C) fusion 
of male and female pronuclei in control oocytes (syngamy), (D and E) fertilised 
oocytes in toxicity and vitrified group, with male and female pronuclei, (F) 
polyspermic fertilisation in vitrified oocytes. Scale bar = 50 ).lm. 
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5.3.5 In vitro embryo development/allowing IVMIIVF 
The effects of cryoloop vitrification on the viability of ovine oocytes 
subsequently matured and fertilised in vitro are presented in Table 5.5., and the 
frequencies of cleavage and subsequent development in Table 5.6 and Fig 5.9. At 
18 hpi, in vitro fertilised oocytes were examined for signs of degeneration such as 
damage of zona pellucida and/or cytoplasm; damaged oocytes were discarded and 
not used for IVC. Vitrification of ovine oocytes significantly (P< 0.05) decreased 
the percentage of viable oocytes following IVF compared to the control group 
(72.3 vs 88.6%, respectively). However, these values did not differ significantly 
from those in toxicity group (83.6%). In contrast, the proportions of degenerate 
oocytes following IVF were significantly higher (P< 0.05) in vitrified group than 
toxicity and control (27.7 vs 16.4 and 11.4%, respectively, Table 5.5). 
The frequencies of cleaved oocytes at 24 and 48 hpi were significantly lower (P< 
0.0 I) in vitrified group as compared to both toxicity and control groups (17.3 vs 
47.0 and 68.9% at 24 hpi and 41.9 vs 85.5 and 89.7% at 48 hpi, respectively, 
Table 5.6 and Fig 5.9). Significant differences were observed in the percentage of 
cleaved oocytes at 24 hpi between toxicity and control groups (P< 0.05). 
Development to the morula stage (day 5 pi) was significantly lower in the vitrified 
group as compared to toxicity and control (36.4 vs 60.7 and 62.6%). Similar 
trends were reported for the frequencies of development to blastocyst (day 7 pi). 
Significantly (P< 0.01) lower percentages of oocytes developed to the blastocyst 
stage in the vitrified group (12.3%) as compared to toxicity (42.7%) and control 
(40.4%) groups (Table 5.6 and Fig 5.9). Interestingly, the proportions of cleaved 
embryos that developed to blastocyst stage did not differ significantly between 
vitrified and control groups (29.4 vs 45.1 %, respectively). No significant 
differences were observed in the frequencies of early blastocysts between groups 
(3.7, 5.9, and 7.4%, in vitrified, toxicity and control, respectively). However, 
significantly (P< 0.05) lower numbers of expanded blastocysts were obtained 
from vitrified oocytes (4.9%) as compared to non treated control (12.3%), but 
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these values did not differ significantly from those obtained in toxicity group (7.7 
%). Hatched blastocysts were significantly (P< 0.01) decreased in vitrified groups 
than in toxicity and control (3.7 vs 29.1 and 20.7%, respectively, Table 5.6 and 
Fig 5.9). 
Table 5.5 Effects of cryoloop vitrification on survival rates following in vitro 
maturation and fertilisation ofovine oocytes. 
Treatment 
No. Viability following IVF No. (%) 
oocytes Viable Degenerated 
Vitrified 224 162 (72.3%t 62 (27.7%t 
Toxicity 140 117 (83.6%)ab 23 (l6.4%)b 
Control 229 203 (88.6%)b 26 (l1.4%)b 
Values with different superscripts in the same column (a vs b) are significantly 
different at P< 0.05. 
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Table 5.6 Developmental potential of m'ine oocytes vitrified at GV-stage using cryoloop 
Treatment No. No. Cleaved (%) No. No. Blastocysts (% of ooc)'tes) Total 
Ooc)'tes hpi ftlorula blastocysts 
f'-") (% of cleaved 
24 48 Earlv Expanded Hatched Total 48 hpi) 
Vitrified 162 28 68 59 6 8 6 20 29.4%b (l7.3%t (42.9%t (36.4%)a (3.7%)a (4.9%)b (3.7%)a (12.3%t 
Toxicity 117 55 100 71 7 9 34 50 50.0%C (47.0%)b (85.3%)b (60.7%)b (5.9%)a (7.7%)bc (29.1%)b (42.7%)b 
Control 203 140 182 127 15 25 42 82 45.l%bC (68.9%t (89.7%)b (62.6%)b (7.4%t (12.3%t (20.7%)b (40.4%)b 
Cleavage rates were evaluated at 24 and 48 hpi (hour post insemination). Values with different superscripts in the same columns are 
significantly different a vs b and a vs cat P< 0.01 while b vs c at P < 0.05. Four replicates were carried out. 
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Figure 5.9 Developmental stages of ovine embryos produced by IVF of 
vitrified/thawed GV-stage oocytes. The figure shows (A) different 
developmental stages at day 7 of embryos produced following IVMJIVF/IVC of 
vitrified/thawed ovine oocytes using cryoloop, (B) expanded and (C) hatched 
blastocysts. Scale bar = 50 ~ m . .
5.3.6 Total cell numbers and apoptotic nuclei olin vitro produced blastocysts 
Total cell numbers and apoptotic nuclei in day 7 in vitro produced blastocysts 
were detected by Hoechst staining and TUNEL assay (Choi 2008) and 
compared between three groups (vitrified, toxicity and control, Table 5.7). The 
total cell numbers and numbers of apoptotic nuclei did not differ significantly 
between treatment and control groups (87.4 ± 7.6 and 87.2 ± 8.7 vs 101 ± 8.4, 
for total cell numbers) and (8.6 ± 1.5 and 8.1 ± 0.6 vs 6.5 ± 0.8, for apoptotic 
nuclei) in vitrified, toxicity, and control, respectively. Also, the apoptotic index 
(number of apoptotic nuclei/number of total cells in blastocyst) did not differ 
significantly between vitrified and control groups (9.4 ± 1.2 vs 6.8 ± 0.8, Table 
5.7 and Fig 5.10). 
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Table 5.7 Total cell numbers and apoptotic nuclei in day 7 blastocyst embryos produced following IVMIIVFIIVC of 
vitrified/thawed ovine GV oocytes. 
Treatment No. Total cell No. Apoptotic Apoptotic index 
Blastocysts numbers/ nuclei (0/0) 
blastocyst 
(mean ± SEM) -<mean ± SEM) (mean ±SEM) 
Vitrified 13 87.4 ± 7.6a 8.6 ± 1.5a 9.4 ± l.2ab 
Toxicity 11 87.2 ± 8.7a 8.1 ± 0.6a 10.2 ± 1.3b 
Control 11 101.0 ± 8.4a 6.5 ± 0.8a 6.8 ± 0.8a 
Values with different superscripts (a vs b) in the same column are significantly different at (P< 0.05). 
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Figure 5.10 Total cell numbers and apoptotic nuclei in day 7 embryos 
determined by Hoechst staining and TUNEL assay. The figure shows (A-C) 
all nuclei appear blue, (D-F) apoptotic nuclei appear· green, and (G-I) merge 
between total cells and apoptotic nuclei in day 7 embryos produced following 
IVM/IVF/IVC of ovine oocytes in vitrified, toxicity, and control groups, 
respectively. Scale bar = 50 f.1m. 
5.3.7 Chromosomal analysis of in vitro produced embryos 
The ploidy of day 7 blastocysts was evaluated Fig 5.11, and the results are 
summarised in Table 5.8. The embryos were categorized as diploid (2n), haploid 
(n), or polyploidy ( ~ ~ 3n); the diploid embryos were considered normal, others 
reported as abnormal. The proportion of embryos with normal diploid 
chromosomal complements (54, 2n, Fig 5.11, A) was higher in blastocysts 
obtained from control and toxicity groups as compared to vitrified (88.0 and 81.8 
vs 71.4%, respectively). However, the differences between three groups were not 
significant. Also, no significant differences were observed in the percentages of 
haploid embryos between three groups (14.3, 13.6, and 8.0%, in vitrified, toxicity, 
and control, respectively). Although, the frequency of polyploidy was higher in 
embryos produced from vitrified oocytes (14.3%) than those obtained from other 
groups (- 4%), the differences were not significant (Table 5.8 and Fig 5.11 B). 
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T a ble 5.8 C hromosoma l composition of dny 7 blllSCOCYS Cs produced by 
fVM/fVF/fVC of ovin e oocy tes v itrified a t GV-stagc 
Treatment No. P l o i r ~ ~ I I No. (%) 
Blastocysts 
Diploid Haploid Polyploid 
Vitrified 7 5 (7 1.4%) 1 ( 14.3%) 1 ( 14.3%) 
Toxicity 22 18 (8 1.8%) 3 ( 13.6%) I (4 .5%) 
Control 25 22 (88.0%) 2 (8.0%) I (4.0%) 
No signi ficant di ffere nces were observed in the freq uencies of diplo id embryos as 
detected by karyotyping of day 7 blastocysts between vitri fied, tox icity and 
contro l groups. 
Figure 5.11 C hromosoma l ana lys is of d ay 7 in vitro produced bla tocysts. The 
figure revea ls cytogenetic ana lysis of ovine embryos produced by IVM/IVF/IVC 
of oocytes vitrified at GV-stage using cryoloop. (A) nonna l diploid (54, 1n) 
chromosomes, and (8 ) abnormal po lyp loid embryos ( ~ ~ 3n). 
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5.4 DISCUSSION 
Cryopreservation of embryos using a slow cooling protocol is an established 
method; however, when applied to oocytes slow cooling resulted in very low 
survival rates (Martino et al. 1996b). Therefore, new methods of cryopreservation 
have been developed, including vitrification. High cooling rates could be achieved 
by decreasing the volume of vitrification solutions in a combination with direct 
and rapid contact with LN2. Vitrification of oocytes and embryos using cryoloop 
has advantages over conventional procedures in that the containerless system 
lacking any insulating layer, coupled with a small volume of less than 1 ,.tI, result 
in both rapid and uniform heat exchange during cooling. Also, containerless 
vitrification is an open system enabling visualization of the sample during 
manipulation. Moreover, cooling and warming are straightforward as the loop is 
plunged directly into the LN2 or in the warming solutions (Lane et al. 199a, b). 
Loss of oocytes after vitrification and warming has been reported in several 
species including goats (Begin et al. 2003), and mice (Gomes et al. 2008). This 
loss can be influenced by the number of oocytes per cryodevice, as increased the 
numbers enhances the time required for movement of the cells through solutions, 
making over exposure or loss of the cells are possible. The post-thaw recovery 
rate (82.6%) reported in the present study was slightly higher than that reported by 
(Begin et al. 2003, 74%) following cryoloop vitrification of IVM goat oocytes. 
This loss can occur, if the cryoloop touches the inner wall of the storage tube 
(Begin et al. 2003). During cryopreservation, oocytes suffer severe adverse 
physiological conditions and this results in various cytological injuries to the 
oocytes (Men et al. 2003a). The survival rates reported here (72.6%) were slightly 
lower than that reported by Bogliolo et al. (2007a, 84.3%) following vitrification 
of ovine GV oocytes. These differences may be due to the cryodevices used in 
vitrification (cryotops in Bogliolo et al.). Following exposure of oocytes to 
cryoprotectant solutions alone (toxicity test) over 90% recovered oocytes were 
viable, suggesting that these combinations of cryoprotectant are efficient for 
vitrification of GV -ovine oocytes. 
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In the present study, the percentage of oocytes with expanded cumulus cells 
following IVM was significantly lower in vitrified group as compared to controls; 
however, this percentage did not affected in toxicity group. These results suggest 
that, the damage of the cumulus cells resulted during vitrification/thawing 
procedures and not from exposure to the cryoprotectants. Interestingly, the results 
in the present study demonstrate that, no significant differences observed in the 
frequencies of oocytes reaching MIl stage in vitrified group as compared to 
control (43.4 vs 63.2%, Table 5.2). This value was higher than those reported by 
Isachenko et al. (2001,27.5%), Silvestre et al. (2006, 12.7%), and Bogliolo et al. 
(2007a, 31.2%) following IVM of vitrified/thawed ovine GV-oocytes. The 
differences between the results may be due to several factors including, 
differences in vitrification protocols, DPS in Isachenco et al., and Silvestre et al. 
and cryotop in Bogliolo et al. studies. The effects of the three cryodevices (DPS, 
cryoloop, and cryotop) on viability and subsequent development of 
vitrified/thawed IVM ovine oocytes were evaluated by Succu et al. (2007a). 
Higher percentages of damaged oocytes were reported following DPS (45%) as 
compared to other methods (20 and 22.8% in cryoloop and cryotop groups, 
respectively); however, spontaneous activation was increased in cryotop group 
(54.5%) as compared to DPS (28.8%) and cryoloop (22.4%) groups. Higher 
maturation rates reported in the present study as compared to other studies may be 
also due to the differences in vitrification solutions used and equilibration time 
(time at which oocytes are equilibrated in lower concentrations of cryoprotectants 
before incubated in vitrification solutions with higher concentrations of 
cryoprotectants). Isachenko et al. (2001) used 40% EG with one step vitrification 
(without equilibration), however, Silvestre et al. (2006) and Bogliolo et al. 
(2007a) used a combination of 20% EG and 20% DMSD with stepwise 
vitrification and 30 sec equilibration time. In the present study, oocytes were 
equilibrated in 10% EG plus 0.25 M trehalose for 3 min before vitrification and 
then vitrified in a solution of 20% EG plus 20% DMSD for less than 1 min. 
Several studies reported that, combinations between tow permeable 
cryoprotectants at lower concentrations decrease the toxicity of vitrification 
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solution (Liebermann and Tucker 2002). Also, shorter equilibration time applied 
in Bogliolo et al studies seems to be not sufficient for the cryoprotectants to 
penetrate the oocytes. 
Searching for indicators of oocyte quality, investigators have reported that normal 
fertilisation and embryo development are more likely in oocytes with normal 
spindles, which may partially serve as an indicator of adequate oocyte 
cytoplasmic maturation (Wang and Keefe 2002; Keefe et al. 2003). A spindle 
apparatus is a dynamic collection of microtubules, comprised of u- and p- tubulin 
and associated structural proteins, which act to coordinate cyto- and karyokinetic 
events essential for normal chromosome segregation (Chen et al. 2003). 
Disorganization and disruption of the spindles can resuit in dispersal of 
chromosomes and subsequent chromosomal anomalies after fertilisation such as 
aneuploidy and polyploidy (Coticchio et al. 2005). Temperature fluctuations are 
known to directly affect cytoskeletal organization and chromosome configuration 
in mouse (Gomes et al. 2008), human (Almeida and Bolton 1995; Wang et al. 
2001), bovine (Wu et al. 1999; Albarracin et al. 2005a, b; Morato et al. 2008a, b), 
porcine (Liu et al. 2003; Rojas et al. 2004), equine (Tharasanit et al. 2006a, b) and 
ovine (Succu et al. 2007a) oocytes. Succu et al. (2007a) reported that spindle 
configuration in vitrified/thawed ovine Mil oocytes is affected by the cryodevices 
used, abnormal configuration was increased in OPS (65.2%) and cryoloop 
(59.2%) vitrified oocytes than in cryotop (55.2%). Also, they reported that 
exposure of oocytes to cryoprotectants alone exerts major toxic effects on spindle 
organization. In the present study, no significant differences were observed in the 
percentage of oocytes with normal spindle and chromatin configuration between 
vitrified, toxicity, and control groups. Alterations that occur to the meiotic spindle 
following IVM of vitrified immature oocytes may be due to cryodamage in the 
key regulatory factors such as MPF and MAPK which are responsible for spindle 
formation and microtubule organization (Wu et al. 1999; Albarracin et al. 2005b). 
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Cryopreservation of oocytes has been reported to induce premature release of 
cortical granules (Carroll et al. 1990), which subsequently affect frequencies of 
fertilisation. In cattle and pigs, lower fertilisation rates have been reported 
following IVF of vitrified/thawed GV and MIl oocytes respectively (Kim et al. 
2007,65.6%; Somfai et al. 2007,51.9%) as compared to control groups. In sheep, 
Tian et al. (2007) reported lower penetration rates (28.2%) after IVF of 
vitrified/thawed MIl oocytes, they suggested that exposure of Mil ovine oocytes 
to vitrification solution containing DMSO resulted in parthenogenetic activation 
and subsequent premature zona hardening. Interestingly, in the present study, no 
significant difference in fertilisation rates was observed between vitrified and 
control groups indicating normal cytoplasmic maturation in vitrified oocytes. 
These results suggest that vitrification of ovine GV oocytes using cryoloop can be 
. 
an alternative to avoid cooling-induced zona hardening. Similarly, previous 
studies in pigs (Somfai et al. 2010) and mice (Eroglu et al. 1998) reported that 
vitrified/thawed GV oocyte can be matured and fertilised in vitro with similar 
trends as fresh controls. 
In the present study, higher rates of degenerated oocytes were reported following 
IVF of vitrified oocytes. Also, lower frequencies of cleavage, morula, and 
blastocyst development were observed in vitrified oocytes as compared to control 
and toxicity groups. However, numbers of cleaved embryos that developed to 
blastocysts were not significantly different between vitrified and control groups 
(Table 5.6). The frequencies of blastocyst development reported in this study 
(29.4%) were much higher than those reported by Succu et al. (2007 a, b, 12.5% 
and 0%, respectively), Succu el al. (2008, 17.0%), and Zhang et al. (2009,2.6%) 
following IVF of vitrified/thawed Mil oocytes. The lower developmental rates 
reported in these studies may be due to structural and biochemical damage caused 
by vitrification of MIl oocytes (Succu el al. 2007 a, b). Also, Succu et al. (2008) 
reported that vitrification can produce changes in mRNA contents in ovine MIL 
Herein, no significant differences were observed in total cell numbers and 
numbers of apoptotic nuclei in blastocysts between treatment and control groups. 
104 
Chapter 5 Cryoloop vitrification ofGV-oocytes 
Cryopreserved oocytes often degenerated via apoptosis in subsequent culture 
(Men et al. 2003b). Insulin-like growth factor I has been reported to inhibit 
apoptosis in subsequent culture (Makarevich and Markkula 2002). FBS contains 
many substances, among of them is growth factors, therefore, the developmental 
advantage of embryo produced from oocytes vitrified and handled in FBS 
containing medium may be because of the anti apoptotic effects of growth factors 
in FBS (Horvath and Seidle 2008). In the present studies, the same batch of FBS 
was used throughout all experiments. Abnormal chromosomal constituents in 
embryos produced by IVF of frozen/thawed oocytes may be due to the stage of 
oocytes, the polyploidy was reported to be higher following IVF of vitrified 
immature oocytes. Also, damage to the cortical granules during oocyte 
cryopreservation may be incorporated in this phenomenon (AI- Hasani et al. 
1987). In the present study, no significant differences were reported in the 
frequencies of normal diploid embryos between treatment and control groups, 
however, polyploid embryos increased in vitrified group, which may be due to the 
higher frequencies of polyspermic fertilisation reported in vitrified oocytes. Taken 
together, the results suggest that, vitrification of immature COCs using cryoloop 
may be advantageous in preserving or restoring developmental competence in 
cryopreserved ovine oocytes. 
In conclusion, immature ovine oocytes vitrified at GV-stage using the cryoloop 
can be matured, fertilised and develop in vitro with high developmental potential 
similar to non vitrified control. Moreover, the results suggest that, good quality 
blastocysts with normal ploidy can be produced from vitrified immature ovine 
oocytes. The vitrification solutions applied in this study did not impair in vitro 
embryo production in sheep. The vitrification method presented here may serve as 
a basic platform for further development of a standard protocol for 
cryopreservation of immature ovine oocytes. However, further studies are needed 
to assess in vivo development of vitrified/thawed immature ovine oocytes and the 
ability to establish pregnancy and produce live offspring. 
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CHAPTER 6 
MPFIMAPK ACTIVITIES, PARTHENOGENETIC AC-
TIVATION AND SOMATIC CELL NUCLEAR TRANS-
FER (SCNT) OF OVINE OOCYTES VITRIFIED AT 
GV-STAGE 
6.1 INTRODUCTION 
Cryopreserved oocyte can, in theory, be used to produce offspring via assisted 
reproductive techniques such as in vitro embryo production (Vajta et al. 1998), 
and can also serve as host cytoplasts for cloning by nuclear transfer (NT) (Dinnyes 
et al. 2000). Vitrification of sheep oocytes is a challenge, and much more difficult 
than in other mammals, such as mice (Gomes et al. 2008) and cattle (Vieira et al. 
2002, Vieira et al. 2008). Various vitrification methods have been used to 
cryopreserve ovine oocytes (Sucuu et al. 2007a, b; Bogliolo et al. 2007a), but live 
births from vitrified ovine oocytes have not been reported. Although the extent 
and exact cause of reduced developmental competence following cryopreservation 
may vary between species, factors shown to contribute to reduced oocyte quality 
include damage to the mitochondria in equine and bovine oocytes (Hochi et al. 
1996; Abe et al. 2005), and enzymes critical to oocyte maturation and subsequent 
development in sheep (mitogen activated protein kinase: MAPK and maturation 
promoting factor; MPF; Bogliolo et al. 2007a). 
The efficiency of cryopreserved gametes and embryos is usually assessed by the 
ability of the resultant embryos to develop into blastocysts or term offspring. 
However, cryopreservation was reported to have side effects on zona quality by 
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cracking the zona or inducing precocious cortical granules exocytosis (Fuku et al. 
1995; Tian et al. 2007) that may compromise fertilisation outcomes (Somfai et al. 
2006). Therefore, an alternative strategy, parthenogenetic activation, could be used 
to assess the developmental potential of cryopreserved oocytes. Parthenogenetic 
activation of oocytes represents a valid tool to investigate the comparative roles of 
paternal and maternal genomes in controlling early embryo development. hence, 
indirectly to assess the quality of the oocytes matured in vitro. Furthermore, an 
optimal protocol for oocyte activation is required for the success of advanced 
technologies such as cloning by NT. Parthenogenetic activation of mammalian 
oocytes can be induced by a D.C. electrical pulse (Zhu et al. 2002) or by 
chemicals that promote intracellular calcium increase, such as, ethanol (Hou et al. 
2009); calcium ionophore A23187 (CA, Liu et al. 1998), ionomycin (Wells et al. 
1999) or strontium (Sr, Meo et al. 2005). These may be used alone or in 
combination with protein synthesis inhibitor such as cycloheximide (CHX) or 
kinase inhibitors such as 6-Dimethylaminopurine (6-DMAP) (Loi et al. 1998). 
Parthenogenetic activation of vitrified oocytes has been reported in cattle (Dinnyes 
et al. 2000, Hou et al. 2005; Yang et al. 2008; Hou et al. 2009), pig (Somfai et al. 
2006; Du et al. 2008), goat (Begin et al. 2003), mouse (Endoh et al. 2007), and 
human (Morbeck et al. 2009). Incorporation of cryopreserved oocyte in NT 
programme as a cytoplast could be an additional way to evaluate its 
developmental potential. 
The aims of this study were to assess 1) MPFIMAPK activities following IVM of 
ovine oocytes vitrified at GV stage, 2) developmental competence following 
parthenogenetic activation and somatic cell nuclear transfer (SCNT) of vitrified! 
thawed ovine GV oocytes. In parthenogenetic activation, the effectiveness of two 
activation protocols was compared (1) a combination of calcium ionophore (A 
23187), cycloheximide, and cytochalasin B (CA+CHXlCB) and (2) strontium and 
Cll (Sr/CB). 
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6.2 MATERIALS AND METHODS 
6.2.1 Vitrification and warming of COCs 
Recovery of ovine oocytes was carried out as previously described (Chapter 2.1). 
COCs were vitrified using cryoloop as described in (Chapter 2.2.3). 
Vitrified/thawed oocytes were matured in vitro for 24 h (Chapter 2.3). At 24 
hpm (hours post maturation) MPFIMAPK kinases activities were evaluated as 
described in (Chapter 2.11). 
6.2.2 Parthenogenetic activation and IVC 
At 24 hpm, oocytes showing first polar body and homogenous cytoplasm were 
selected and activated using two different protocols, CA+CHXlCB or Sr/CB as 
described in (Chapter 2.6).4-5 hpa (hours post activation), presumptive zygotes 
were transferred into culture medium (Chapter 2.8). Embryo development, total 
cell numbers, and numbers of apoptotic nuclei in day 7 blastocysts were evaluated 
as described in (Chapter 2.8.1,2.8.2 and 2.9). 
6.2.3 Somatic cell nuclear transfer (SCNT) 
At 15-16 hpm, SCNT was performed as described in (Chapter 2.7). 
Reconstructed embryos were activated using Sr/CB protocol as described earlier 
(Chapter 2.7). Presumptive zygotes were cultured for 7 days in C.SOF at 39°C 
(Chapter 2.8). Total cell numbers, apoptotic nuclei, and chromosome numbers in 
day 7 blastocyst stage embryos were evaluated. 
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6.3 RESULTS 
6.3.1 MPF and MAPK activities 
MPF and MAPK activities were measured at 24 hpm in ovine oocytes vitrified at 
GV stage versus fresh control (Fig 6.1). Vitrification of ovine GV oocytes resulted 
in lower activities of both MPF and MAPK as compared to control group; 
however, the difference was not statistically significant (Fig 6.1). 
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Figure 6.1 Maturation promoting factor (MPF) and mitogen-activated 
protein kinase (MAPK) activities. The figure shows MPF and MAPK activities 
in vitrified GV and control ovine oocytes at 24 hpm detected with an in vitro 
double-kinase by phosphorylation of histone HI and myelin basic protein (MBP), 
respectively. (A) Phospho-image of PAGE, 32p radioactivity representing kinase 
activities. (B) Relative kinase activities (cprnlmm2). Ten oocytes were assayed at 
each treatment, and three replicates were performed. 
109 
Chapter 6 SCNT of vitrified oocytes 
6.3.2 Frequencies of cleavage following parthenogenetic activation 
The effects of vitrification and exposure to vitrification solution on cleavage rates 
following IVM and parthenogenetic activation of ovine oocytes by two different 
methods (CA+CHXlCB versus Sr/CB) are summarised in Table 6.1. Cleavage 
was significantly (P< 0.05) lower in vitrified oocytes activated by two protocols 
(CA+CHXlCB and Sr/CB) at both 24 (6.2 and 3.8%) and 48 hpa (28.4 and 27.5%) 
as compared to toxicity and control groups. Cleavage rates were significantly 
increased (P< 0.05) at 24 and 48 hpa in toxicity and control oocytes activated by 
CA+CHXlCB as compared to Sr/CB activated oocytes (71.4, 85.7, 74.5, and 
92.7% vs 21.7, 40.0, 43.2, and 63.3%, respectively, Table 6.1). 
Table 6.1 Cleavage rates following parthenogenetic activation of ovine 
oocytes vitrified at GV stage 
Treatment Method of No. No. Cleaved oocytes (%) 
activation Oocytes hpa 
24 48 
Vitrified CA+CIIXlCB 81 5 (6.2%)8 23 (28.4%)a 
Sr/CB 80 3 (3.8%t 22 (27.5%)a 
Toxicity CA+CIIXlCB 56 40 (71.4%t 48 (85.7%)DC 
Sr/CB 60 13 (21.7%)D 24 (40.0%t 
Control CA+CIIXlCB 55 41 (74.5%t 51 (92.7%)D 
Sr/CB 139 60 (43.2%)d 88 (63.3%t 
Values with different superscripts in the same column (a, b, c) are significantly 
different (P< 0.05). Ca+CHXlCB: calcium ionophore (A 23187) + cycloheximide 
and cytochalasin B. Sr/CB: strontium + CB. hpa: hours post activation. 
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6.3.3 In vitro embryo development/ollowing parthenogenetic activation 
Day 5 morula and frequencies of blastocyst development (day 7 pa) as well as 
total cell numbers following parthenogenetic activation of ovine oocytes vitrified 
at GV stage are presented in Table 6.2. Irrespective of activation method no 
significant differences were observed in the frequencies of development to morula 
between vitrified and toxicity groups (range 18.8 to 35.7%). However, vitrification 
of oocytes resulted in significantly (P< 0.05) lower frequency of development to 
morula stages in two activation protocols as compared to control groups (39.6 to 
49.1%) 
As presented in Table 6.2, no blastocysts developed in vitrified oocytes activated 
by CA+CHXlCB; however, 3.8% of oocytes developed following activation by 
Sr/CB. This frequency was significantly lower (P< 0.05) than that obtained in 
toxicity and control oocytes activated by two methods (20 to 27.3%). Based on the 
numbers of cleaved embryos, no significant differences were observed in the 
frequencies of blastocyst development between vitrified (13.6%); or toxicity and 
control oocytes activated by CA+CHXlCB (25 and 21.6%). However, numbers of 
cleaved embryos reaching blastocyst stages were significantly lower in control 
oocytes activated by CA+CHXlCB than those activated by Sr/CB (43.2%). 
No significant differences were observed in the proportions of hatched blastocysts 
produced from vitrified oocytes (1.3%) as compared to toxicity and control groups 
(4.3 to 7.1 %). In addition, total cell numbers in blastocyst stage embryos did not 
differ significantly between vitrified oocytes (85 ± 13.9) and other groups (103 ± 
9.9 , 89.6 ± 8.4, 104.9 ± 6.3, and 105.6 ± 6.7, in toxicity and control oocytes 
activated by CA+CHXlCB or Sr/CB, respectively, Table 6.2). 
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Table 6.2 In vitro embryo development following parthenogenetic activation of ovine oocytes vitrified at GV stage 
Treatment Method of No. No. No. Blastocysts Total No. Total cell 
activation Oocytes Morula (% ofoocytes) Blastocysts numbers/ 
(%) (% of cleaved blastocyst 
Early Expanded Hatched Total 48 hpa) (mean ±SEM) 
Vitrified CA+CHXlCB 81 18 0 0 0 0 N/A N/A 
(22.2%t (0.0)1 (0.0)1 (O.ot (0.0)' 
15 2 0 1 3 
Sr/CB 80 (18.8%)1 (2.5%)ac (O.ot (1.25%)ab (3.8%)1 13.6%1 85.0± 
13.9 
Toxicity CA+CHXlCB 56 20 4 4 4 12 
(35.7%)ab (7.1%)bC (7.1%)bC (7.1%)b (21.4%)b 25.0%8b 103± 
9.9 
Sr/CB 60 17 5 4 3 12 
(28.3%)ab (8.3%)bc (6.7%)bC (5.0%)b (20.0%)b 50.0%b 89.6± 
8.4 
Control CA+CHXlCB 55 27 7 1 3 11 
(49.1%)b (12.7%)b (1.8%)ac (5.8%)b (20.0%)b 21.6%8 104.9± 
6.3 
Sr/CB l39 55 16 16 6 38 
(39.6%)' (11.5%)b (11.5%)b (4.3%),b (27.3%)b 43.2%b 105.6± 
6.7 
Values with different superscripts in the same column (a, b, c) are significantly different (P< 0.05).Ca+CHXlCB: calcium ionophore (A 
23187) plus cycloheximide and cytochalasin B, Sr/CB: strontium plus CB. hpa: hours post activation. NI A: not applied. Three replicates were 
carried out. 
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6.3.4 Apoptosis in blastocysts produced following parthenogenetic activation 
Apoptotic cell numbers and apoptotic index of day 7 blastocysts produced by 
Sr/CB activation of vitrified, toxicity, and control oocytes are presented in Table 
6.3 and Fig 6.2. No significant differences were observed in the numbers of 
apoptotic nuclei (determined by TUNEL assay) between vitrified, toxicity, and 
control groups (15.8 ± 2.8, 10.6 ± 1.3, and 12.9 ± 0.7, respectively). The same 
trend was observed in terms of apoptotic index (number of apoptotic nuclei/total 
cell numbers in blastocysts), with values of 17.8 ± 5.2, 12.1 ± 0.9, and 15.1 ± 1.2 
for vitrified, toxicity, and control groups, respectively. 
Table 6.3 Numbers of apoptotic nuclei and apoptotic index in day 7 
blastocysts produced by Sr/CB parthenogenetic activation 
Treatment 
Vitrified 
Toxicity 
Control 
No. 
Blastocysts 
4 
8 
15 
No. Apoptotic Apoptotic index 
nuclei 
(mean±SEM) (mean ±SEM) 
15.8 ± 2.8 17.8 ± 5.2 
10.6 ± 1.3 12.1 ± 0.9 
12.9 ± 0.7 15.1 ± 1.2 
Figure 6.2 Representative blastocyst stage embryos stained with Hoechst and 
TUNEL assay. (A) total cell numbers appear blue, (B) apoptotic nuclei appear 
green, and (C) merge between total cells and apoptotic nuclei in day 7 blastocysts 
produced following IVM and parthenogenetic activation of vitrified/thawed ovine 
GV oocytes. Scale bar = 50 Jlm. 
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6.3.5 Frequencies of enucleation andfusion 
Enucleation and fusion of ovine oocytes vitrified at GV stage and used as 
cytoplast recipients for SCNT is presented in Fig 6.3. High frequencies of 
enucleation ( ~ 9 9 % ) ) and fusion (- 98%) were achieved in both vitrified and control 
oocytes. 
Figure 6.3 Enucleation of ovine oocytes vitrified at GV -stage. (A) Holding the 
Anaphase-I-Telophase-I (AIffI) oocyte before enucleation (AIITI spindle is 
showed by: black arrow). (B) Hole in the zona pellucida made by laser to assist in 
enucleation indicating by black arrow. (C, D and E) penetration of the zona 
pellucida by enucleation pipette. (F, G and H) confirmed by epiflourescence light 
(AIfTI spindle marked by white arrow). 
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6.3.6 Cleavage and subsequent development of SCNT embryos 
The developmental potential of SCNT embryos produced using vitrified/thawed 
GV oocytes as cytoplast recipients is presented Table 6.4. The frequencies of 
cleaved embryos 24 and 48 hpa were significantly lower (P< 0.05) in 
vitrified/thawed group (31 and 48%) than in control group (55.1 and 85 .0%). 
However, no significant difference was observed in the frequencies of 
development to morula (38.0 vs 46.7%) and blastocyst stages (13.0 vs 23.4%). 
Based on 48 hpa cleavage, the same percentage of blastocyst development was 
obtained in both groups (- 27%). A similar trend was observed in the proportions 
of early, expanded, and hatched blastocysts (4.0, 2.0, and 7.0 vs 6.5, 6.5, 10.3%, in 
vitrified and control groups, respectively, Fig 6.4 A). 
6.3.7 Total cell numbers and apoptosis in blastocysts produced by SCNT 
As shown in Table 6.5 and Fig 6.4 B, no significant differences were observed in 
total cell numbers, numbers of apoptotic nuclei or apoptotic index as detected by 
Hoechst and TUNEL assay in blastocysts produced by SCNT of vitrified versus 
control oocytes (90.3 ± 4.9, 13.1 ± 0.9, and 14.9 ± 1.4 vs 97.6 ± 4.6, 13.2 ± 1.4, 
13.6 ± 1.1 , respectively). 
Figure 6.4 Day 7 blastocysts produced by SeNT. The figure shows (A) phase 
contrast day 7 hatched blastocysts (B) stained with Hoechst produced by SCNT 
using ovine oocytes vitrified at GV stage as cytoplast recipients. Scale bar = 
50flm. 
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Table 6.4 In vitro embryo development of SCNT embryos produced using ovine oocytes vitrified at GV stage as cytoplast 
recipients 
Treatment No. No. No. No. Blastocysts Total No. 
fused Cleaved(%) Morula (% of fused oocytes) Blastocysts 
oocytes hpa (%) (% of cleaved 
48hpa) 
24 48 Earlv Expanded Hatched Total 
Vitrified 100 31 48 38 4 2 7 13 27.1%a 
(31.0%t (48.0%t (38.0%t (4.0%t (2.0%)a (7.0%t (13.0%)a 
Control 107 59 91 50 7 7 11 25 27.5%a 
(5S.1%)b (8S.0%)b (46.7%t (6.5%t (6.S%)a (l0.3%)a (23.4%t 
---- - ----
Values with different superscripts in the same column are significantly different (P< 0.05). Four replicates were performed. 
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Table 6.5 Total cell numben and apoptotic nuclei in day 7 blastocysts 
produced by SCNT of ovine oocytes vitrified at GV stage 
Treatment No. Total cell No. Apoptotic Apoptotic index 
Blastocysts numbers nuclei 
(mean±SEM) Lmean±SEM) imean±SEM) 
Vitrified 8 90.3 ± 4.9 13.1 ± 0.9 14.9 ± 1.4 
Control 21 97.6±4.6 13.2 ± 1.4 13.6 ±1.1 
6.3.8 Karyotyping of seNT blastocysts 
The ploidy of SeNT derived blastocysts was evaluated and the results are 
summarized in Table 6.6. Embryos were categorized as diploid (54, 2n), haploid 
(n). or polyploid ( ~ ~ 3n); diploid embryos were considered as normal, others were 
reported as abnormal. The proportion of embryos with diploid chromosomal 
complements was lower in blastocysts obtained by SCNT of vitrified oocytes as 
compared to control (60.0 vs 75.0%, respectively). But, the difference between 
two groups was not significant. Also, no significant differences were observed 
between two groups in terms of haploid (20 vs 10.0%) and polyploid (20 vs 15%) 
embryos. 
Table 6.6 Cytogenetic analysis of day 7 blastocysts produced by SCNT of 
ovine oocytes vitrified at GV stage 
No. Ploidy No. (%) 
Treatment 
Blastocysts Diploid Haploid Polyploid 
Vitrified 5 3 (60.0%) 1 (20.0%) 1 (20.0%) 
Control 20 15 (75.0%) 2 (10.0%) 3 (15.0%) 
Chromosomal constituents of day 7 blastocyst embryos produced by SCNT of 
ovine oocytes vitrified at GV -stage were by karyotyping. No significant 
differences were observed between vitrified and control groups. 
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6.4 DISCUSSION 
Little infonnation is available on the biochemical and molecular changes that 
occur after oocyte cryopreservation. Concerning this point, the activities of MPF 
and MAPK following 24 h IVM of vitrified/thawed GV oocytes were compared to 
fresh control oocytes. The activities of both kinases were decreased in vitrified 
oocytes as compared to control; however, the difference was not significant (Fig 
6.1). These two factors are known to playa pivotal role in meiotic and mitotic cell 
cycles (Nurse 1990). Previously, it has been reported that, the activity ofMPF was 
significantly lower in OPS, cryoloop, and cryotop vitrified MIl ovine oocytes 
(Succu et al. 2007a), however, the activity was restored after 2 h culture in OPS, 
cryoloop vitrified oocytes but not in cryotop group. Bogliolo et al. (2007a) 
reported that the activities of MPF and MAPK (24 hpm) did not differ between 
ovine oocytes vitrified at GV -stage with cumulus cells and control group either 
denuded or cumulus-enclosed. However, the activities were decreased when the 
cumulus cells were removed prior to vitrification. These results suggest that, 
cryopreservation may induce the degradation of molecules involved in the 
signaling pathways known to regulate kinase activity, and this adverse effect may 
be more evident when oocytes are free of cumulus cells (Bogliolo et al. 2007a). 
Efficient oocyte activation is a key step for success of nuclear transfer (Campbell 
1999). Parthenogenetic activation of oocytes provides a good model for evaluation 
of the developmental potential of cryopreserved oocytes (Morbeck et al. 2009). 
The present study was designed to compare two protocols (1) CA+CHXlCB, (2) 
Sr/CB on activation of vitrified/thawed ovine GV oocytes. Interestingly, no 
blastocysts stage embryos developed In vitrified oocytes activated by 
CA+CHXlCB; however, 3.8% blastocysts were obtained following Sr/CB 
activation (Table 6.2). The results indicate that strontium is efficient in 
parthenogenetic activation of vitrified/thawed ovine oocytes. Parthenogenetic 
activation studies have shown that the most effective stimuli are those which 
promote multiple intracellular calcium peaks (Vitullo and Ozil 1992). In mice, 
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strontium has been reported to induce a series of intracellular calcium rises by 
displacing bound Ca2+ pulses, releasing it from intracellular stores and promotes 
Ca2+ pulses (Jellerette et al. 2000). This occurs through IP3 (Inositol-I, 4, 5-
triphosphate) receptors, which is similar to that seen in normal fertilisation (Zhang 
et al. 2005). Previous studies have shown that CA plus 10 mM SrCl2 could be used 
more effectively for activation of fresh ovine MIl oocytes as compared to other 
concentrations of srCh and to CA+CHXlCB (Choi and Campbell 2008). The 
results in the present study suggest that, although vitrified oocytes activated by 
CA+CHXlCB had the ability to cleave and develop to morula stage in frequencies 
comparable to Sr/CB group; it failed to produce blastocyst stage embryos. 
However, the two activation protocols resulted in the same proportions of 
blastocyst development in other groups (toxicity and control). Incorporation of 
calcium ionophore in parthenogenetic activation of vitrified oocytes seems to exert 
a harmful effect on blastocyst development, an observation which requires further 
investigation. CB has been reported to play an important role in parthenogenetic 
activation, it prevents second polar body extrusion, resulting in diploid parthenotes 
which are less apoptotic and have higher developmental capacity as compared to 
haploid (Liu et al. 2002). 
In general freshly matured oocytes from in vitro or in vivo sources are used as 
cytoplast recipients for NT. Development of successful cryopreservation 
procedures would immensely benefit nuclear transfer research and practice 
because it would eliminate seasonal fluctuations in oocyte quality and also the 
dependence on timing of slaughter and oocyte shipment. The present study 
evaluated the use of ovine oocytes vitrified at GV stage as cytoplast recipients for 
SCNT. Although, the frequencies of cleaved embryos at 24 and 48 hpa were 
significantly lower in vitrified group as compared to control, development to 
morula and blastocyst stage embryos did not differ significantly (Table 6.4). 
These results indicate that vitrified ovine oocytes can be used as cytoplast 
recipients for SCNT and produce high frequencies of good quality blastocyst 
embryos. Also, the results suggest that vitrification of immature ovine oocytes 
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provides an opportunity to establish oocyte banking that can be used as a tool for 
improvement of genetic selection, widespread applications of reproductive 
biotechnologies in both animal and human species, and also for preservation of 
endangered species. Oocyte vitrification has been reported to reduce the level of 
maternal mRNAs in ovine oocytes (Succu et al. 2008) which could be attributed to 
the lower cleavage in SCNT vitrified oocytes. It has been reported that, the 
damaging effects of freezing-thawing were apparent only up to the two-cell stage 
but beyond this stage no further influences were observed on the development to 
morula or blastocysts (Schroeder et al. 1990). The reduced frequencies of 
blastocyst development following parthenogenetic activation of vitrified oocytes 
as compared to SCNT indicates that the nuclear materials, surrounding 
microtubules and meiotic spindles were adversely affected by cryopreservation 
(Kubota et al. 1998; Dinnyes et al. 2000; Tominoga et al. 2005); however, the 
effects on cytoplasmic components should not be neglected (Dinnyes et al. 2000). 
Regarding the quality of blastocysts, the results suggest that vitrification of ovine 
GV oocytes resulted in production of good quality blastocysts following activation 
and SCNT. In contrast, previous studies in cattle and pigs reported lower cell 
numbers in blastocysts produced by SCNT and parthenogenetic activation of 
vitrified/thawed MIl oocytes as compared to control (Atabay et al. 2004; 
Tominaga et al. 2005; Somfai et al. 2006). Similar developmental potential 
reported here following SCNT of vitrified oocytes compared to control may be 
due to several factors include vitrification protocol, cryoprotectant combinations, 
and activation method. Furthermore, in these studies only morphologically high 
quality oocytes, i.e. uniform granular, homogeneously distributed cytoplasm 
surrounded by compact layers of cumulus cells were used. Given that the ability of 
an embryo to withstand freezing and thawing has been used in the part as a useful 
indicator for quality (Rizos et al. 2001), it is possible that the selection of best 
quality oocytes here may have influenced cryotolerance and hence the 
developmental potential ofvitrifiedlthawed oocytes following SCNT. 
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In the present study, cytogenetic analysis of day 7 SCNT blastocysts revealed 
lower proportions of diploid embryos obtained from vitrified oocytes as compared 
to those produced from control, but the difference was not significant. Data 
regarding the cytogenetic status of NT embryos are limited and the results are 
confounded by differences between NT protocols, karyotyping methods, 
developmental stages, types of donor cells, donor cell-cytoplast cell cycle 
synchronization, and perhaps species (Campbell et al. 1999; Slimane-Bureau and 
King 2002; Li et al. 2004). The abnormal chromosome constitution reported here 
may also attribute to the cytoskeletal injuries resulted from vitrification and 
thawing (Bos-Mickich and Whittingham 1995). 
In summary, the main finding in these studies is that vitrified-thawed ovine 
oocytes can be used successfully for the first time as recipient cytoplasts for SCNT 
with high frequencies of blastocyst development. This finding has important 
implications for nuclear transfer research. Although, lower values of MPF/MAPK 
activities were reported in vitrified/thawed oocytes as compared to control, the 
difference was not significant. Vitrified GV oocytes can develop up to morula 
stage following IVM and parthenogenetic activation, irrespective to activation 
protocol. Moreover, strontium can be used effectively for parthenogenetic 
activation of vitrified/thawed ovine oocytes. The results show that, 
parthenogenetic development forms a solid platform to test the developmental 
potential of vitrified immature ovine oocytes after ICSI and NT. Further studies 
are required to demonstrate the ability of nuclear transfer produced embryos to 
develop in vivo, establish pregnancy, and produce offspring. 
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CHAPTER 7 
VITRIFICATION OF IMMATURE OVINE OOCYTES 
WITH CRYOLOOP: EFFECT OF CYTOCHALASIN B 
PRE-TREATMENT ON VIABILITY AND SUBSEQ-
UENT DEVELOPMENT 
7.1 INTRODUCTION 
Cryopreserving reproductive tissues or cells has become an increasingly 
widespread means of preserving or salvaging genetic material for subsequent use 
in assisted reproduction. However, while live offspring have been produced after 
fertilisation of frozen-thawed oocytes in a number of species, the overall success 
of oocyte cryopreservation in terms of subsequent developmental competence is 
still very low (Tharasanit et a1. 2006a; Ledda et a1. 2007) . 
Immature oocytes differ from mature ones in that their chromatin has yet to 
condense and is protected within a membrane-bound vesicle (the germinal vesicle: 
GV), while the meiotic spindle has yet to assemble. In this latter respect, the 
microtubule spindle of mature (metaphase II: MIl) oocytes is extremely 
susceptible to damage during freezing and thawing (for review, Chen et al. 2003). 
Poor oocyte survival following cryopreservation has been associated with 
disruption of important microstructures such as the plasma membrane (Agaca et 
a1. 1998), the cytoskeleton (Saunders and Parks 1999), the chromosomes (Chen et 
a1. 2003), and the cortical granules (Carroll et a1. 1990), all of which are critical to 
oocyte fertilisability and subsequent developmental competence (Saunders and 
Parks 1999). Recently, vitrification has been used for the cryopreservation of 
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oocytes as an alternative to traditional slow-freezing (Vajta 2000). Many studies 
have been conducted to improve vitrification protocols including increases in 
cooling and warming rates (Vajta and Kuwayama 2006; Ledda et a/. 2007). 
Moreover, stabilizing the cytoskeleton system during vitrification may also be 
beneficial for improvement of survival and subsequent development of 
vitrified/thawed oocytes and embryos (Zhang et a/. 2009). 
Cytochalasin B (CB) as a cytoskeletal relaxant was considered to make the skeletal 
elements less rigid (Fujihira et al. 2004). In mature oocytes, CB reduced damage 
to microtubules and may enhance stabilization of spindle microtubules during 
vitrification (Zhang et a/. 2009). In the case of GV oocytes, no organised meiotic 
spindle is present, and this relaxant effect may preserve the functionality of the gap 
junctions between oocyte and granulosa cells and permit a faster and more uniform 
penetration of the cryoprotectants (Vieira et al. 2002). To date, studies on the 
effect of CB on viability and subsequent development of vitrified oocytes are few, 
whilst the results are controversial and dependent upon species. In pig and sheep 
Somfai et al. (2006) and Zhang et al. (2009) reported positive effects of CB pre-
treatment on viability and subsequent development of vitrified/thawed MIl 
oocytes. In contrast, other studies in cattle and sheep did not report any effects of 
cytochalasin pre-treatment on survival and in vitro development of 
vitrified/thawed GV oocytes (Vieira et al. 2002; Silvestre et a/. 2006). 
The aims of these studies were to investigate the effect of CB pre-treatment prior 
to vitrification of immature ovine oocytes (obtained from mature ewes) on 
viability, in vitro fertilisation status, and subsequent development following IVM 
IIVFIIVC. 
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7.2 MATERIALS AND METHODS 
7.2.1 Cytochalasin B (CB) treatment 
Before v i t r i f i c a t i o ~ ~ selected COCs obtained at slaughter (Chapter 2.1) were 
randomly divided into two groups and incubated with or without 7.5 J.1g/ml CB in 
TCM-199 plus 10% FBS for 60 min at 39°C. Oocytes from each group were 
vitrified or treated as toxicity and control. 
7.2.2 Vitrification and warming of coes 
After washing three times in a base medium (H-TCM 199 supplemented with 10% 
heat inactivated FBS), COCs were vitrified using cryoloop as described in 
(Chapter 2.2.3). Following vitrification and warming, oocytes were 
morphologically examined to evaluate their viability (see Chapter 2.2.4). 
7.2.3 IVMI IVFI IVC 
IVMlIVFIIVC and embryo evaluation were performed as previously described 
(Chapter 2.3, 2.5, 2.8, 2.8.1). Total cell numbers of day 7 blastocyst stage 
embryos were determined using Hoechst stain as described in (Chapter 2.8.2). At 
18 h post-insemination (hpi), frequencies of in vitro fertilisation and polyspermy 
were determined as previously described (Chapter 2.5.3). 
7.2.4 Statistical Analysis 
Survival, frequencies of in vitro f e r t i l i s a t i o ~ ~ and development were analysed 
using Chi square test. Total cell numbers were analysed using un-paired student t-
test. All results are considered to be statistically significant at P< 0.05. 
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7.3 RESULTS 
7.3.1 Effect of CB pre-treatment on viability of vitrified COCs 
The effects of CB pre-treatment on viability of vitrified/thawed GV ovine oocytes 
are presented in Table 7.1 and Fig 7.1. No significant differences were observed 
in survival rates between CB treated and non treated oocytes in both vitrified and 
toxicity groups (values ranged from 88.4 to 93.9%). 
Table 7.1 Effect of cytochalasin B (CB) pre-treatment on viability of 
vitrified/thawed ovine GV-oocytes. 
Treatment No.Oocytes No. Normal % 
Vitrified 304 274 (90.1%) 
Toxicity 216 203 (93.9%) 
CB-vitrified 404 357 (88.4%) 
CB-toxicity 277 250 (90.3%) 
- Normal 
100 
80 
60 
~ ~Q 
40 
20 
0 
vitrified Toxicity CB-vitrified CB-toxicity 
Figure 7.1 Effect of CB pre-treatment on viability of vitrified/thawed ovine 
GV oocytes. The graph represents the percentages (± SEM) of viable oocytes 
(nonnal) in vitrified and toxicity groups following exposure to CB prior to 
vitrification. Eight replicates were perfonned for each experimental group. 
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7.3.2 Effect of CB treatment on fertilisation events following IVF 
The effects of CB pre-treatment on frequencies of in vitro fertilisation and 
polyspenny of ovine oocytes vitrified and exposed to vitrification solutions at GV-
stage are presented in Table 7.2 and Fig 7.2. 
Although, CB treatment resulted in higher percentages of fertilisation in vitrified 
oocytes than those vitrified without treatment (57.0 vs 40.7%, respectively), the 
differences were not significant. No significant differences were observed in tenns 
of fertilisation between CB-vitrified, toxicity (72.3%), CB-toxicity (75.4%) and 
CB-control groups (67.3%). However, significant differences (P< 0.05) were 
observed between both vitrified groups (CB treated and non treated) and control 
group (81.1%). CB pre-treatment did not affect the frequencies of in vitro 
fertilisation in toxicity and control groups (Table 7.2). 
No significant differences in polyspermy were observed between vitrified, CB-
vitrified, CB-toxicity, and CB-control groups (11.1, 17.2, 14.0, and 11.2%, 
respectively). However, the frequencies of polyspermy were decreased in both 
toxicity and control oocytes (3.6 and 2.1 %) as compared to other groups (Table 
7.2 and Fig 7.2). 
The proportion of unfertilised oocytes were significantly (P < 0.05) higher in 
vitrified (48.1%) oocytes than those reported in other groups (24.1, 25.8, 10.5, 
21.4, and 16.8% in toxicity, CB-vitrified, CB-toxicity, CB-control, and control, 
respectively). 
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Table 7.2 Effect of cytochalasin D (CD) pre-treatment on in vitro fertilisation 
of ovine oocytes vitrified at GV -stage 
Fertilisation 
Treatment No. No. No. No. Oocytes Fertilised Polyspermic Unfertilised 
% % % 
Vitrified 81 33 {40.7%)b 9 (11.1%tb 39 (48.1%t 
Toxicity 83 60 (72.3%)8C 3 (3.6%)bc 20 (24.1 %)bc 
CD-vitrified 93 53 (57.0%)bC 16 (17.2%t 24 (25.8%)b 
CD-toxicity 57 43 (75.4%)8C 8 (14.0%)a 6 (1O.5%t 
CD-control 98 66 (67.3%)ac 11 (11.2%)ab 21 (21.4%)00 
Control 95 77 (81.1%)a 2 (2.15%t 16 (16.8%)bC 
Values with different superscripts in the same column are significantly different (a, 
b, c P< 0.05). Fertilised oocytes (characterised by presence of spermlswollen 
sperm head in ooplasm, or a male and/or female pronucleus). Polyspermy (oocytes 
with more than one sperm in ooplasm or more than two pronuclei). Unfertilised 
oocytes (no signs of sperm penetration). Four replicates were performed. 
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Vitrified CB-vitrified 
Figure 7.2 In vitro fertilisation of ovine oocytes. The figure represents 
fertilisation events of ovine oocytes stained with Hoechst at 18 hpi. (A and B) 
fertilised oocytes with male (MP) and female pronucleus (FP), (C and D), 
polyspermy (oocytes with ~ ~ 3 pronuclei), and (E and F) unfertilised oocytes (no 
signs of sperm penetration). Scale bar = 50 Ilm. 
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7.3.3 Effect of CB treatment on in vitro embryo development following IVF 
The development of ovine oocytes vitrified at GV stage and treated with CB 
before vitrification is presented in Table 7.3, Fig 7.3 and 7.4. 
Cleavage was significantly (P < 0.05) lower in vitrified and CB-vitrified oocytes 
at both 24 hpi (12.5 vs 9.1%) and 48 hpi (25.0 vs 16.2%) compared to other groups 
(59.5, 35.9, 77.8 and 60.4% at 24 hpi and 75.9, 67.2, 82.2, and 75.8% at 48 hpi in 
toxicity, CB-toxicity, CB-control, and control oocytes, respectively Table 7.3). 
Development to morula stage was significantly lower (P< 0.05) in vitrified and 
CB-vitrified oocytes (21.4 vs 10.1%) than in toxicity, CB-control, and control 
(45.7, 50.0 and 64.8%, respectively); however, no significant difference was 
observed between vitrified and CB-toxicity groups. 
Development to blastocysts stage (day 7 pi) was significantly decreased (P< 0.05) 
in both vitrified and CB-vitrified oocytes (4.5 and 3.0%) than other groups (31.0, 
27.3, 31.1 and 48.4% in toxicity, CB-toxicity, CB-control and control oocytes, 
respectively). Based on the numbers of cleaved oocytes (48 hpi), 16.1 and 18.8% 
of the cleaved embryos were developed to blastocysts in both vitrified and CB-
vitrified groups. These values did not differ significantly from CB-control 
(37.8%). Also, no significant difference was observed between both toxicity 
groups (CB treated or non-treated, ..., 40%). However, the percentage (63.8%) in 
control oocytes was significantly higher (P < 0.05) than other groups. 
Expanded and hatched blastocysts stage embryos were significantly lower (Table 
7.3 and Fig 7.3) in both vitrified and CB-vitrified as compared to other groups. No 
significant differences were observed in total cell numbers between all groups 
(92.5 ± 25.5, 98.6 ± 8.5, 103.7 ± 19.6, 107.7 ± 8.3, 100.8 ± 7.9, and 122.6 ± 10.3 
in vitrified, toxicity. CB-vitrified, CB-toxicity, CB-control, and control, 
respectively, Table 7.2 and Fig 7.4). 
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Table 7.3 Effect of cytochalasin B (CD) pre-treatment on development of ovine oocytes vitrified at GV stage 
Treatment No. No. Cleaved (%) No. No. Blastocysts (% of oocytes) Total No. Cell No I 
Oocytes hpi Morula Blastocysts blastocyst 
(%) (%of mean± 
cleaved 48 SEM 
24 48 Early Expanded Hatched Total hpi) 
Vitrified 112 14 31 24 3 1 1 5 16.1%8 92.5 ± 25.5 
(12.5%t (25.0%)8 (21.4%)8 (2.7%)ac· (0.9%t (0.9%)8 (4.5%t 
Toxicity 116 69 88 53 10 16 10 36 40.9%OC 98.6± 8.5 
(59.5%)b (75.9%)b (45.7%)bd (8.6%)ade (13.S%)b (S.6%)b (31.0%)b 
CD-vitrified 99 9 16 10 1 2 0 3 18.8%8 103.7± 19.6 
(9.l%t (16.2%)8 (10.I%t (1.0%)ad (2.0%t (0.0%)8 (3.0%t 
CD-toxicity 128 46 86 42 7 20 8 35 40.7%° 107.7 ± S.3 
(35.9%t (67.2%)b (32.S%)ad (5.5%td (15.6%)b (6.2%)b (27.3%)b 
CB-control 90 70 74 45 7 12 9 28 37.S%8C 100.S ± 7.9 
(77.S%)b (S2.2%)b (50.0%)b (7.8%)ce (13.3%)b (lO.O%)b (3 1. l%)bd 
Control 91 55 69 59 18 18 8 44 63.8%° 122.6±10.3 
(60.4%)b (75.8%)b (64.8%)b (19.S%)b (19.8%)b (8.8%)b (4S.4%td 
Values with different superscripts in the same column are significantly different ( ~ ~ b, c, d, e P < 0.05). Three replicates were carried 
out. 
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Figure 7.3 Day 7 blastocysts produced by IVF of ovine oocytes vitrified at GV 
stage and pre-treated with CD. The figure shows day 7 blastocysts obtained 
following IVMJIVFIIVC of ovine oocytes (A and B) vitrified, (C) CB-vitrified, 
(D) toxicity, (E) CB-toxicity and (F) control groups. Scale bar = 50 J.lm. 
131 
Chapter 7 Cytochalasin B and oocyte vitrification 
Figure 7.4 Total cell numbers in day 7 in vitro produced blastocysts. The 
figure shows day 7 blastocysts stained with Hoechst obtained following 
NMlIVF/IVC of ovine oocytes from (A) vitrified, (B) CB-vitrified, (C) toxicity, 
(D) CB-toxicity, (E) CB-control and (F) control groups. Scale bar = 50llm. 
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7.4 DISCUSSION 
Damage to the cytoskeleton is one of the major cryOInJunes In an oocyte 
vitrification program (Chen et al. 2003). In particular, the meiotic spindle of 
matured oocytes is vulnerable to cryoinjury with depolymerization of its 
microtubules occurring at lower temperatures. As the temperature drops and the 
ice proliferates, the concentration of electrolytes and other solutes within the 
oocyte can reach very high levels which may be damaging to intracellular proteins. 
Hence, methods for the potential protection of intracellular environment are 
important for successful cryopreservation (Morato et al. 2008a, b, c). 
Stabilizing of the cytoskeleton during vitrification may be beneficial for improving 
the post-thaw survival and subsequent development of vitrified oocytes. Several 
cytoskeleton stabilizers have been used to reduce injury to oocytes and embryos 
during vitrification including CB (Fujihira et al. 2004; Silvestre et al. 2006; 
Somfai et al. 2006; Bogliolo et al. 2007a) and cytochalasin D (CD, Vieira et al. 
2002; Magnusson et al. 2008). Cytochalasins inhibitors of micro filament synthesis 
that disrupt actin polymerization (Therodoropoulos et al. 1994) and prevent 
cytokinesis without affecting karyokinesis (Modlinski 1980). In MIl oocytes, CB 
reduces damage to microtubules and may enhance microtubule stabilization during 
vitrification (Zhang et al. 2009). In GV oocytes, the relaxant effect of CB may 
preserve gap junction functionality between oocytes and cumulus cells and allow 
faster and uniform penetration of cryoprotectants (Vieira et al. 2002). The 
beneficial effects of eB during oocyte cryopreservation are not clear and the 
results are controversial, probably differ according to the species. Isachenko et al. 
(1998) reported improvement in the frequencies of in vitro maturation from 5.6 to 
22.0% in vitrified/thawed porcine GV oocytes following eB treatment before 
vitrification. Furthermore, Fujihira et al. (2004) observed that treatment of porcine 
GV oocytes with eB at a concentration of 5.0 J.lg/ml for 30 min or 7.5 J.lg/ml for 
10 or 30 min before vitrification had beneficial effects on in vitro maturation rates. 
Also, Somfai et al. (2006) suggested that, eB pre-treatment increased survival and 
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development of vitrified/thawed porcine MIl oocytes. In ovine, Zhang el 01. (2009) 
observed that pre-treatment of vitrified/thawed MIl ovine oocytes with 7.5 or 10 
J.1g!ml CB for 20-25 min had a positive effect on subsequent development to 
blastocyst stage following IVF. In contrast, other studies have reported no effects 
of CB pre-treatment on vitrified/thawed MIl bovine (Vieira el 01. 2002) and GV 
ovine (Silvestre el 01. 2006) oocytes. Moreover, Bogliolo el 01. (2007a) observed a 
severe reduction in viability (16%) in CB pre-treated vitrified/thawed GV ovine 
oocytes as compared to controls (85%). In the above mentioned ovine studies, the 
effect of CB pre-treatment on viability and subsequent in vitro maturation of 
vitrified/thawed GV oocytes were only evaluated (Silvestre el 01. 2006; Bogliolo el 
01. 2007a). Therefore, the present study investigated the effect ofCB pre-treatment 
prior to vitrification on viability, in vitro fertilisation and subsequent development 
of ovine oocytes vitrified at GV stage. The survival rates reported here in both 
vitrified and toxicity groups, irrespective to CB treatment (88.4 to 93.9%) were 
slightly higher than that obtained by Bogliolo et 01. (2007a, 84.3%) following 
vitrification of GV ovine oocytes. 
It has been reported that problems with cryopreserved oocytes are obvious around 
fertilisation (Horvath and Seidel 2008). Decreased fertilisation rates following 
cryopreservation may be partly attributed to alterations of the zona pellucida 
(Horvath and Seidel 2008). Carroll et 01. (1990) reported lower fertilisation rates in 
frozen/thawed mouse oocytes as compared to control. Moreover, Tian et 01. (2007) 
observed lower penetration rates following IVF of vitrified/thawed MIl ovine 
oocytes than control, suggesting that, exposure of oocytes to vitrification solutions 
resulted in premature release of cortical granules and blockage of sperm entry. 
Earlier studies reported that, the actin cytoskeleton of the gametes during 
fertilisation process has been affected by cytochalasin with noticeable alterations 
in fertilisation (Rogers et 01. 1989). In the present study, CB pre-treatment resulted 
in higher frequencies of fertilised oocytes in vitrified group (57%) than non treated 
(40.7%); however, the difference was not significant. The cleavage rates and 
development to blastocysts were significantly lower in both vitrified and CB-
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vitrified oocytes as compared to other groups. However, in correlation to the 
numbers of cleaved embryos, no significant differences were observed in the 
frequencies of blastocyst development between vitrified, CB-vitrified and CB-
control groups. In addition, no significant differences were noticed in terms of 
total cell numbers per blastocyst between treatment and control groups. 
In the present study, the frequencies of in vitro fertilisation, cleavage, blastocyst 
formation, and the quality of blastocysts did not differ between the control and the 
toxicity groups. This indicates that high concentrations of cryoprotectants had no 
adverse effect on developmental competence of ovine oocytes. The reasons for 
improved results in toxicity trials may be due to the strictly controlled short 
exposure time to cryoprotectants during vitrification overcoming the detrimental 
effect of high concentrations of cryoprotectant. 
These results suggest that, pre-treatment of immature ovine oocytes with7.5 J-lg/ml 
CD for 60 min has no harmful effects on viability and subsequent development 
foHowing IVF. In contrast, Silvestre et 01. (2006) and Bogliolo et al. (2007a) 
found negative effects of CB treatment on survival of vitrified/thawed GV ovine 
oocytes. 
In conclusion, pre-treatment of immature ovine oocytes with the cytoskeleton 
stabilizer (CD) prior to vitrification improved the frequencies of in vitro 
fertilisation. In addition, the results show that cryopreservation of ovine GV ovine 
oocytes combined with CD pre-treatment resulted in good quality late stage pre-
implantation embryo development following IVF. Further investigations are 
required to evaluate the effects of other chemicals which act as cytoskeleton 
stabilil.crs on the viability and developmental potential of vitrified/thawed ovine 
oocytes for example Taxol. 
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CHAPTER 8 
EFFECT OF CAFFEINE TREATMENT ON SPINDLE 
CONFIGURATION, MPFIMAPK ACTIVITIES, AND 
SUBSEQUENT DEVELOPMENT OF OVINE OOCYTE-
S VITRIFIED AT GERMINAL VESICLE (GV) STAGE 
8.1 INTRODUCTION 
Cryopreservation of immature ovine oocytes has been reported to decrease the 
levels of maturation promoting factor (MPF) and mitogen-activated protein kinase 
(MAPK) after IVM (see Chapter 6, and Bogliolo et al. 2007a). MPF is a cyclin 
dependent serine/threonine protein kinase, its activation occurs in late 02 by de-
phosphorylation of T14 and Y15 by cdc25 phosphatase (Taieb et al. 1997, Fig 
8.1). Active MPF phosphorylates a range of proteins initiating entry into M-phase 
resulting in nuclear envelope breakdown, chromatin condensation, and 
microtubule organization (Verde et al. 1990). MAPKs are serine/threonine kinases 
activated by phosphorylation of the threonine and tyrosine residues (Posada and 
Cooper 1992). lligh levels of both kinases are responsible for the onset of 
germinal vesicle breakdown (GVBD) and required for the arrest of oocytes at Mil 
stage (Kalous et al. 1993; Nurse 1990). MPF activity is regulated by a 
combination ofcdc2 with cyetin B and phosphorylation ofcdc2 at T14 and Y15. 
Caffeine, a phosphodiesterase inhibitor has been reported to increase the activity 
of MPF by inducing the dephosphorylation of cdc2 at T14 and Y15 in pig oocytes 
(Kikuchi et al. 1999), cultured mammalian cells (Steinmann et al. 1991) and 
Xenopus eggs (Smythe and Newport 1992). Previous studies have been reported 
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that treatment of ovine oocytes with 10.0 mM caffeine from 18- 24 bours p ." 
onset of maturation (hpm) increased the activities of both MPF and MAP kinases. 
Moreover, when used as cytoplast recipients for somatic cell nuclear transfer 
(SCNT), caffeine-treated oocytes increased the occurrence of NEBD and 
premature chromosome condensation (PCC) in the donor nucleus and improved 
the quality of blastocysts stage embryos obtained, in tenns of total cell numbers 
(Lee and Campbell 2006). 
Based on these observations, this study was designed to evaluate the effects of 
caffeine treatment during in vitro maturation on MPFIMAP kinases activities, 
chromatin and spindle organization, and subsequent in vitro embryo development 
following IVMlIVFIIVC of ovine oocytes previously vitrified at the GV stage. 
Caffeine 
pre-M PF 
(i.actin) 
MPF(attive) 
Figure 8.1 Activation of MPF. MPF activity is controlled by association of cdc2 
with cyclin B and phosphorylation of cdc2 at T14 and YlS. Caffeine, a 
phosphodiestrase inhibitor mcreases the activity of MPF by inducing the 
dephosphorylation of cdc2 at T14 and YlS, and by inhibition of MytllWeel 
kinases. 
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8.2 MATERIALS AND METHODS 
8.2.1 Oocyte vitrification and IVM 
Cumulus oocyte complexes (COCs) obtained from slaughtered sheep ovaries 
(Chapter 2.1) were matured in vitro without any treatment (Control),following 
exposure to vitrification solutions without being plunged into liquid nitrogen 
(Toxicity), or vitrified using cryoloop as previously described (Vitrified, Chapter 
2.2.3). Following vitrification and warming, viable oocytes were matured in vitro 
(Chapter 2.3). 
8.2.2 Caffeine treatment 
At 18 hpm, cumulus cells were removed from all groups by repeated pipetting of 
COCs in H-TCM 199IPVP containing 300 IV/ml hyaluronidase. After washing in 
maturation medium, oocytes from each group were incubated in maturation 
medium supplemented with (+) or without (-) caffeine (10 rnM) for another 6 h till 
24hpm. 
8.2.3 MPFIMAPK activities, spindle and chromosome configuration 
At 24 hpm, analysis of MPF and MAPK activities were performed in all groups as 
described in (Chapter 2.11), spindle and chromatin morphology were evaluated as 
described in (Chapter 2.4). 
8.2.4 In vitro fertilisation and culture (IVFRVC) 
Following 24 h IVM, oocytes from all groups were fertilised and cultured as 
described in (Chapter 2.5 and 2.8). 
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8.3 RESULTS 
8.3.1 Effect of caffeine treatment on MPF and MAP kinases activities 
The effect of caffeine (10 mM, 18 to 24 hpm) treatment on MPF and MAP kinases 
activities of ovine oocytes vitrified and exposed to vitrification solutions at GV 
stage are presented in Fig 8.1. Supporting the previous results in Chapter 6, 
activities of both MPF and MAP kinases (24 hpm) were decreased in vitrified 
oocytes as compared to control; however, the activities were not affected in 
toxicity group (t-test). The activities of both kinases were decreased in vitrified 
oocytes treated with caffeine (vitrified +) than those non-treated (vitrified -). 
However, caffeine treatment increased the activities of both kinases in control 
oocytes as compared to untreated controls (Fig 8.2). 
A 
Histone HI 
MBP 
Control Toxicity Vitrified Control Toxicity Vitrified 
(-) (+) 
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Figure 8.2 ffccts of caffeine treatment on maturation promoting factor 
(MPF) and mitogen-activated protein kinase (MAPK) activities. Oocytes from 
different gr ups contr I toxicity and vitrified were incubated in IVM medium 
upplemented with (+) r without (-) caffeine (10 mM, 18 - 24 bpm), at 24 bpm 
maturation pr m ting factor (MPF) and mitogen-activated protein kinase (MAPK) 
activitie were evaluated. (A) Phospho-image of histone Hl (MPF) and myelin 
basic pr tein (MAPK) ph sphorylation. (B) Relative activities (32p incorporation 
[cpm/mm2]) f MP and MAPK kinases. Ten oocytes were analysed for each 
gr up and three replicate were performed. Bars represent mean ±SEM. 
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8.3.2 Effect of caffeine treatment on spindle and chromatin configuration 
Spindle and chromatin organization of ovine oocytes vitrified at GV stage and 
subsequently matured in caffeine (10 mM) containing IVM medium for 6 h (18-24 
hpm) is presented in Table 8.1 and Fig 8.3. No significant differences (P > 0.05, 
i) were observed in the frequencies of normal, abnormal spindle and normal 
chromatin configuration between vitrified oocytes either treated (+) or not treated 
with caffeine (-), and both non treated toxicity and control oocytes (47.8, 43.8, 
52.3,45.7 vs 67.6%, respectively). 
Also, no significant differences were observed in proportions of normal spindle 
and chromatin configuration between vitrified, toxicity and control oocytes 
matured in caffeine containing medium (Table 8.1 and Fig 8.3). 
The percentages of oocytes with mIssmg spindles significantly increased in 
vitrified and toxicity groups and ranged from 23 to 28% as compared to control (7 
to 9%). Frequencies of oocytes with abnormal chromosome significantly increased 
(P < 0.05) in both vitrified groups as compared to control oocytes (52.2 and 56.1 
vs 22.7 and 32.4% in caffeine treated (+) and non-treated (-), respectively). 
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Vitrified (+) Vitrified (-) 
Figure 8.3 Spindle and chromatin configuration. The figure shows (A and B) 
normal barrel shaped metaphase II spindle (green) with compact chromosome 
(blue) arranged at the equator of the structure obtained following 24 h IVM of 
ovine oocytes vitrified at GV stage and matured either in caffeine containing 
medium (+) (10 mM, 18- 24 hpm) or without caffeine (-) . (C and D) represent 
abnormal spindle configuration with dispersed chromatin. Scale bar = 50 /lm. 
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Table 8.1 Effect of caffeine treatment on spindle and chromatin configuration of ovine oocytes vitrified at GV -stage 
Spindle configuration Chromosome configuration 
Treatment Caffeine No. No. No. No. No. No. treated Oocytes Normal Abnormal Missing Normal Abnormal 
(%) (%) (%) (%) (%) 
(+) 46 22 11 13 22 24 
(47.8%)ab (23.9%)a (28.3%)a (47.8%)ab (52.2%)a 
Vitrified (-) 57 25 16 16 25 32 
(43.8%t (28.1%)a (28.1%)a (43.8%)a (56.1 %)a 
(+) 44 23 11 10 23 21 
(52.3%)ab (25.0%)a (22.7%)ac (52.3%)ab (47.7%tc 
Toxicity (-) 46 21 13 12 21 25 
(28.3%)a (26.1%)a (45.7%t (54.3%)a 
(45.7%)a 
(+) 44 34 6 4 34 10 
(77.3%)b (13.6%t (9.1%)bC (77.3%)b (22.7%)b 
Control 
(-) 102 69 26 7 69 33 
(67.6%)ab (25.5%)a (6.8%)b (67.6%)ab (32.4%)bc 
a,b,c different superscripts in the same column are significantly different (P< 0.05). (+) matured with caffeine (10 mM, 18-24 hpm), (-) 
without caffeine. Four replicates were carried out. 
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8.3.3 Effect of caffeine treatment on frequency of cleavage following IVF 
The effect of caffeine treatment (10 mM, 18-24 hpm) on cleavage at 24 and 48 hpi 
of vitrified/thawed ovine immature oocytes are presented in Table 8.2. Cleavage 
was significantly lower (P< 0.001, i) in vitrified (+ and -) at both 24 (2.8 and 
4.3%) and 48 hpi (30.3 and 32.2%) as compared to other groups. At 24 hpi, 
frequencies of cleaved embryos were also decreased (P< 0.05) in toxicity (31.6 
and 22.6%, + and -, respectively) and control (+, 31.5%) as compared to control (-, 
45.2%). However, this trend was not observed at 48 hpi with cleavage values 
ranging from 58.1 to 78.6%, Table 8.2. 
Table 8.2 Effect of caffeine treatment on cleavage rates following IVF of ovine 
oocytes vitrified at GV stage 
Treatment Caffeine No. No. Cleaved (%) 
treated OoC)1es hpi 
24 48 
(+) 142 4 (2.8%t 43 (30.3%t 
Vitrified 
(-) 115 5 (4.3%t 37 (32.2%t 
(+) 98 31 (31.6)b 77 (78.6%)b 
Toxicity 
(-) 93 21 (22.6%)b 54 (58.l%)b 
(+) 149 47 (31.5%)b 94 (63.l%)b 
Control 
(-) 96 52 (45.2%)C 67 (69.8%)b 
Values with different superscripts in the same column are significantly different (a, 
b, c, P< 0.05). (+) oocytes matured in 10 mM caffeine for 6 h, (-) oocytes matured 
without caffeine. 
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8.8.4 Effect of caffeine treatment on suhsequent development/of/owing IVF 
Effects of caffeine treatment (10 mM, 18-24 hpm) on morula, blastocyst 
development and total cell numbers in blastocyst embryos after IVMlIVFIIVC of 
ovine vitrified/thawed GV-oocytes are presented in Table 8.3 and Fig 8.4. 
Development to morula (day 5 pi) was significantly lower (P< 0.05, i) in either 
vitrified groups (25.4 and 24% in + and -, respectively) than in toxicity (+, 45.1 %) 
and control (+, 41.6%) groups. However, no significant differences (P> 0.05) 
were observed between vitrified oocytes, toxicity (-, 35.5%), and control (-, 
38.5%). Caffeine treatment resulted in higher frequencies of day 7 blastocyst stage 
embryos (4.2%) compared to non treated vitrified oocytes (1.7%); but the 
difference was not significant. These were significantly lower (P< 0.001, i) than 
in other groups (30 - 32%). 
Morphological evaluation of the blastocysts produced revealed no hatched 
blastocysts in either vitrified group; however, 12.2, 16.1, 16.1, and 8.3% were 
reported in toxicity and control oocytes (+ and -, respectively). The numbers of 
expanded blastocysts significantly decreased (P< 0.05, i) in both groups of 
vitrified oocytes (0.7 and 1.7%) as compared to toxicity (+ and -) and control (-) 
groups (10.2, 12.9 and 11.5%, respectively, Fig 8.4 A). However, no significant 
differences were observed between vitrified (-) and control groups (+, 6.7%). Total 
cell numbers were significantly lower (P< 0.05, I-test) in vitrified (+) blastocysts 
(54 ± 8.5) as compared to other treatments (107.2 ± 5.9, 117.3 ± 6.2, 109.6 ± 5.4, 
and 100.6 ± 11.7, in toxicity and control + and -, respectively); however, this value 
did not differ significantly from those reported in vitrified (-, 87.0 ± 0.0) group 
(Table 8.3 and Fig 8.40, C and D). 
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Figure 8.4 Day 7 ovine blastocysts produced by IVF. The figure shows day 7 
blastocysts produced by IVF of ovine oocytes matured in IVM medium 
supplemented with 10 mM caffeine (18 to 24 bpm), (A) expanded blastocyst from 
vitrified oocytes, (B, C and D) blastocysts stained with Hoechst and produced 
from vitrified, toxicity and control oocytes, respectively. Scale bar = 50Jlm. 
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Table 8.3 Effect of caffeine treatment on subsequent development of ovine oocytes vitrified at GV stage 
Treatment Caffeine No. No. No. Blastocysts (% of oocytes) Total Total cell 
treated Oocytes Morula blastocysts numbers! 
(%) (% of cleaved blastocyst 
Early Expanded Hatched Total 48 hpi) mean±SEM 
Vitrified (+) 142 36 5 1 0 6 13.9%a 54.0± 
(25.4%t (3.5%)00 (0.7%)a (O.O%)a (4.2%t 8.5a 
(-) 115 28 0 2 0 2 5.4%a 87.0± 
(24.3%t (O.O%t (1.7%)00 (O.O%t (1.7%t Oac 
Toxicity (+) 98 53 9 10 12 31 40.3%D 107.2± 
(45.1%)bC (9.2%t (10.2%)b (12.2%)b (31.6%)b 5.9bc 
(-) 93 33 3 12 15 30 55.5%D 117.3± 
(35.5%)00 (3.2%)ab (12.9%)b (16.1 %)b (32.2%)b 6.2b 
Control (+) 149 62 11 10 24 45 47.9%D 109.6± 
(41.6%)bC (7.4%)ab (6.7%)bC (16.1%)b (30.2%)b 5.4bc 
(-) 96 37 10 11 8 29 43.3%D 100.6± 
(38.5%)00 (10.4%)b (11.5%)b (8.3%)b (30.2%)b 11.7bc 
Values with different superscripts in the same column are significantly different (a, b, c, P< 0.05). (+) oocytes matured with 10 mM 
caffeine for 6 h, (-) oocytes matured without caffeine. Four replicates were carried out. 
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8.4 DISCUSSION 
Developing effective methods to cryopreserve mammalian oocytes has proven 
very challenging, with those from domestic species, notably cattle, pig, and sheep, 
being especially sensitive to cryopreservation procedures (Mullen et al. 2007). 
Many characteristics make mammalian oocytes particularly susceptible to 
cryoinjury, including the large amount of lipid in some taxa including ovine 
(McEvoy et al. 2000), large volume (Mullen et al. 2007), and the presence of MIl 
spindle (Tharasanit et al. 2006a). Due to the inability of these cells to proliferate in 
culture and the relatively small number of oocytes obtainable from a given 
individual, the proportions that survive cryopreservation are important (Mullen et 
al.2007). 
As previously reported vitrification of ovine GV oocytes reduced the activities of 
MPF and MAP kinases as compared to fresh control oocytes (Bogliolo et al. 
2007a). Previous studies reported that treatment of ovine oocytes with 10 mM 
caffeine 18-24 hpm increased the activities of both MPF and MAP kinases. 
Therefore, based on these observations, the present studies hypothesised that 
incubation of vitrified/thawed ovine GV oocytes with caffeine during IVM can 
restore the activities of MPF and MAPK, spindle and chromosome integrities, and 
subsequent development following IVF. Supporting the previous results in 
Chapter 6, vitrification of ovine GV oocytes decreased the activities of MPF and 
MAPK following 24 h IVM as compared to control oocytes. Caffeine treatment 
decreased the level of MPF and MAP kinases in vitrified oocytes than those 
vitrified and matured in vitro without caffeine treatment, but the difference 
between two groups was not significant. However, it increased the activities of 
both kinases in control group, confirming the previous results obtained by Lee and 
Campbell (2006). The reason for this is unclear, but it may be that caffeine has 
different action on vitrified oocytes than that on control. These observations 
require further investigation. One of the mechanisms that regulate MPF activity is 
the modification of the phosphorylation status ofp.34cdc2 kinase by MytllWeel and 
148 
Chapter 8 Caffeine treatment and oocyte vitrification 
cdc25. The addition of caffeine in culture medium suppresses MytllWeel activity, 
resulted in the inhibition of the shift from active MPF to pre-MPF, the inactive 
form (see Fig 8.1) and subsequent increase in MPF activity (Kikuchi et al. 1999). 
The mechanism of action of caffeine may differ in COCs and denuded oocytes. In 
COCs caffeine like other purine derivatives, possibly acts by blocking cAMP 
phosphodiesterase and cdc2 kinase, increasing cAMP levels and thus changing the 
signalling pathway (Chesnel et al. 1994). Regarding toxicity group (oocytes 
exposed to vitrification solutions without freezing), the activities of both kinases 
were not affected in this group as compared to control oocytes, indicating that 
vitrification and warming are responsible for the alterations in the activities of both 
kinases, not the cryoprotectants. In contrast to the observations presented here, 
Bogliolo et al (2007b) reported that caffeine treatment can increase MPF and MAP 
kinases activities in vitrified MIl ovine oocytes and thus contributed towards 
maintaining a regular chromatin organization in the metaphase plate and also 
preventing parthenogenetic activation. Discrepancies between these results may 
relate to, the differences in stage at which oocytes were vitrified (MIl vs GV), 
vitrification methods (Cl)'otop vs cryoloop) or caffeine treatment regime. In the 
study by Bogliolo et al oocytes were treated with 20 rnM caffeine for 2 h (21 to 23 
hpm) and then vitrified and warmed. However, in the studies reported here, 
oocytes were vitrified at GV stage, incubated in maturation media until 18 hpm 
and then cultured in IVM medium supplemented with 10 mM caffeine for 6 h (Lee 
and Campbell 2006). It has been reported that, treatment of oocytes with caffeine 
at a concentration higher than 10 rnM and for a period over 6 h decreases oocyte 
viability (Lee and Campbell 2006). Previous studies reported lower MPF kinase 
activity in ovine oocytes either obtained from mature or pre-pubertal ewes vitrified 
and exposed to vitrification solutions at MIl stage (Succu et al. 2007 a, b), despite, 
the activity was restored after 2 h culture in oocytes obtained from mature animals 
but not from pre-pubertal ones. Bogliolo et al. (2007a) found that denudation of 
ovine COCs before vitrification decreases MPF and MAPK activities; however, 
these activities were not affected if oocytes vitrified while cumulus layer intact. 
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In the present study, the effects of caffeine treatment on spindle and chromosome 
morphology of vitrified, toxicity, and control oocytes were evaluated. The results 
show that, caffeine treatment did not affect the proportions of oocytes with normal 
spindles and chromatin organization. The effects of caffeine treatment on spindle 
morphology of mouse oocytes have been studied by Miao et al. (2007) and the 
results showed that oocytes have various spindle morphologies in relation to 
caffeine concentrations. Higher percentages of normal morphology were observed 
in oocytes treated with 5 or 10 mM caffeine as compared to those treated with 0 or 
1 mM (Miao et al. 2007). 
In the present study, the effect of caffeine (10 mM, 18-24 hpm) treatment on 
cleavage and subsequent in vitro embryo development of vitrified/thawed GV, 
toxicity, and control oocytes was assessed. The results showed that, caffeine 
treatment did not affect cleavage (24 and 48 hpi), morula development (day 5pi) in 
vitrified, toxicity, and control groups (Table 8.2). However, it increased the 
percentage of day 7 blastocyst stage embryos in vitrified group as compared to non 
treated oocytes (Table 8.3). Irrespective to caffeine treatment, the developmental 
rates in vitrified oocytes were significantly lower as compared to toxicity and 
control groups. A part from the various injuries that occur to the oocytes during 
vitrification and warming, the lower developmental potential reported here could 
be related to the removal of cumulus cells before fertilisation, however, these 
effects were not observed in toxicity and control oocytes. Thus, the results suggest 
that presence of cumulus cells during IVF of vitrified sheep oocytes is necessary to 
maintain the integrity of oocytes and subsequent development. Bogliolo et al. 
(2007a) observed that cumulus cells behave differently and display distinct 
morphologies, showing a lower grade of physical interaction with the oocytes, 
when cultured with vitrified denuded oocytes compared to the control group. 
Previous studies reported that denudation of ovine oocytes at 24 hpm followed by 
immediate fertilisation decreases the frequencies of cleaved oocytes (Maalouf et 
al. 2009). Herein, although caffeine treatment reduced MPF and MAP kinases 
activities and did not affect the cleavage rates in vitrified oocytes, it did increase 
150 
Chapter 8 Caffeine treatment and oocyte vitrification 
the frequencies of blastocyst stage embryos, suggesting that caffeine increased the 
developmental potential of vitrified oocytes by mechanisms other than elevation of 
MPF and MAPK activities. Caffeine has been reported to extend the fertilisation 
period of in vitro matured ovine oocytes by reducing polyspermy and retaining the 
ability to develop to blastocyst (Maalouf et al. 2009) other studies demonstrated 
that caffeine treatment has effects at an epigenetic level, histone acetylation in 
aged mouse oocytes was reduced (Huang et al. 2007). The percentage of 
blastocysts reported in these studies in vitrified oocytes matured in caffeine 
containing IVM medium (+, 14%) as calculated per cleaved embryo was slightly 
higher than that reported by Succu et al. (2007a) following IVF ofvitrifiedlthawed 
ovine MIl oocytes (12.5%). This indicates an improvement in vitrification protocol 
of GV oocytes. Total cell numbers were decreased in blastocysts obtained from 
vitrified (+) oocytes as compared to those obtained following IVMlIVFIIVC of 
vitrified oocytes matured in vitro without caffeine (-), but the difference was not 
significant. However, the value in vitrified (+) group was significantly lower than 
in toxicity and control groups. No significant differences were noticed between 
vitrified (-), toxicity (+) and control blastocysts (Table 8.3). Maalouf et al. (2009) 
observed no effects of caffeine treatment on the quality of in vitro produced ovine 
blastocysts in terms of mean cell numbers or ICM: TE ratio. 
In conclusion, GV -stage ovine oocytes vitrified with cryoloop can subsequently 
mature in vitro without any effects on spindle configuration and subsequently 
following fertilisation and development to the blastocyst stage. Caffeine treatment 
of ovine oocytes vitrified at GV stage increased the frequencies of blastocyst 
development, but no effects on the quality of in vitro produced blastocysts. The 
results suggest that, caffeine improved blastocyst rates in vitrified oocytes by 
mechanisms other than an increase in MPF and MAP Kinases activities. Further 
studies are required to evaluate the effects of different caffeine concentrations on 
developmental competence of vitrified oocytes following IVF, parthenogenetic 
activation, and SCNT. 
151 
Chapter 9 Demecolcine pre-treatment and oocyte vitrification 
CHAPTER 9 
EFFECT OF DEMECOLCINE PRE-TREATMENT ON 
VIABILITY, TIMING OF FIRST POLAR BODY EXTR-
USION, SPINDLE CONFIGURATION, AND SUBSEQU-
ENT DEVELOPMENT OF OVINE OOCYTES VITRIFI-
ED AT GERMINAL VESICLE (GV) STAGE 
9.1 INTRODUCTION 
Mammalian oocytes remain one of the most difficult cell types to successfully 
cryopreserve (Men el 01. 2003a). Stabilizing the cytoskeleton structure during 
vitrification could be beneficial for improving the post-thaw survival and 
subsequent development of vitrified oocytes. Several cytoskeleton stabilizers have 
been used to reduce injury to oocytes and embryos during vitrification including 
cytochalasins (Chapter 7) and taxol (Morato el 01. 2008a, b; Zhang et 01. 2009). 
Another chemical, demecolcine (Deme), a cytoskeletaI modifier has been widely 
used in nuclear transfer (Nn studies to increase the efficiency of enucleation in 
different species including pig (Yin et 01. 2002), cattle (Russell et 01. 2005; Tani et 
01. 2006), mice (Ibanez et 01. 2003), goat (Lan et 01. 2008), and sheep (Hou et 01. 
2006). Moreover, incubation of ovine GV oocytes with demecolcine has been 
reported to induce germinal vesicle breakdown (GVBD) and chromosome 
condensation which subsequently led to meiosis resumption (Hou et 01. 2006). 
Demecolcine has also shown to increase MPF and MAPK activities in cattle and 
goat oocytes (Tani et 01. 2006; Lan et 01. 2008). However, no studies have been 
reported the effects of demecolcine pre-treatment on viability of vitrified/thawed 
oocytes. 
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The objectives of these studies were to investigate the effects of demecolcine pre-
treatment on viability, timing of first polar body (PBI) extrusion, spindle, 
chromatin configuration and subsequent development of vitrified/thawed ovine 
GV oocytes following IVM and IVF or IVM and parthenogenetic activation. 
9.2 MATERIALS AND METHODS 
9.2.1 Demecolcine treatment, vitrifICation, and in vitro maturation (/Vjf) 
COCs obtained from mature ewes were randomly divided into three groups (1) 
untreated control, (2) vitrified, and (3) Deme + vitrified (oocytes were incubated 
with 0.1 J.1g/ml demecolcine in TCM-199 medium supplemented with 10% FBS 
for 20 min at 39°C prior to vitrification). Following vitrification and warming 
(Chapter 2.2.3), oocytes were matured in vitro for 24 h as previously described 
(Chapter 2.3). At 24 hpm (hour post onset of maturation). oocytes meiotic spindle 
and chromatin morphology was examined as previously described (Chapter 2.4). 
9.2.2 In vitro fertilisation and culture (IVFRVC) 
24 hpm, oocytes from three groups were fertilised in vitro and cultured for 7 days 
in C.SOF medium as previously described (Chapter 2.5 and 2.8). 
9.2.3 Parthenogenetic activation 
24 hpm, in vitro matured oocytes were activated by 10 mM srCh (strontium 
chloride) and 7.5 JIg/mt CB (cytochalasin B) in calcium free CZB medium for 4-5 
h at 39°C and a humidified atmosphere of 5% C02 in air. Following activation, 
oocytes were cultured in vitro for 7 days as previously described (Chapter 2.8). 
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9.3 RESULTS 
9.3.1 Effect of Deme pre-treatment on viability of vitrified oocytes 
The effect of Deme pre-treatment on viability of vitrified/thawed GV ovine 
oocytes is presented in Fig 9.1. No significant (X2) differences were observed in 
the proportions of viable oocytes between deme+vitrified and vitrified groups 
(90.8%, 324/357 and 87.2%, 2111242, respectively). 
100 - Viable 
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0 
Deme+vitrified Vitrified 
Figure 9.1 Effect of demecolcine (Deme) pre-treatment on viability of ovine 
oocytes vitrified at GV-stage. The graph shows the percentage (± SEM) of viable 
and in deme+vitrified (oocytes treated with 0.1 Ilg/ml demecolcine for 20 min 
prior to vitrification) and vitrified groups. Six replicates were carried out. 
9.3.2 Timing of first polar body (PBJ) extrusion 
The effects of demecolcine pre-treatment on kinetics of PBI extrusion in ovine 
vitrified/thawed GV oocytes are presented in Fig 9.2 and Fig 9.3. Numbers of 
oocytes showing PBI were evaluated at 18, 20, 22, and 24 hpm. At 18 hpm, the 
proportion of oocytes with PBI was significantly higher (P< 0.05, X2) in 
deme+vitrified (20.4%, 20/98) oocytes as compared to non-treated group (8.5%, 
10/118); however, these percentages were significantly lower (P< 0.01) than 
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control (47.1%, 41/87). Demecolcine pre-treatment also increased the numbers of 
oocytes with PBI at 20, 22, and 24 hpm (34.7, 37.8, and 51.0%, respectively, Fig 
9.2 and Fig 9.3) as compared to the oocytes that vitrified without treatment (22.0, 
27.1, and 43.2%, respectively), but, the differences were not significant. These 
percentages were significantly lower (P< 0.01) than control (55.2, 58.6, and 
88.5%). 
100 ....... 18 h - 20 h ---22 h - 24 h 
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Figure 9.2 Effect of demecolcioe (Deme) pre-treatment 00 timing of first polar 
body extrusion (PDI) in ovine oocytes vitrified at GV -stage. The graph shows 
the proportions (± SEM) of ovine oocytes extruding PBI at 18, 20, 22, 24 hpm in 
deme+vitified (oocytes treated with 0.1 Jlglml demecolcine prior to vitrification), 
vitrified, and control groups. Four replicates were performed. 
Figure 9.3 Ovine oocyte showing first polar body (PHI) fonowing 24 h IVM. 
The figure shows 24 h in vitro matured oocyte with PBI (arrow) obtained from 
vitrified GV ovine oocytes. 
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9.3.3 Effect of Deme pre-treatment on spindle and chromosome organization of 
ovine oocytes vitrified at GVstage 
Effects of demecolcine pre-treatment prior to vitrification of immature ovme 
oocytes on spindle and chromatin configuration 24 hpm are summarized in Table 
9.1 and Fig 9.4. Percentage of oocytes with normal spindle and chromatin 
configuration was significantly decreased (P< 0.05, i) in vitrified groups as 
compared to control (42.5 and 41.8 vs 76.5%). Numbers of oocytes with missing 
spindles were significantly increased (P< 0.001) in deme+vitrified and vitrified 
groups as compared to control (47.5 and 32.7 vs 3.9%). Abnormal spindle 
morphology was significantly lower (P< 0.05) in deme+vitrified oocytes as 
compared to vitrified group (10.0 vs 25.5%). These were not significant as 
compared to control (19.6%). Proportions of oocytes with abnormal chromosome 
organization were significantly higher (P< 0.05) in vitrified groups as compared to 
control (57.5 and 58.2 vs 32.5% Table 9.1 and Fig 9.4). 
Figure 9.4 Spindle and chromatin configuration of ovine oocytes following 24 
IVM. The figure shows (A) normal barrel shape metaphase II spindle (green) with 
compact chromosome (blue) arranged at the equator of the structure obtained 24 
bpm of ovine oocytes vitrified at GV stage and treated with 0.1 J.lglml demeco1cine 
prior to vitrification. (B and C) show abnormal spindle with dispersed chromatin. 
Scale bare = 50 J.lm. 
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Table 9.1 Effect of demecolcine (Deme) pre-treatment on spindle and chromatin configuration of ovine oocytes vitrified at GV-
stage. 
Treatment 
Spindle configuration Chromosome configuration 
No. 
Oocytes No. Normal No. Abnormal No. Missing No. Normal No. Abnormal 
(%) (%) (%) (%) (%) 
Deme 40 17 4 19 17 23 
+Vitrified (42.5%t (1O.0%)8C (47.5%)8 (42.5%t (57.5%t 
Vitrified 55 23 14 18 23 32 (41.8%t (25.5%)b (32.7%)8 (41.8%)8 (58.2%)8 
Control 51 39 10 2 39 12 (76.5%)b (19.6%)bC (3.9%)b (76.5%)b (23.5%)b 
a,b,c different superscripts in the same column are significantly different (P< 0.05). Four replicates were performed. 
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9.3.4 Effect of Deme pre-treatment on in vitro emhryo development following 
IVMlIVFIlVC of ovine oocytes vitrified at GV stage 
Effects of demecolcine pre-treatment (0.1 J.1g/ml for 20 min), prior to vitrification 
of ovine GV oocytes on cleavage (24 and 48 hpi), morula (day 5 pi), blastocyst 
development (day 7 pi) and total cell numbers in blastocyst stage embryos are 
presented in Table 9.2 and Fig 9.5.Cleavage at 24 and 48 hpi and morula 
development were significantly lower (P< 0.01, r:) in deme+vitrified (6.1, 43.1, 
and 28.5%) and vitrified groups (3.3, 30.1, and 22.9 %) as compared to control 
(50.4, 82.4, and 46.4%). Blastocyst development in deme+vitrified (9.8%) and 
control (33.6%) was significantly higher (P< 0.01) than in vitrified group (1.3%). 
The same trend was observed, when the numbers of blastocyst calculated as a 
percentage from cleaved embryos (22.6 and 40.8 vs 4.3%, in deme+vitrified, 
control, and vitrified groups, respectively, Table 9.2). 
Hatched blastocysts were significantly lower (P< 0.05) in deme+vitrified oocytes 
as compared to control group (4.9 vs 12.8%, Fig 9.5 A), however, no hatched 
blastocysts developed in vitrified oocytes that not treated with deme prior to 
vitrification. Expanded blastocysts were significantly lower (P< 0.05) in treated 
groups as compared to control (1.6 and 1.3 vs 13.6%). No significant differences 
(I-test) were observed in total cell numbers between groups (97.0 ± 13.3, 91.0 ± 
4.0, and 106.0 ± 5.1 in deme+vitrified, vitrified, and control, respectively, Table 
9.2 and Fig 9.5 B). 
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Table 9.2 Effect of demecolcine (Deme) pre-treatment on in vitro embryo development following IVl\fIIVFIIVC of ovine 
oocytes vitrified at GV-stage. 
No. No. No. Blastocysts (% of oocytes) Blastocysts Total cell 
Treatment No. Cleaved(%) ~ I o r u l a a (% of cleaved numbers! OoC)'tes hpi blastocyst 
24 48 (%) Early Expanded Hatched Total 48 hpi) mean:SEM 
Deme 123 10 53 35 3 2 6 12 22.6%- 97.0 
+Vitrified (6.1%)- (43.1%)- (28.5%t (2.4%)ab (1.6%)- (4.9%)- (9.8%)- :13.3 
Vitrified 153 5 46 35 0 2 0 2 4.3%b 91.0 (3.3%t (30.1%)- (22.9%)- (O.O%)b (l.3%t (O.O%)b (1.3%)b ±4.0 
Control 125 63 103 58 9 17 16 42 40.8%C 106 (50.4%)b (82.4%)b (46.4%)b (7.2%t (13.6%)b (l2.8%t (33.6%)C : 5.1 
-
Values with different superscripts in the same column are significantly different at P< 0.05. Four replicates were performed. 
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Figure 9.S Day 7 in vitro produced blastocysts. The figure shows (A) day 7 
hatched blastocyst (B) stained with Hoechst and produced by IVMlIVFIIVC of 
ovine oocytes vitrified at GV stage and treated with 0.1 Jlg/ml demecolcine for 20 
min before vitrification. Scale bar = 50 Jlm. 
9.3.5 Effect of Deme pre-treatment on parthenogenetic development of ovine 
oocytes vitrified at GV stage 
Cleavage at 24 and 48 hpa in deme+vitrified (10.3 and 40.7%) and control groups 
(52.5 and 76.7%) were significantly higher (P< 0.05, i) than in vitrified oocytes 
(3.3 and 30.1 %). The same trend was observed for morula development (26.2 and 
48.4 vs 9.9% in deme+vitrified, control, and vitrified groups, respectively). 
Development to Blastocyst stage embryos (day 7 pa) was higher in deme+vitrified 
oocytes (4.8%) as compared to vitrified group (1.8%); but the difference was not 
significant (P> 0.05). These values were significantly lower (P< 0.001) as 
compared to control group (24.2%). Lower proportions of hatched blastocysts 
developed in vitrified groups as compared to control (Table 9.3). However, total 
cell numbers per blastocyst were not significant (84.0 ± 7.0,86.0 ± 4.0, and 95.1 ± 
5.6 in deme+vitrified, vitrified, and control groups, respectively). 
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Table 9.3 Effect of demecolcine (Deme) pre-treatment on parthenogenetic development ofvitrifiedlthawed ovine immature 
oocytes. 
No. No. No. Blastocysts (% of oocytes) Blastocysts Total cell 
Treatment No. Cleaved(%) Morula (% of cleaved numbers! Oocytes hpa blastocyst 
24 48 (%) Early Expanded Hatched Total 48 hpa) mean:i:SEM 
Deme 145 15 59 38 3 3 1 7 11.9%8 84 
+Vitrified (10.3%)' (40.7%)a (26.2%)a (2.1%)' (2.1 %)a (0.7%)' (4.8%)a ±7.0 
Vitrified 111 4 26 11 1 0 1 2 7.7%8 86 (3.6%)b (23.4%)b (9.9%)b (0.9%)8 (O.O%)a (0.9%)' (1.8%)' ±4.0 
Control 219 115 168 106 21 21 11 53 31.5%b 95.1 (52.5%t (76.7%t (48.4%t (9.6%)b (9.6%)b (5.0%)b (24.2%)b ± 5.6 
-- -
Values with different superscripts in the same column are significantly different at P< 0.05. Four replicates were performed. 
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9.4 DISCUSSION 
Demecolcine, a cytoskeletal modifier, has been reported to improve the efficiency 
of enucleation in NT (Yin et al. 2002; Russell et al. 2005; Tani et al. 2006) and 
induce GVBO and chromosome condensation in GV oocytes (Hou et al. 2006). In 
these studies, the effect of Deme pre-treatment on timing of PBI extrusion in 
vitrified/thawed ovine GV oocytes was evaluated. The results demonstrate that 
lower percentage (8.5%) of vitrified oocytes displayed PBI extrusion at 18 hpm; 
however, this value significantly increased to 20.4% when oocytes were treated 
with demecolcine prior to vitrification. The results suggest that vitrification of 
immature oocytes results in delay of PBI extrusion and demecolcine pre-treatment 
improve this delay. Also, Oeme pre-treatment increased the numbers of oocytes 
with PBI at 20, 22 and 24 hpm. Cooling of GV oocytes to 0 or 4°C has been 
reported to affect meiotic spindle formation and polar body extrusion although the 
telophase I spindle divided normally into two chromosomes sets (Wu et al. 1999). 
Previous studies reported that PBI is not normally extruded following IVM of 
vitrified GV oocytes even after separation of chromosomes (Abe et al. 2005), 
indicating that vitrified oocytes have the ability to mature normally to telophase I 
stage; however, damage to some regulatory factors can be occurred which 
subsequently influence the extrusion of PBI (Wu ef al. 1999). High numbers of 
oocytcs with no visible PBI was also reported following vitrification of IVM 
buffalo oocytes (Boonkusol et al. 2007); this was due to alterations in spindle fibre 
formation. A delay in maturation was also reported following vitrification of GV 
equine oocytes (llochi el al. 1994). The role of demecolcine for the increase in the 
rates of PDI extrusion in vitrified oocytes is unclear; and requires further 
investigation. Previous studies reported that incubation of ovine GV ovine oocytes 
with dcmecolcine induced GVBD, chromosome condensation and subsequent 
resumption of meiosis (I lou et al. 2006). Earlier studies also showed that 
demccolcine can induce germinal vesicle migration in amphibians and gold fish 
oocytes (llabibi and Lessman 1986). Alterations in spindle and chromosome 
configuration following oocyte cryopreservation have been extensively studied in 
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different species (Chen et al. 2003; Ledda et al. 2007; Morato et al. 2008 a, b, c, 
d). In these studies, Numbers of oocytes with nonnal spindles were significantly 
decreased in vitrified groups as compared to control. Although, Demecolcine pre-
treatment decreased the numbers of oocytes with abnonnal spindle morphology in 
vitrified group, it increased the numbers of oocytes with missing spindle. The 
exact explanation to this observation is unclear; but, demecolcine as a microtubule 
inhibitor, can bind to tubulin dimmers and prevent microtubule polymerization, 
thus, resulting in the loss of dynamic spindle microtubules (Ibanez et al. 2003; 
Russell et al. 2005). In the present study, the effect of demecolcine pre-treatment 
on subsequent development following IVF and parthenogenetic activation of 
vitrified oocytes was also investigated. Demecolcine pre-treatment increased the 
frequencies of cleavage, morula and blastocyst development in vitrified oocytes as 
compared to non treated vitrified group. The higher developmental frequencies in 
demccolcine treated oocytes may be due to the higher frequencies of PBI extrusion 
in treated oocytes which subsequently improve maturation, fertilisation and 
subsequent development. In addition, demecolcine has been reported to increase 
MPF and MAPK activities in cattle and goat oocytes, respectively (Tani et al. 
2006; Lan et al. 2008), but this was not studied in sheep, which requires further 
investi gations. 
In conclusion. vitrification of GV-stage oocytes delays the kinetics of in vitro 
maturation as detennined by extrusion of PBI; pre-treatment of oocytes with 
demecolcinc prior to vitrification enhances this delay. Moreover, pre-treatment of 
vitrified oocytcs with dcmccolcine could improve the developmental potential of 
ovine vitrified/thawed GV-stage oocytes. Further studies are required to evaluate 
the effects of different concentrations of demecolcine on viability of vitrified 
oocytes and to examine the incidence of chromosomal abnonnalities in the 
blastocysts produced from oocytes pre-treated with demecolcine. 
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CHAPTER 10 
GENERAL DISCUSSION 
Oocyte cryopreservation has the potential to be an important adjunct to assisted 
reproductive technologies (ARn in human and domestic animals. Long-term 
storage of oocytes from patients in danger of losing ovarian function is one of the 
most important reasons for cryopreservation of human oocytes, and it extends to 
highly valuable females of any species. In animals, oocyte preservation permits 
genetic material from a female to be stored unfertilised until she expresses her 
potential and the appropriate mate can be selected. However, despite significant 
recent progress, the efficiency of oocyte cryopreservation is still very low. In 
contrast to cryoprescrvation of sperm and embryos, with oocytes the entity is a 
single, large, highly specialized ceJl that has to survive the procedure to be able to 
undergo fertilisation and cleavage. Oocytes are susceptible to a range of damages 
due to exposure to low temperature including rupture of intercellular 
communication between the cumulus cells and oocyte, premature release of 
cortical granules, hardening of the zona pellucida, change in lipid bilayers or lysis 
of oocyte membranes, damage to the structure of cytoskeleton or mitochondria, 
damage to cytoplasmic organelles such as smooth endoplasmic reticulum, 
decreasing the activities of maturation promoting factor (MPF) and mitogen 
activated protein kinase (MAPK), disorganization of meiotic spindle, loss or 
clumping of microtubules, scattered chromosomes, and subsequent decrease in 
fertilisation and developmental rates (Ilochi el aI. 1998; Wu el aI. 1999, Men et aI. 
2003a, b; Abc et aI. 2005; Albarracin et aI. 2005a, b; Bogliolo et aI. 2007a; Succu 
el aI. 2007a, b). The success of oocyte cryopreservation depends on several factors 
include size, stage of maturity, membrane permeability, oocyte quality, presences 
or absences of cumulus cells, species, and other factors related to the 
cryoprescrvation procedures (Fabbri 2006). The most encouraging results in 
domestic animals have been reported in cattle. where cryopreservation of 
immature and mature oocytes has been resulted in healthy offspring following in 
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vitro fertilisation (IVF) and culture (Vieira et al. 2002; Papis et al. 2000). 
Ilowever, few experiments have been conducted on small ruminants, especially 
with sheep (BogJiolo et al. 2007a). These studies were designed to establish a 
technique for oocyte cryopreservation which would support subsequent 
development following different in vitro techniques. Sheep were chosen as an 
experimental model. 
Currently, there are two techniques used for oocyte cryopreservation slow-freezing 
and vitrification. Vitrification is less hannful to the cells, such as oocytes and 
embryos whose chilling sensitivity is high, than conventional methods of slow-
freezing (Martino et al. 1996b, Vajta et al. 1998). The key aim of any vitrification 
protocol is to achieve high cooling rates in combination with high concentrations 
of cryoprotectants (Liebermann and Tucker 2002). A balance between maximizing 
cooling rate and minimizing the cryoprotectant concentrations is important to 
minimize the osmotic or chemical toxicity that occur by using high concentrations 
of cryoprotectants. 
The efTects of exposure of immature ovine oocytes to different combinations of 
cryoprotectant on viability and subsequent in vitro maturation (IVM) were 
evaluated (Chapter 3). The viability of oocytes was not affected by the types and 
concentrations of cryoprotectants. Ilowever, following IVM, significantly lower 
maturation rates (16.1%) were observed in oocytes exposed to VSII (25% ethylene 
glycol (EO) + 25% DMSO) as compared to those exposed to VSI (20% EG + 20% 
DMSO, 50'(1'10) or to VSIII (25% EO + 25% glycerol, 45.1 %). The results indicate 
that a combination of 20010 EG and 20% DMSO can be used effectively for the 
vitrification of ovine oocytes. 
As discussed earlier, high cooling rate remains the key factor for successful oocyte 
vitrification. various devises have been used to decrease the volume of vitrification 
solutions and subsequently increase the cooling rates (Chapter 1.6.1.3). Solid 
surface vitrification (SSV) and cryoloop share the advantages of using a 
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containerless system and small volumes of solution (less than 1 J..lI) which favours 
rapid heat exchange during cooling, therefore, it prevents chilling injury and 
cracking of zona pellucida (Dinnyes et 01. 2000; Lane et 01. 1999a,b). In the 
present study, recovery, viability, frequencies of maturation, fertilisation, cleavage 
and subsequent development following IVMlIVFIIVC of ovine oocytes vitrified at 
GV stage using SSV or cryoloop were determined (Chapter 4 and Chapter 5). 
Following SSV, 75.7% of vitrified oocytes were recovered; of those oocytes 
recovered 74.8% were viable. Maturation, fertilisation, cleavage and blastocyst 
development were significantly decreased in SSV vitrified oocytes as compared to 
fresh control (Chapter 4). Following cryoloop vitrification, 82.6% of 
vitrificdlthawed oocytes were recovered and 72.6% were viable. Frequencies of 
maturation (oocytes at Mil stage) and fertilisation following IVMlIVF did not 
differ significantly between vitrified and control groups. However, polyspermic 
fertilisation significantly (P< 0.001) increased in vitrified oocytes as compared to 
control (17.0 lIS 3.5%, Chapter 5). Previous studies reported that exposure of 
oocytes to cryoprotectants and cryopreservation resulted in clustering, 
degeneration, loss, and premature release of cortical granules and subsequent zona 
hardening which can lead to a defective blocking of polyspermy (LeGal and 
Massip 1999; Tian el al. 2007). Cleavage (24 and 48 hpi, hours post insemination), 
morula (day 5pi), and blastocyst (day 7pi) development were significantly 
decreased in cryoloop vitrified oocytcs as compared to non vitrified control 
groups. Iligh frequencies of cleaved embryos developed to blastocyst stage 
(29.4%) in vitrified group (Chapter 5) indicating that even though some 
polyspermy almost certainly occurred, this may not have been a major problem. 
Previous studies reported that mouse oocytes frozen and thawed in medium 
containing foetal bovine serum (FBS) could be fertilised and develop at 
frequencies similar to control (Carroll el al. 1993). In the present study, the 
oocytes were handled in vitrification and thawing media contain FBS that might be 
responsible for similar developmental potential of vitrified oocytes as compared to 
control. The results presented here suggest that exposure of oocytes to SSV 
(Chapter 4) and cryoloop (Chapter 5) vitrification solutions (Toxicity control) 
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did not affect viability, maturation, fertilisation and subsequent development as 
similar frequencies as compared to control were achieved. The reasons for 
improved the results in toxicity trials may be due to the strictly controlled short 
exposure time to cryoprotectants during vitrification overcoming the detrimental 
effect of high concentrations of cryoprotectant Technical difficulties associated 
with SSV (controlling the size of the droplets) may explain the lower 
developmental frequencies in SSV vitrified oocytes as compared to those vitrified 
using cryoloop. 
Parthenogenetic activation and nuclear transfer (NT) could be an alternative 
approaches to evaluate the developmental potential of vitrified oocytes. Here, the 
effectiveness of two protocols (1) a combination of calcium ionophore (A 23187), 
cycloheximide and cytochalasin B (CA+cHXlCB), (2) strontium and CB (Sr/CB) 
on parthenogenetic activation ofvitrifiedlthawed ovine GV oocytes was evaluated. 
Development of somatic cell nuclear transfer (SCNT) embryos using ovine 
oocytes vitrified at GV stage as cytoplast recipients was also evaluated (Chapter 
6). No blastocyst stage embryos developed in vitrified oocytes activated by 
CA+CllXlCB; however, 3.8% were obtained following Sr/CB activation. The 
results indicate that strontium is efficient in parthenogenetic activation of 
vitrified/thawed ovine oocytes. Following SCNT, although the frequencies of 
cleaved embryos were significantly decreased in vitrified oocytes as compared to 
control group, development to morula and blastocyst stage embryos was not 
significantly different These results indicate that ovine oocytes vitrified at GV 
stage can be used as cytoplast recipients for SCNT and produce high frequencies 
of good quality blastocyst embryos. This may be due to various factors including 
vitrification protocol, cryoprotectant combinations, activation method, oocyte 
quality, and the stage of oocyte enucleation anaphase-I1telophase-I (AIITI). 
Previous studies reported that enucleation at AIITI removes significantly less 
cytoplasm than enucleation at MIl which is beneficial for the developmental 
competence of the recipient cytoplast (Lee and Campbell 2006). 
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Cytoskeleton stabilization using cytochalasin B (CB) can be a possible approach to 
improve the cryotolerance of vitrified oocytes (Vieira et al. 2002). The effects of 
CB pre-treatment prior to vitrification (7.5 Jlglrnl for 60 min) on viability, 
fertilisation and subsequent development following IVMJIVFIIVC of 
vitrified/thawed ovine GV oocytes were evaluated (Chapter 7). No significant 
differences were observed in survival rates between CB treated and non treated 
oocytes in both vitrified and toxicity groups. CB treatment resulted in higher 
fertilisation rates in vitrified oocyte as compared to non treated group (57.0 vs 
40.7%), but the difference was not significant. No significant differences were 
observed in the frequencies of blastocyst development between CB-vitrified 
oocytes and vitrified group. These results suggest that pre-treatment of immature 
ovine oocytes prior to vitrification with 7.5 Jlglml CB for 60 min has no adverse 
effects on viability and subsequent development. In contrast, Silvestre et al (2006) 
and Bogliolo et al. (2007a) reported negative effects of CB treatment on survival 
of vitrified/thawed ovine GV oocytes. 
The effects of caffeine treatment during in vitro maturation on MPFIMAPK 
kinases activities, spindle. chromatin configuration, and subsequent in vitro 
embryo development following IVMJIVFIIVC of ovine oocytes previously 
vitrified at the GV stage were evaluated (Chapter 8). Caffeine treatment (10.0 
mM, 18-24 hpm) decreased the levels of MPFIMAPK kinases in vitrified oocytes 
as compared to non treated group, but the difference was not significant. No 
significant differences were observed in the proportion of oocytes with normal 
spindle and chromatin configuration between vitrified and control groups 
(Chapter S). Caffeine treatment did not affect these proportions in vitrified 
oocytes (Chapter 8). Caffeine treatment increased the frequencies of blastocysts 
development in vitrified oocytes as compared to non treated vitrified group. These 
results suggest that caffeine treatment improved the blastocyst development in 
vitrified oocytes by mechanism other than an increase in MPFIMAPK kinases 
activities as it does in fresh control oocytes (Lee and Campbell 2006). 
168 
Chapter 10 General discussion 
The effects of demecolcine (deme) pre-treatment on viability, timing of first polar 
body (PDI) extrusion, spindle, chromatin organization, and subsequent 
development of vitrified/thawed GV oocytes following IVM and IVF or IVM and 
parthenogenetic activation were evaluated (Chapter 9). The results show that the 
frequencies of PDI at 18 hpm were significantly decreased in vitrified oocytes as 
compared to deme + vitrified (oocytes treated with 0.1 ~ g l m l l demecolcine for 20 
min prior to vitrification) and control groups (8.5 vs 20.4 and 47.1%, respectively). 
Also, demecolcine pre-treatment increased the frequencies of PBI in vitrified 
oocytes at 20, 22, and 24 hpm as compared to non-treated. The results indicate that 
vitrification of immature oocytes resulted in a delay in the kinetics of PBI 
extrusion and dcmecolcine pre-treatment improve this delay. DemecoIcine pre-
treatment did not affect the proportions of oocytes with nonnal spindle and 
chromatin configuration; however, it increased the numbers of oocytes with 
missing spindle. As previously discussed in (Chapter 9) demecolcine can bind to 
tubulin dimmers and prevent microtubule polymerization, thus, resulting in loss of 
dynamic spindle microtubules (Ibanez el al. 2003; Russell et al. 2005). Following 
IVF and parthenogenetic activation, the frequencies of cleaved embryos, morula 
and blastocysts development were increased in vitrified oocytes pre-treated with 
demecolcine prior to vitrification as compared to non treated vitrified oocytes. 
In conclusion, thcse results demonstrate that ovine oocytes vitrified at GV stage 
can be matured, fertilised, and develop up to blastocyst stage embryos. Cryoloop 
may be superior to SSV for vitrification of ovine oocytes as this technique resulted 
in an increased developmental potential of vitrified/thawed oocytes after 
IVMJIVFIIVC. Exposure of immature oocytes to SSV and cryoloop vitrification 
solutions did not affect in vitro embryo production in sheep. Vitrification of 
immature oocytes did not significantly affect the proportions of oocytes with 
normal spindle, chromatin configuration and MPFIMAPK kinase activities 
following IVM as compared to control. Viability, maturation, fertilisation, and 
subsequent development of vitrified/thawed ovine GV oocyte can be improved by 
the treatments of oocytes with different chemicals either prior to vitrification such 
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as cn and demecolcine or during IVM such as caffeine. Vitrified GV oocytes can 
develop up to morula stage following parthenogenetic activation, irrespective to 
activation protocol. Strontium can be used effectively for parthenogenetic 
activation of vitrified immature ovine oocytes. Vitrified-thawed ovine oocytes can 
be used successfully for the first time as cytoplast recipients for SCNT with 
production of high frequencies of blastocyst development. The results demonstrate 
that good quality blastocysts could be produced from vitrified immature oocytes 
following IVF, parthenogenetic activation or SeNT. The results presented here are 
encouraging and vitrification protocols (Fig 10.1) applied in the present studies 
could be a promising tool for the establishment of oocyte banking (Fabbri et al. 
2001; Fabbri 2006) for widespread application of ART in both humans and 
animals. 
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IIVM24h 
Activation Sr/CB 
4-5h 
Immature ovine oocytes 
10% EG + 0.25 M Trehalose 3 min 
20% EG + 20% DMSO 60 sec 
Cryoloop vitrification 
IVF 18 h 
Ive 7 days 
, 
IVM 18 h 
Caffeine 10 mM 
6h 
General discussion 
CB 7 . 5 ~ g l m l l 60 
min 
Deme 0.1 ~ g / m l l
20 min 
IVM 15-16 h 
~ ~ Enucleation 
IVM22-24h I 
! Fusion 
Activation Sr/CB 
4-5h 
Figure lO.lThe best conditions used for vitrification of immature ovine 
oocytes applied in this thesis and resulted in high developmental competence 
following IVF, parthenogenetic activation or SeNT. 
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APPENDIXA 
MEDIA AND STOCK SOLUTIONS 
I. Media and Stock Solutions for Oocyte Culture 
Ovary Collection Medium (PBS): 
8 g NaCI 
0.2 g FCCI 
1.44 g 
0.24 g 
Adjust pH to 7.4 with 5 N NaOH and make up to 1 L final volume with dH20 . 
Sterilise by autoclaving for 20 minutes at 15 Ib/in2. 
Oocyte Dissection Medium: 
18 ml Tissue Culture Medium 199 with Earle's salts 
containing 25 mM HEPES, 25 mM sodium bicarbonate, 
3 mM L-glutamine, L-Amino Acids (H-TCM 199) 
2 ml Heat-inactivated Foetal Bovine Serum 
Sterilise by filtration through a 0.22 J.lm Millipore filter and equilibrate in an 
atmosphere of 5% C02 in air with maximum humidity at a temperature of 39°C for 
at least 2 hours prior to use. 
Sodium pyruvate stock: 
11 mg Sodium pyruvate (Sigma P-4506) 
1 ml reM 199 
Stock solution was stored at 4°C. Sodium pyruvate stock was diluted in maturation 
medium to a working concentration of 0.2 mM. 
17p-estradiol stock: 
1 mg 1 7 ~ - e s t r a d i o l l (Sigma E-8875) 
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1 ml Ethyl alcohol 
Stock solution was stored at -20°C for a maximum of one month. 1 7 ~ - e s t r a d i o l l
stock was diluted in maturation medium to a working concentration of 1 Jlg/ml. 
Gentamycin stock: 
50 mg 
Iml 
Gentamycin (Sigma G-3632) 
Normal saline 
Stock solution was stored at 4°C. Gentamycin stock was diluted in maturation 
medium to a working concentration of 50 J.lg/ml. 
Cysteamine (2- Mercaptoethylamine) stock: 
7.714 mg Cysteamine (Sigma M-9768) 
1 mt TCM 199 
Stock solution was dispensed in 20 J.lI aliquots, and stored at -20°C. Cysteamine 
stock was diluted in maturation medium to a working concentration of 100 JlM. 
FSH (Follicular stimulating hormone) stock: 
400 mg FSH (Folltropin®-V; Vetrepharm) 
80 ml Normal saline 
Stock solution was dispensed in 20 JlI aliquots, and stored at -20°C. FSH stock was 
diluted in maturation medium to a working concentration of 5 Jlg/ml. 
LH (Luteinizing hormone) stock: 
25 mg LH (Lutropin -V; Vetrepharm) 
5 ml Normal saline 
Stock solution was dispensed in 20 JlI aliquots, and stored at -20°C. LH stock was 
diluted in maturation medium to a working concentration of 5 Jlg/ml. 
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Oocyte Maturation Medium: 
9 ml Tissue Culture Medium 199 with Earle's salts 
containing 25 mM sodium bicarbonate, 3 mM L-
glutamine 
1 
5 
5 
1 
0.2 
100 
50 
ml 
Jlglml 
Jlglml 
Jlglml 
mM 
JlM 
Jll/ml 
Heat-inactivated Foetal Bovine Serum 
FSH (Folltropin®-V; Vetrephann) 
LH (Lutropin-V; Vetrephann) 
1 7 ~ - e s t r a d i o l l
Sodium pyruvate 
Cysteamine 
Gentamycin 
Sterilised by filtration through a 0.22 Jlm Millipore filter and equilibrated in an 
atmosphere of 5% C02 in air with maximum humidity at a temperature of 39°C for 
at least 2 hours prior to use. 
II. Media and Stock Solutions for Vitrification of Ovine Oocytes 
Cryoprotectants Used in Vitrification Solutions: 
Ethylene Glycol (EG, Sigma E-9129) 
Dimethylsulfoxide (DMSO, Sigma D 4540) 
Glycerol (GL Y, Sigma G-6279) 
Trehalose (T, Sigma T-0167) 
Polyvinylpyrrolidone (PVP, Sigma, PVP 40) 
Different Vitrification Solutions (VS): 
Base Medium 
18 ml 
2 ml 
PBS 
FBS 
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Cryoprotectants: 
Media Base Medium 
Equilibration 1.8 ml 
VSI 1.2ml 
VSII I ml 
VSII I ml 
Warming I 1.8 ml 
Warming II 2ml 
SSV Vitrification Solutions: 
Base Medium (20% FBS) 
24 ml 
6 ml 
EO 
0.2ml 
0.4 ml 
0.5 ml 
0.5 ml 
0.2ml 
-
H-TCM 199 
FBS 
Equilibration Solution (4% EG) 
DMSO 
-
0.4ml 
0.5 ml 
-
-
-
9.6 ml Base medium 
0.4 ml EO 
Vitrification Solution (35% EG) 
5 ml Base mediwn 
1.5132 g 
0.5 g 
3.5 ml 
Fill up to 10 ml 
Trehalose 
PVP 
EO 
Warming Solution (0.3 M Trebalsoe) 
9 ml Base mediwn 
1.134 g 
Fill up to 10 ml 
Trehalose 
Media and stock solutions 
OLY T 
- 0.189 gm 
- -
- -
0.5 ml 
-
-
0.756 gm 
-
0.378 gm 
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Cryoloop Vitrification Solutions: 
Base Medium 
18 
2 
ml 
ml 
Equilibration Solution 
1.8 ml 
0.2 ml 
0.189 g 
Vitrification Solution 
1.2 ml 
0.4 ml 
0.4 ml 
Warming Solutions 
Warming Solution I 
1.8 ml 
0.2 ml 
0.756 g 
Warming Solution II 
2 ml 
0.378 g 
H-TCM 199 
FBS 
Base medium 
EG 
Trehalsoe 
Base medium 
EG 
DMSO 
Base medium 
EG 
Trehalose 
Base medium 
Trehalsoe 
III. Media and Stock Solutions for Ovine IVF 
Stock C (33mM Na Pyruvate) 
Na Pyruvate 36mg 
Dissolve in 10mls MQ water. Filter and store at 4°C for up to I week. 
Stock GLN (1 OmM glutamine) 
Glutamine 73mg 
Dissolve in SOmis MQ water. Filter and store at 4°C for up to 1 week or aliquot 
and keep at -20°C. 
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Stock B (250mM NaHC03) 
NallC03 1.0505g 
Phenol red 5mg (or 3 drops) 
Dissolve NallC03 in 50mls MQ water and add phenol red. Filter and store at 4°C 
for up to 2 weeks. 
StockH 
Hepes 
(250mM Hepes) 
5.9575g 
Dissolve in lOOmIs MQ water. Filter and store at 4°C for up to 1 month. 
Stock L (330mM Na Lactate) 
Na lactate (60% syrup) 1.41mls 
Dissolve in 30mls MQ water. Filter and store at 4°C for up to 1 month. 
Stock S3 
NaCI 
KCI 
KlhP04 
glI00ml 
6.294 
0.534 
0.162 
Filter and store at 4°C for 3 months. 
Stock D (171mM CaCh.21hO) 
CaCh.2I hO 1.260g 
gl200ml 
12.588 
1.068 
0.324 
Dissolve in 50mls MQ water. Filter and store at 4°C for up to 3 months. 
Stock M (49mM MgCh.6H20 ) 
MgCh.6H20 500mg 
Dissolve in 50ml MQ water. Filter and store at 4°C for up to 3 months. 
Stock G (60mM glucose) 
Glucose 540mg 
Dissolve in 50mIs MQ water. Filter and store at 4°C for up to 3 months. 
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Sperm Washing Medium 
To SOml TeG water, add: 
Stock S2 (S3) 10.OmI 
Stock H 8.4ml 
Stock B l.6ml 
Stock e l.Oml 
StockGLN l.Oml 
StockM l.Oml 
Stock L l.Oml 
StockG 4.0ml 
StockD 1.0mI 
BSA Fraction V 300mg 
Stock PenlStrep O.Sml 
water up to 100mi 
pH 7.2-7.4 
mOsm 283 +/- 10 
Filter and keep in the fridge for up to 2 months. 
Fertilisation Medium 
To 25ml Tea H20, add: 
Stock S2 S.Oml 
StockB S.Oml 
Stock e l.Sml 
Stock L l.Sml 
StockM O.5ml 
StockGLN S.OmI 
StockD l.Oml 
Penlstrep O.25ml 
lhO Up to SOml 
pH 7.9 
mOsm 283 ± 10 
Filter and fridge for up to 2 weeks. 
IVF - add 2% sheep serum to fertilisation medium and equilibrate before use. 
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IV. Media and Stock Solutions for Nuclear Transfer 
Composition of modified Synthetic Oviduct Fluid (mSOF) medium: 
Component MW Concentration gIL 
NaCI 58.44 107.63 mM 6.2899 
KCI 74.55 7.16mM 0.5338 
KH2P04 136.10 1.19 mM 0.1620 
MgS04 120.40 1.51 mM 0.1818 
CaCh'2H2O 147.00 1.78 mM 0.2617 
Sodium lactate (60% syrup) 112.10 5.35mM 757 Jil 
NaHC0 3 84.01 25.00mM 2.1002 
Na-pyruvate 110.00 7.27mM 0.7997 
L-Glutamine 146.10 0.20mM 0.0292 
Tri-Sodium-citrate 294.10 0.34mM 0.1000 
Myo-inositol 180.20 2.77mM 0.4992 
Phenol-red 10.0 Jig/ml 10mg 
ddIhO Up to lL 
The osmolarity of SOF was adjusted to 270 to 280 mOsm and to pH 7.4 with 1 N 
sodium hydroxide and stored at 4°C for a maximum of one week. For use 45.0 
J.lVml BME amino acids, 5.0 JiVml MEM amino acids and 5% heat inactivated 
FBS were added whenever needed. The medium was sterilised by filtration 
through a 0.22 J.1m Millipore filter and equilibrated in an atmosphere of 5% C02 in 
air with maximum humidity at a temperature of 39°C for at least 2 hours prior to 
use. 
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Composition of HEPES - buffered Synthetic Oviduct Fluid (H-SOF) medium: 
Component MW Concentration gIL 
NaCI 58.44 107.63 mM 6.2899 
KCI 74.55 7.16mM 0.5338 
KlhP04 136.10 1.19 mM 0.1620 
MgS04 120.40 1.51 mM 0.1818 
CaCh·2H2O 147.00 1.78 mM 0.2617 
Sodium lactate (60% syrup) 112.10 5.35 mM 757 III 
NaIlCO) 84.01 5.00mM 0.4200 
Na-pyruvate 110.00 7.27mM 0.7997 
L-Glutamine 146.10 0.20mM 0.0292 
Tri-Sodium-citrate 294.10 0.34mM 0.1000 
IIEPES 238.30 20.00mM 4.7660 
Phenol-red 10.0 Ilg/ml 10mg 
ddlhO Up to lL 
Chatot Ziomek Barister (CZB) medium: 
Stock media 
Component amount Component amount 
Ultra pure water 990ml Na-Lactate 5.3 ml 
NaCI 4760 mg D-Glucose 1000mg 
KCI 360mg KH2P04 160mg 
MgS047l hO 290mg EDTA2Na 40mg 
Mix well, it is 1000 ml. Then make the CZBas following: CaCh stock for CZB is 
0.189 g in 10 ml water 
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CZB: 
Component amount Component amount 
Stock media 99ml Pyruvate 3mg 
NaHCO] 211 mg Glutamine 15 mg 
CaCh·2H20 stk 1 ml BSA 500mg 
Adjust pH to 7.4., For Calcium free CZB, do not add calcium chloride stock 
solution. 
Hyaluronidase stock (300 IU/mg): 
100 mg Hyaluronidase (Sigma H-3506) 
1.1 g PVP 
110 ml Ca2+_, Mg2+-free Dulbecco's phosphate-buffered saline 
(DPBS-) 
Stock solution was dispensed in 1 ml aliquots and stored at -20°C. 
Cytochalasin B stock: 
10 mg 
1 ml 
Cytochalasin B (Sigma C-6762) 
DMSO 
Stock solution was dispensed in 1 0 ~ l l aliquots, and stored at -20°C. Cytochalasin 
B stock was diluted in H-SOF at a working dilution of 5 ~ g l m l . .
Hoechst 33342 stock: 
25 mg 
5 ml 
Hoechst 33342 (Sigma B-2261) 
ddH20 
Stock solution was dispensed in 1 0 ~ l l aliquots, and stored at -20°C. Cytochalasin 
B stock was diluted in H-SOF at a working dilution of 5 ~ g l m l . .
Ca2+ Ionophore (A23187) stock: 
5 mg Ca2+ Ionophore (A23187) (Sigma C-7522) 
1.91 ml DMSO 
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Stock solution (5 mM) was dispensed in 10 I.d aJiquots, and stored at -20°C. Ca2+ 
Ionophore (A23187) stock was diluted in H-SOF at a working dilution of 5 JlM. 
Cycloheximide (CIIX) stock: 
5 mg Cycloheximide (Sigma C-6255) 
1 ml Ca2+_, Mg2+-free Dulbecco's phosphate-buffered saline 
(DPBS-) 
Stock solution was dispensed in 20 JlI aliquots, and stored at -20°C. 
Cycloheximide (CHXM) stock was diluted in mSOFaaci at a working dilution of 
IOIlg/mI. 
Caffeine solution: 
9.6 mg 
5 ml 
Caffeine (Sigma C-8960) 
Maturation medium 
Caffeine was dissolved for 2-3 min and sterilised by filtration through a 0.22 JlID 
Millipore filter. Prior to use the medium was equilibrated in an atmosphere of 5% 
C02 in air with maximum humidity at a temperature of 39°C for at least 2 hours. 
Fusion medium (0.3 mM Mannitol): 
2.73 g Mannitol (Sigma M-4125) 
50 III 100 mM MgS04 (246.5 mg/IOml) 
5.96 mg HEPES 
25 mg BSA 
50 ml ddlhO 
Stock solution was dispensed in 3 ml aliquots and stored at -20°C 
Strontium stock solution: 
226.62 mg 
or 158.53 mg 
I ml 
Strontium chloride hexahydrate (Sigma 255521) 
Strontium chloride anhydrous (Sigma 439665) 
ddlhO 
Stock solution was dispensed in 10 JlI aliquots and stored at room temperature. 
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v. Media and Stock Solutions for In vitro Double Kinase Assay 
Oocyte collection buffer: 
6.4 mM EDTA (pH 7.4) 
10 mM NaF 
100 mM Na3 V04 in DPBS 
Ice cold lysis buffer: 
45 mM p-glycerophosphate (PH 7.3) 
12 mM p-nitrophenylphosphate 
20 mM 3-(N-morpholino)-propanesulfonic acid (MOPS) 
12 mM MgCh 
12 mM ethyleneglycol bis (2-amino-ether) tetra acetic acid 
(EGTA) 
1.4 mM EDTA 
20 mM Na3V04 
10 mM NaF 
2 mM dithiothreitol (DIT) 
2 mM phenylmethylsulphonyI fluoride 
2 mM benzamidine 
20 Ilg/ml leupeptin 
20 Ilg!ml pepstatin 
20 Ilg!ml aprotinin 
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VI. Reagents and Gel Preparation for SDS-PAGE Slab Gels 
Bio-Rad's Preweighed Acrylamide: 
37.5:1 mixture (Catalog Number 161-0106,200 g) 
90 g acrylamidelbis (30 g/ 100 ml) to 300 ml with dH20 
1.5 M Tris-HCL, pH 8.8: 
27.23 g Tris base 
-80 ml ddH20 
Adjust to pH 8.8 with 1 N HCL, and make up to 150 ml with ddH20 and store at 
4°C. 
10% SDS: 
Dissolve 109 SDS in water with gentle stirring and bring to 100 ml with ddH20 . 
2X SDS sample buffer 
5.0 ml 0.5 M Tris-HCL, pH 6.8 
4.0 ml glycerol 
0.8 g SDS 
617.0 mg DTT 
2 mg 1% (w/v) bromophenol blue 
8.0 ml to 20 ml with ddH20 
Store at -80°C 
5X electrode (Running) buffer (pH 8.3): 
9 g Tris base 
43.2 g glycine 
3g SDS 
To 600 ml with ddH20 
Store at 4°C. Warm to 37°C before use if precipitation occurs. Dilute 60 rol 5X 
stock with 240 ml ddH20 for one electrophoretic run 
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Separating gel (15%) preparation -0.375 M Tris, pH 8.8: 
4.7ml ddH20 
5.0ml 
lOml 
200 III 
100 III 
14 III 
4x Tris-HCI (1.5 M, pH 8.8) 
30% stock acrylamidelbis 
lO%SDS 
10% (w/v) ammonium persulfate (APS) 
TEMED 
A total of 10 ml is sufficient for 2 mini gels 
Staking gel (4%) preparation- 0.125 M Tris, pH 6.8: 
6.0ml ddH20 
2.5 ml 4x Tris-HCl (0.5 M, pH 6.8) 
1.4 ml 
100 III 
50 J.lI 
10 III 
30% stock acrylamidelbis 
10%SDS 
10% (w/v) ammonium persulfate (APS) 
TEMED 
A total of 5 ml is sufficient for 2 mini gels 
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Composition of Separating gel mixtures 
Final acrylamide concentration 
Stocks solution (ml) 
6% 10% 12% 14% 15% 
30% acrylamide/0.8% 2.000 3.330 4.000 4.700 5.000 
biacrylamide 
4x Tris.CI (PH 8.8) 2.500 2.500 2.500 2.500 2.500 
10% (w/v) SDS 0.100 0.100 0.100 0.100 0.100 
10%(w/v) ammonium 0.050 0.050 0.050 0.050 0.050 
persulfate 
TEMED 0.007 0.007 0.007 0.007 0.007 
ddH20 5.350 4.020 3.350 2.650 2.350 
Total volume· 10 10 10 10 10 
• A total volume of 10 ml gel mixture is sufficient for two mini gels 
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APPENDIXB 
CRYOPRESERVA TION OF OOCYTES IN DIFFERENT SPECIES 
Cryo(!reservation of oocl:tes from different mammalian s(!ecies. 
Species Stage CPAs Freezing Viability Results (%) Reference 
method assal.. 
Bovine MIl EG Vitr IVF 15BR Martino et al. (1996a) 
Bovine MIl EG+F+S Vitr IVF 72.4 FR Hochi et al. (1998) 
Bovine Mil EG+DM Vitr IVF 25·BR Vajta et al. (1998) 
Bovine MIl EG+S Vitr IVF lOBR Otoi et al. (1998) 
Bovine GV EG+PR+S Slow IVFINT tl5BR Kubota et al. (1998) 
Bovine MIl EG+PR+S Slow IVFINT 12·116 BR Kubota et al. (1998) 
Bovine MIl EG+DM+F+S Vitr IVF 33BR Lane et al. (1999a) 
Bovine MIl EG+S Vitr IVF 14.8· BR Papis et al. (2000) 
Bovine MIl EG+PVP+T Vitr IVFINT 15/17 BR Dinnyes et al. (2000) 
Bovine MIl EG+DM+F+S Vitr IVFIICSI 25.8/16 BR Mavrides and Morroll (2002) 
Bovine MIl EG+DM+F+S Slow IVFIICSI 15.4/9.4 BR Mavrides and Morroll (2002) 
Bovine GV EG+DM+S Vitr IVF 6.1*BR Vieira et al. (2002) 
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Bovine MIl EG+DM+S Vitr Comet 26.1 Degen. Men et al. (2003b) 
Bovine MIl EG+DM+S Slow Comet 46 Degen. Men et al. (2003b) 
Bovine MIl EG+T+PVP Vitr NT 24BR Atabay et al. (2004) 
Bovine Mil EG+PR Vitr IVF 7.4BR Chian et al. (2004) 
Bovine GV EG+S Vitr IVM 44.5 MR Martins et al. (200S) 
Bovine MIl EG+DM+S Vitr IVF 2.SBR Albarracin et al. (200Sa) 
Bovine Mil EG+DM+S+F Vitr NT 16.3·BR Hou et al. (2005) 
Bovine GV EG+S+F Vitr IVF 8BR Abe et al. (2005) 
Bovine MIl EG+S Vitr IVFINT 12/33 BR Tominaga et al. (200S) 
Bovine GV EG+DM+S Vitr IVM 20MR Cetin and Bastan (2006) 
Bovine GV EG+DM+S Vitr IVF 2.3BR Kim et al. (2007) 
Bovine GV EG+DM Vitr IVM 29.2MR Yamada et al. (2007) 
Bovine MIl EG+DM+PVP Vitr IVF 2.6BR Horvath and Seidel (200S) 
Bovine GV EG+DM+S Vitr IVF 5.S· BR Vieira et al. (200S) 
Bovine Mil EG+DM+S Vitr IVF 3.2BR Morato et al. (200Sb) 
Bovine MU EG+S Vitr IVFINT • 0.917.4 BR Yang et al. (200S) 
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Bovine MIl EG+DM+S+F Vitr PA 23.2 BR Hou et al. (2009) 
Bovine MIl EG+T+PVP Vitr IVF 8BR Sripunya et al. (2010) 
Ovine GV EO+S Vitr NM 32.6MR Isachenko et al. (2001) 
Ovine MIl EG+DM+S Vitr NF 9.4BR Kelly et al. (2005) 
Ovine GV EG+DM+S Vitr IVM 12.7MR Silvestre et al. (2006) 
Ovine MIl EG+DM+S+F Vitr IVF 28.2 FR Tian et al. (2007) 
Ovine MIl EG+DM+S Vitr IVF 12.5 BR Succu et al. (2007a) 
Ovine MIl EG+DM+S Vitr NF 0 Succu et al. (2007b) 
Ovine MIl EG+DM+S Vitr IVF 34.3 CR Berlinguer et al. (2007) 
Ovine GV EG+DM Vitr IVF 31.2MR Bogliolo et al. (2007a) 
Ovine MIl EG+DM Vitr IVF 17BR Succu et al. (2008) 
Ovine MIl EG+DM+S Vitr IVF 2.6BR Zhang et al. (2009) 
Porcine GV EG Vitr IVM 5.6MR Isachenko et al. (1998) 
Porcine GV EG Vitr IVF OCR Rojas et al. (2004) 
Porcine MIl EO Vitr IVF 10.4 CR Rojas et al. (2004) 
Porcine GV EO Vitr ICSI 13.5 BR Fujihira et al. (2004) 
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Porcine MIl EG+T+PVP Vitr PA 2.6BR Somfai et al. (2006) 
Porcine MIl EG+DM+S+F Vitr PA OBR Shi et al. (2006) 
Porcine GV EG+S+PVP Vitr IVF 9.5BR Gupta et al. (2007) 
Porcine MIl EG+S+PVP Vitr IVF 3.4BR Gupta et al. (2007) 
Porcine MIl EG+T+PVP Vitr IVF 9BR Somfai et al. (2007) 
Porcine MIl EG+DM+S Vitr PA 1.3 BR Du et al. (2008) 
Porcine MIl EG+DM+S Vitr PA 3BR Lin et al. (2009) 
Porcine GV EG+T+PVP Vitr IVF 5.1 BR Somfai et al. (2010) 
Equine GV EG+S+F Vitr IVM 30MR Hurtt et al. (2000) 
Equine MIl EG+DM+S+F Vitr Morphology 73· Viable Maclellan et al. (2002) 
Equine GV EG Slow IVM 1.2MR Tharasanit et al. (2006a) 
Equine GV EG+DM+S Vitr IVM 27.6MR Tharasanit et al. (2006a) 
Equine MIl EG Slow ICSI 7.5CR Tharasanit et al. (2006a) 
Equine GV EG+DM+S Vitr ICSI 1 BR Tharasanit et al. (2006b) 
Equine GV EG+DM+S Vitr IVM 32.6MR Tharasanit et al. (2009) 
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Goat MIl EG+DM+S+F Vitr PA OBR Begin et al. (2003) 
Goat GV PR+T Vitr IVF 17.8 FR Kharche et al. (200S) 
Goat MIl PR+T Vitr IVF 8FR Sharma et al. (2006) 
Goat GV EG Vitr IVF 31.4 FR Garg and Purohit (2007) 
Buffalo GV EG Vitr IVF 13.S BR Wani et al. (2004b) 
Buffalo MIl EG+T+PVP Vitr PA 13.6 BR Bookusol et al. (2007) 
Buffalo MIl EG+T+PVP Vitr IVF I.SBR Gasparrini et al. (2007) 
Buffalo MIl EG+DM Vitr IVF S.SBR Gautam et al. (2008) 
Buffalo MIl DM Slow IVF 0.6BR Gautam et al. (2008) 
Buffalo GV EG+DM Vitr IVM 41.S MR Mahmoud et al. (2009) 
Buffalo MIl EG+DM Vitr IVF 7.8BR Attanasio et al. (2009) 
Cat GV EG+DM Vitr IVF 4.3BR Cocchia et al. (2010) 
Mouse MIl PR+S Slow IVF 43.7· BR Stacheki et al. (2002) 
Mouse GV DM+S Slow IVF 18.2 BR Ruppert-Lingham et al. (2003) 
Mouse MIl EG+DM+S+F Vitr ICSI StCR Endoh et al. (2007) 
Mouse MIl EG+DM+S Vitr Morphology 98 Viable Gomes et al. (2008) 
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Mouse MIl EG+DM+S+F Vitr IVF 76.1 BR Wang et al. (2009) 
Human MIl EG+S Vitr ICSI 65* Viable Kuleshova et al. (1999) 
Human GV EG+S Vitr IVF 23BR Hong et al. (1999) 
Human MIl PR+S Slow ICSI 58FR Fabbri et al. (2001) 
Human MIl EG+DM+S+F Vitr Morphology 83 Viable Liebermann and Tucker (2002) 
Human MIl PR+S Slow ICSI 59·FR Boldt et al. (2003) 
Human MIl EG+S+F Vitr ICSI 73.7* FR Saki and Dezfuly (2005) 
Human MIl EG+DM+S Vitr ICSI 94.3* CR Lucena et al. (2006) 
Human GV EG+DM+S Vitr IVM 71 MR Isachenko et al. (2006) 
Human MIl PR+S Slow PA 100CR Morbeck et al. (2009) 
Human MIl EG+DM+S Vitr PA 40CR Morbeck et al. (2009) 
GV: germinal vesicle; MIl: metaphase II; CPAs: cryoprotectants; EG: ethylene glycol; DM: DMSO; S: sucrose; T: trehalose; F: Ficoll; 
PR: 1-2 propanediol; PVP: polyvinylpyrrolidone; Vitr: vitrification; Slow: slow freezing; IVM: in vitro maturation IVF: in vitro 
fertilisation; ICS!: intracytoplasmic sperm injection; PA: parthenogenetic activation; NT: nuclear transfer; Comet: comet assay, BR: 
blastocyst rate; CR: cleavage rate; FR; fertilisation rate; MR: maturation rate; Degen: degeneration to DNA. * pregnancy and live births 
reported in these studies. 
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APPEND/XC 
VITRIFICATION OF BOVINE BLASTOCYSTS AND 
ESTABLISHEMENT OF PREGNANCY 
Achievement of pregnancy from vitrified blastocysts using Cryoloop 
Day 7 bovine blastocysts produced by in vitro maturation and in vitro fertilisation 
of Ovum Pick Up (OPU) oocytes were vitrified using the Cryoloop method 
applied in the present study. After storage in liquid nitrogen for one month, 
blastocysts (6) were thawed and then transferred to the synchronised recipient 
heifers. Pregnancy diagnosis was performed 45 days after transfer. One animal 
was diagnosed pregnant. This indicates that the Cryoloop vitrification technique 
applied in this study can use effectively for preservation of bovine blastocyst stage 
embryos. 
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